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Introduction 
 
The discovery of antibiotics was an enormous advance in medicine, which 
enabled mankind to fight bacterial diseases that could not be eradicated before. 
Nevertheless, with the ongoing process of bacterial resistance against (new) 
antibiotics, bacterial infections still pose a significant threat to human and animal 
health. Bacterial infections in humans can be categorized in multiple ways. A very 
easy way is the distinction between mono-infections, where only one bacterial 
species is the causative agent, and polymicrobial infections, where multiple bacterial 
species can be isolated from the site of infection. Mono-infections are well known to 
the general public because of news reports about Salmonella in chicken meat, 
methicillin resistant Staphylococcus aureus (MRSA) in hospitals and childhood 
immunization programs. Although less known to the public, community acquired as 
well as hospital acquired polymicrobial infections occur very frequently and can pose 
serious threats to human health.  
This thesis is focused on polymicrobial infections in the human intra-
abdominal cavity. The abdomen is located between the thorax and the pelvis. The 
abdominal cavity is lined by the peritoneum: a serous sac, consisting of mesothelium 
and a thin layer of irregular connective tissue, that covers most of the viscera 
(internal organs) contained therein. Some abdominal organs, like the kidneys, are 
located retroperitoneally, but retroperitoneal infections are not considered here. 
 
 
Intra-abdominal infections and peritonitis 
 
In clinical practice, the term intra-abdominal infection (IAI) is often used as a 
synonym for peritonitis. However, these two are not the same (Fig. 1). Peritonitis is 
defined as an inflammation of the peritoneum, but this is not necessarily caused by 
bacteria (Farthmann and Schöffel, 1998). IAIs comprise a heterogeneous group of 
conditions encompassing bacterial peritonitis, intra-abdominal abscesses and 
infections of intra-abdominal organs like appendicitis and pancreatitis (Farthmann 
and Schöffel, 1998). IAIs are a common cause of hospitalization with approximately 
two million intra-abdominal procedures carried out annually in the USA (Onderdonk 
et al., 1990). These infections can be community acquired (e.g. appendicitis, stab 
wounds or traffic accidents) or hospital acquired, often as a complication of intra-
abdominal surgery where the contents of the gut came into contact with the 
peritoneal cavity. 
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Fig. 1. Bacterial peritonitis in relation to intra-abdominal infections and peritonitis. 
 
 
The morbidity and mortality of IAI is significant. Data from hospitals in The 
Netherlands show that there are over 5300 new patients with serious forms of 
peritonitis each year (Bosscha et al., 1999). Extrapolated to the western world, this 
means that there must be more than half a million cases per year. Intra-abdominal 
abscesses occur in approximately 25% of patients treated for generalized peritonitis 
(Reijnen et al., 2003). Depending on the anatomic origin of the bacterial 
contamination, mortality ranges from 5 tot 50% (Brook, 1989; Farthmann and 
Schöffel, 1998). Complications like bacteremia and multiple-organ failure (MOF) 
frequently occur, increasing mortality rates up to 80% (Anaya and Nathens, 2003). 
IAIs have been found in 25% of the patients with MOF on a surgical intensive care 
unit (ICU) (Darling et al., 1988). The high morbidity of peritonitis indicates that the 
annual cost of treatment of these infections is significant. 
Bacterial peritonitis can be divided into three classes (Farthmann and 
Schöffel, 1998; Marshall, 2004). Primary peritonitis refers to spontaneous bacterial 
invasion of the peritoneal cavity. This mainly occurs in cirrhotic and immuno-
compromised patients and the infections are characteristically aerobic and 
monomicrobial (Wittmann et al., 1996). Secondary peritonitis refers to peritoneal 
infections secondary to intra-abdominal lesions like perforation of the hollow viscus, 
bowel necrosis or penetrating infectious processes. Tertiary peritonitis is defined as 
peritonitis arising at least 48 hours after the apparently successful treatment of 
primary or secondary peritonitis. It is characterized by persistent or recurrent 
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infections with organisms of low intrinsic virulence that are different from the 
organisms involved in primary or secondary peritonitis and it has a significant 
mortality. 
 
 
Host defense systems 
 
Once peritoneal contamination occurs, the body attempts to defend against 
this invasion with powerful mechanisms devised to deal with breaches in the integrity 
of the gut (Table 1) (reviewed by Hall et al., 1998). The first mechanism involves 
physical clearance of the infectious agent using the circa 100 ml of serous peritoneal 
fluid (Robinson, 1962). Bacteria are removed through gaps (stomata) in the 
mesothelial lining of the diaphragm into the lymph system (Tsilibary and Wissig, 
1983; Nakatani et al., 1996). The second mechanism is destruction of the bacteria 
using the innate immune system. Complement activation is involved in the 
opsonization of microorganisms, enhancement of inflammatory responses, clearance 
of immune complexes and cell lysis (Pascual and French, 1995). The migration of 
polymorphonuclear neutrophils (PMNs) into the peritoneum is enhanced and also 
other cells of the innate immune system like macrophages and mast cells are 
involved (Caldwell and Watson, 1994). 
 
 
Table 1. Host defense systems in peritoneal infections 
 
System Mechanism 
1. Clearance Serous peritoneal fluid 
Stomata 
2. Innate immune system Polymorphonuclear neutrophyls 
Macrophages and mast cells 
3. Abscess formation Coagulation favored over fibrinolysis 
Fibrin clot formation 
 
 
The third defense mechanism of the peritoneal cavity is containment of the 
infection as an abscess. This is the result of a shift in the balance between the 
coagulation and fibrinolysis systems in favor of coagulation (van Goor et al., 1994; 
Vipond et al., 1994). Tissue thromboplastin converts prothrombin to thrombin, which 
polymerizes fibrinogen in the peritoneal fluid to form fibrin networks. Bacteria become 
physically trapped in these fibrin clots, by which bacterial spread is prevented and the 
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formation of abscesses is promoted (Zinsser and Pryde, 1952). In healthy individuals, 
enzymes of the fibrinolytic system readily dissolve fibrin, but inflammation inactivates 
this system. This mechanism of bacterial localization in abscesses decreases the 
early rapid mortality that would otherwise be associated with bacterial peritonitis 
(Rotstein, 1992). However, as bacteria within fibrin deposits are protected from host 
clearance mechanisms and phagocytosis, bacterial proliferation can occur rather 
unopposed and a persistent infection can be established (Rotstein, 1992). As will be 
discussed below, several bacterial species can produce specific virulence factors that 
actively interfere with the host fibrinolytic system, thereby promoting either the 
formation or dissolution of fibrin clots. 
  
 
Microbiology of peritonitis 
 
Normal intestinal flora consists of many bacterial species, e.g. in the colon 
alone more than 400 species of anaerobic bacteria can be found (Savage, 1977). 
Therefore, the initial microflora entering the peritoneal cavity upon a breech in the 
integrity of the gut is always polymicrobial. Nevertheless, only a very limited number 
of different bacterial species is recovered from intra-abdominal abscesses (Hau et 
al., 1979; Wittmann et al., 1996; Farthmann and Schöffel, 1998). Escherichia coli is 
the aerobic Gram-negative species most often isolated from IAI (32-61%) and 
Bacteroides fragilis is the most frequently isolated anaerobic bacterium (circa 46%) 
(Hau et al., 1979; Brook, 1988; Goldstein and Citron, 1988; Aldridge, 1995; 
Farthmann and Schöffel, 1998). Precise numbers are difficult to obtain from the 
literature, because of differences in the inclusion of groups of species or isolation 
sites in the calculation. Enterococci and streptococci are the most frequently isolated 
gram-positive species from IAI (Hau et al., 1979; Farthmann and Schöffel, 1998). 
The frequent isolation of both E. coli and B. fragilis from bacterial peritonitis 
has led to the concept of bacterial synergy between these species (Fig. 2) (Meleney 
et al., 1932; Altemeier, 1942). This concept has been worked out in studies with 
experimentally induced infections in mice (Brook et al., 1984; MacLaren et al., 1984) 
and in rats (Onderdonk et al., 1974; Onderdonk et al., 1976; Dunn et al., 1984; 
Rotstein et al., 1985a). Synergism was assayed as the induction of sepsis or 
abscesses or as an increase in death count. In 1985, Brook demonstrated in mice 
mutual enhancement of growth between E. coli and B. fragilis in induced 
subcutaneous abscesses (Brook, 1985). In 1991, Verweij et al. developed a model 
for experimental peritonitis in rats using a fibrin clot model (Verweij et al., 1991) that 
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was modified by Bosscha et al. to create a standardized and reproducible model of 
IAI (Bosscha et al., 2000). In the later studies, bacterial counts were measured of 
both E. coli and B. fragilis in mixed infections and compared to the cell counts from 
the same organisms in mono infections. The synergistic effect between both species 
was demonstrated by the increased numbers of viable cells isolated from the site of 
infection and the ability to induce persistent infection only in the presence of both 
species. 
 
 
Fig. 2. Interactions between E. coli, B. 
fragilis and the human host in bacterial 
peritonitis. The positive interactions 
between E. coli and B. fragilis indicate 
the microbial synergy between the two 
species. 
 
 
 
 
 
 
 
 
 
Virulence factors in bacterial synergy 
 
The molecular basis of the synergy between E. coli and B. fragilis in bacterial 
peritonitis is only partially understood. At least two classes of virulence mechanisms 
can be identified in this context: the inhibition of phagocytosis by polymorphonuclear 
neutrophyls (PMNs) and the provision of essential growth factors (Table 2). It has 
been observed that obligate anaerobes, including B. fragilis, can inhibit phagocytosis 
of various aerobic species (Ingham et al., 1977; MacLaren et al., 1984). The 
inhibitory effect of B. fragilis on PMN function is caused by the secretion of short-
chain fatty acids (Rotstein et al., 1989b) and succinic acid (Hart et al., 1986). Also the 
polysaccharide capsule of B. fragilis appears to play an important role in this 
phenomenon (Rotstein et al., 1985b). In this respect it is noteworthy that most B. 
fragilis strains isolated from abscesses or blood infections are encapsulated, 
whereas only 10% of the strains isolated from faeces of healthy individuals is 
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encapsulated (Brook et al., 1992). Besides inhibition of phagocytosis, the 
encapsulation of B. fragilis has been reported to promote adhesion to the peritoneal 
wall (Rotstein et al., 1985b), improve resistance to oxygen exposure (Patrick et al., 
1984) and increase resistance to penetration of antibiotics (Brook and Gillmore, 
1994). Encapsulated strains of B. fragilis and even purified capsule alone can induce 
abscess formation (Zaleznik and Kasper, 1982; Tzianabos et al., 1993). 
 
 
Table 2. Virulence factors in the synergy between E. coli and B. fragilis 
 
1. Inhibition of phagocytosis by polymorphonuclear neutrophyls 
  - Secretion of short-chain fatty acids 
  - Secretion of succinic acid 
  - Encapsulation 
   + Promotes cell adhesion 
   + Increases oxygen resistance 
   + Increases antibiotic resistance 
   + Induces abscess formation 
2. Provision of essential growth factors 
  - Iron and heme acquisition 
3. Production of β-lactamases 
4. Secretion of tissue-destructing proteases 
5. Provision of an anaerobic environment 
 
 
Proteins secreted by E. coli or B. fragilis can aid in the provision of essential 
growth factors and nutrients to either or both species. For instance, the human body 
keeps the concentration of free iron extremely low (circa 10-18 to 10-24 M (Braun, 
2001; Bullen et al., 2005)) by keeping iron in a protein-bound form in the circulation 
(e.g. in transferrin, lactoferrin, hemoglobin and albumin). Bacteria need much higher 
concentrations of iron to maintain growth (circa 1 µM) (Weinberg, 1974) and have 
developed highly specialized mechanisms to acquire iron or heme (recently reviewed 
by Wandersman and Delepelaire, 2004). Otto et al. identified a hemoglobin protease 
(Hbp) secreted by E. coli that contributes to the synergistic abscess formation and 
heme-dependent growth of B. fragilis in a mouse infection model (Otto et al., 1998; 
Otto et al., 2002). Hbp degrades hemoglobin in vitro and binds the released heme 
group. It has been proposed that heme-bound Hbp provides the heme as an iron or 
heme source to the bacteria in peritoneal infections. This would match the 
observation that the presence of hemoglobin within the peritoneal cavity enhances 
mortality rates in peritonitis (Yull et al., 1962). Otto has found that B. fragilis 
possesses hemolysin activity, especially upon conditions of iron-starvation (B.R. 
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Otto, unpublished observations). In fact, as many as nine functional hemolysin 
proteins have been characterized in B. fragilis (E.R. Rocha and coworkers, 
unpublished observations). These findings underline the importance of iron provision 
during infections. 
Other factors that have been implicated in the synergy between E. coli and 
B. fragilis are the production of β-lactamases by B. fragilis, greatly increasing the 
tolerance of E. coli to β-lactam antibiotics (Bryant et al., 1980; Cuchural and Tally, 
1986; Aldridge et al., 1994), the secretion of proteases that cause tissue destruction 
(collagenases and hyaluronases) and the provision by E. coli of an anaerobic 
environment for B. fragilis, and also inhibiting neutrophyl killing (Aldridge, 1995). In 
our lab, several proteins have been found in B. fragilis that could potentially function 
as virulence factors in pathogenic synergy. These include a putative extracellular 
protease of circa 30 kDa, a putative mucin-binding protein of 44 kDa, an adhesion 
protein of circa 40 kDa, the α-enolase (46 kDa) that is an iron-regulated heme-
binding protein, as well as a 60 kDa putative plasminogen-binding protein (Pbp). The 
first three proteins await further characterization. The characterization of the two 
latter proteins is described in two chapters of this thesis. The potential role of the α-
enolase and of the Pbp in virulence still has to be investigated. For E. coli, the results 
from the murine infection model (Otto et al., 2002) indicate that Hbp very likely acts 
as a virulence factor in vivo. 
 
 
Bacterial iron and heme uptake systems 
 
Iron in biological systems 
Iron is an essential compound for most living organisms, including bacteria 
and man. It serves as a catalytic center of enzymes for redox reactions, either alone 
or incorporated into heme or iron-sulfur clusters. However, free iron ions cannot be 
used by living organisms, because under aerobic conditions oxidized iron (FeIII) in 
solution forms insoluble complexes and ferrous iron (FeII) is readily converted into 
FeIII in the presence of oxygen with concomitant production of free radicals that can 
damage biological macromolecules (Ratledge and Dover, 2000; Braun and Braun, 
2002b). Iron in biological systems is therefore almost exclusively liganded to carrier 
proteins and the concentrations of free iron are kept very low (circa 10-18 to 10-24 M) 
(Bullen, 2005; Braun, 2001). Pathogenic bacteria in the human host are confronted 
with a serious problem, because they need micromolar concentrations of iron for their 
survival and growth (Braun, 2001). Therefore, bacteria have evolved several 
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mechanisms to acquire iron from the various sources in the human body (recently 
reviewed by Wandersman and Delepelaire, 2004). In Gram-negative bacteria, like E. 
coli and B. fragilis, these mechanisms rely on specific outer membrane receptors that 
recognize the various iron and heme-containing molecules (Fig. 3) (Braun and Braun, 
2002a). Two classes are distinguished. The first class involves a direct recognition 
between the receptor and the iron- or hemesource from the host, the second class 
involves the secretion of scavenger molecules that sequester iron or heme from 
these sources and deliver it to the bacterium. The various uptake systems more or 
less converge once the iron or heme is transported into the cell through the outer 
membrane receptors. 
 
 
 
Fig. 3. Iron and heme uptake systems in Gram-negative bacteria. On the upper half of the 
schematic cell, direct binding of the iron or heme compound to an outer membrane receptor is 
depicted. On the lower half, iron or heme is sequestered by actively secreted siderophores or 
hemophores, respectively. All known outer membrane receptors are TonB-ExbB-ExbD 
dependent (omitted for clarity). Import into the cytoplasm involves an ATP-binding cassette 
(ABC) protein dependent inner membrane protein. Question marks indicate uncertain 
pathways. TF = transferrin of lactoferrin, Hb = hemoglobin, Hp-Hb = haptoglobin-hemoglobin, 
FeII = ferrous iron, FeIII = ferric iron, OM = outer membrane, PP = periplasm, IM = inner 
membrane. 
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Iron sources in the human body 
Potential iron sources in the human host are FeII, transferrin and lactoferrin 
and ferritins. FeII is the major form of free iron under anaerobic or reducing 
conditions (Wandersman, 2004), which is supposed to be the situation in peritoneal 
infections. Although available in only very low concentrations, the ion is highly soluble 
and freely diffuses through bacterial outer membrane porins. Transport across the 
inner membrane is carried out by an ATP binding cassette (ABC)-type ferrous ion 
transporter conserved in many bacteria (Kammler et al., 1993). Transferrin (Tf) is 
found in serum, whereas lactoferrin is found in lymph and mucosal secretions. Both 
proteins are glycoproteins of circa 80 kDa with a very high affinity for FeIII (Ka ~1020 
M-1). They function as iron chelators protecting the body against iron toxicity. Tf has 
an iron transport function. Many bacterial species have Tf and/or lactoferrin uptake 
systems, of which the Neisserial Tbp system is the best characterized (Cornelissen, 
2003). Transferrin can be bound by two outer membrane proteins, TbpA and TbpB. 
TbpA is a classical receptor molecule that is essential for the receptor function and 
TbpB is a surface localized lipoprotein that is not necessarily required (Boulton et al., 
1999). The mechanism of iron transfer from Tf to TbpA is unknown. However, once 
the iron molecule is translocated to the periplasm, it is bound by the periplasmic 
protein FbpA (Gomez et al., 1998). Similar receptors exist in Neisseria for lactoferrin 
(LbpAB) (Pettersson et al., 1998; Schryvers et al., 1998). Ferritins are intracellular 
iron storage proteins (Carrondo, 2003). Although ferritins can be found in plasma as 
a consequence of cell lysis, there is no evidence that they are used as iron sources 
by bacteria. 
 
Heme sources in the human body 
Potential heme sources in humans are free heme, hemoglobin (Hb), 
haptoglobin-hemoglobin, hemopexin, albumin and other hemoproteins. Heme (iron 
protoporphyrin IX) is a constituent of many enzymes, but because of its high toxicity it 
is hardly freely available. Nevertheless, a heme receptor (HemR) has been described 
in Yersinia enterocolitica (Bracken et al., 1999). This receptor can actually bind both 
heme and hemoglobin. The bacterial requirements for heme are a factor 103 lower 
than that for iron. Hemoglobin is the oxygen transporter molecule in red blood cells. It 
is an α2-β2 tetramer with each subunit binding one heme molecule (Perutz et al., 
1960). Upon lysis of red blood cells, possibly by the action of bacterial hemolysins in 
an infection, hemoglobin becomes available as a heme source to bacteria. 
Hemoglobin receptors have been found, for instance in Neisseria meningitides 
(HmbR) (Richardson and Stojiljkovic, 1999). Once released from red blood cells, 
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hemoglobin rapidly oxidizes to methemoglobin, which quickly dissociates into α-β 
dimers. These dimers bind heme with a lower affinity, and therefore it can be difficult 
to make a clear distinction between heme and hemoglobin utilization by bacteria. 
Hemoglobin from lysed red blood cells is normally bound with a high affinity by 
haptoglobin (Evans et al., 1999). The haptoglobin-hemoglobin complex is cleared 
from the circulation in the liver and then degraded. Heme that is released from 
hemoglobin subunits in the body is quickly bound by hemopexin (Paoli et al., 1999). 
Heme-hemopexin is also transported to the liver, where heme is taken off and 
hemopexin is recycled. No direct bacterial binding of heme-hemopexin has been 
demonstrated so far, but a putative haptoglobin-hemoglobin receptor (HpuAB) from 
N. meningitidis has been described (Lewis et al., 1997). Specialized receptors for 
hemo-albumin or other hemoproteins (e.g. myoglobin or cytochrome b) have not 
been found so far. Upon comparison of the known heme, hemoglobin and 
hemoglobin-haptoglobin receptors, it was found that they all contain several highly 
conserved histidine residues as well as two conserved motifs: the FRAP and NPNL 
boxes (Bracken et al., 1999). It is expected that these conserved residues and motifs 
are directly involved in the recognition and internalization of the heme molecules. 
 
Bacterial iron- and heme-scavenging systems 
Besides the ability to bind iron or heme sources directly, many 
microorganisms can excrete siderophores and/or hemophores to capture iron or 
heme and shuttle it back into the cell. Siderophores are small iron-chelating 
molecules with a very high affinity for FeIII (the calculated affinity constant being 
above 1030 M-1). In the more than 500 different siderophores, three chemical types of 
iron ligation groups are distinguished (Drechsel and Jung, 1998): hydroxamates (e.g. 
aerobactin and ferrichrome), catechol rings (e.g. enterobactin) and hydroxyacids (e.g. 
pyochelin). Little is known about the excretion of siderophores. One report describes 
that EntS, a proton-motive force dependent membrane efflux pump, is directly 
involved in enterobactin export (Furrer et al., 2002). In the extracellular environment, 
the high affinity of siderophores for iron is expected to extract iron from the host iron 
sources. Ferrisiderophores are recognized at the cell surface of Gram-negative 
bacteria by outer membrane receptors like FhuA (for enterobactin) and FepA (for 
ferrichrome) of E. coli. The crystal structures of both proteins reveal that they are 
very similar, with a 22-stranded β-barrel spanning the outer membrane and a central 
channel that contains a molecular plug or “cork” (Fig. 4) (Ferguson et al., 1998; 
Locher et al., 1998; Buchanan et al., 1999). The ferrisiderophores are internalized 
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through the channel upon structural rearrangement of the barrel and dislocation of 
the plug (Ferguson and Deisenhofer, 2004).  
Hemophores, that are yet only found in Gram-negative bacteria, are defined 
as specialized extracellular proteins that acquire heme from diverse sources and 
bring it to a specific outer membrane receptor (Wandersman and Delepelaire, 2004). 
These molecules capture free heme or extract heme from hemoglobin in the 
extracellular environment. A family of hemophore systems called HasA (heme 
acquisition system) has been described in Serratia, Pseudomonas and Yersinia 
species. In most species, the secretion apparatus, the hemophore and the outer  
 
 
 
Fig. 4. Comparison of the FhuA 
and FepA crystal structures 
(PDB indentifiers 1QJQ and 
1FEP). Side and top views are 
shown. In the side views, part 
of the β-strands was deleted to 
visualize the central globular 
domain (cork structure). Figure 
adapted from (Braun and 
Braun, 2002b). 
 
 
 
 
 
 
 
 
 
 
membrane receptor are encoded by genes located in one operon (Ghigo et al., 
1997). The hemophore is secreted by ABC transporters consisting of an inner 
membrane ATPase, a membrane fusion protein and an outer membrane protein 
belonging to the TolC family (Létoffé et al., 1994). TolC forms a β-barrel in the outer 
membrane and has a large periplasmic domain that forms a tunnel between the inner 
and outer membranes (Koronakis et al., 2000). The secretion of HasA is also 
dependent on the cytosolic SecB chaperone (Delepelaire and Wandersman, 1998). 
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Heme is extracted from heme carriers like hemoglobin, hemopexin or hemo-albumin 
due to the high affinity of HasA for heme (a Kd of 10-11 M) and it binds to HasA in a 
1:1 stoichiometry (Izadi et al., 1997). The hemophore is recognized at the cell surface 
by the outer membrane receptor HasR, which can also bind heme and hemoglobin 
directly (Létoffé et al., 1999). A second hemophore system is the HxuA system of 
Haemophilus influenzae. This system is required for heme and heme-hemopexin 
utilization by this species (Cope et al., 1995). HxuA is a 100 kDa hemophore, that is 
dependent for its secretion on HxuB that forms a β-barrel in the outer membrane 
(Cope et al., 1994). This type of secretion pathway is designated the two-partner 
secretion pathway and is related to the autotransporter pathway that is described 
below. After binding of heme-loaded hemopexin, the complex is recognized by the 
outer membrane receptor HxuC (Cope et al., 1995). This receptor can also bind 
heme and hemoglobin directly. 
 
Internalization of captured heme and iron molecules 
Once the iron, the iron-loaded siderophore or heme is bound by the outer 
membrane receptor, the molecules are generally internalized by a conserved 
mechanism that involves the TonB complex (Frost and Rosenberg, 1975). This 
cytoplasmic membrane complex, consisting of TonB, ExbB and ExbD in the ratio 
1:7:2 (Higgs et al., 2002), transduces energy from the proton motive force to allow 
substrate internalization into the periplasmic space. The involved outer membrane 
receptors contain a stretch of five conserved residues, the TonB box, close to their N-
termini (reviewed in Braun, 2003 and Faraldo-Gomez and Sansom, 2003). Although 
many details about the events in this process are still unknown, it is assumed that 
substrate binding to the receptor triggers conformational changes of the plug and 
induces closure of the outside loops of the barrel around the substrate (reviewed in 
Ferguson and Deisenhofer, 2004). The action of the TonB complex, contacting the 
TonB box, is proposed to displace the plug from the β-barrel and allow transfer of the 
substrate into the periplasm (Fig. 5). In the periplasmic space, a periplasmic binding 
protein immediately picks up the substrate. Periplasmic FeIII binding proteins (FbpA) 
with an extremely high affinity for iron (Kd 10-18 M) have been found and were 
crystallized from Haemophilus and Neisseria species (Adhikari et al., 1995; 
Dhungana et al., 2003). Periplasmic siderophore binding proteins have been 
characterized in E. coli (e.g. FhuD and FebB) (Sprencel et al., 2000; Clarke et al., 
2002) and homologues of FhuD are present in Staphylococcus aureus (Sebulsky et 
al., 2003). Their affinities for siderophores are in the micromolar or nanomolar range. 
Subsequent transport of the substrate across the cytoplasmic membrane is carried 
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out by an inner membrane ATPase complex (ABC permeases) (Koster, 2001). These 
are found in both gram-positive and Gram-negative bacteria. 
Not much is known about the intracellular fate of iron and heme. Two 
processes have been proposed for the release of iron from siderophores. Either the 
iron is released from the siderophore upon reduction by electron donors and the 
siderophore is recycled (Müller et al., 1998), or the siderophore is degraded 
intracellularly, releasing the iron molecule (Brickman and McIntosh, 1992). Iron is 
stored intracellularly in ferritins, found in most living organisms, or bacterioferritins, 
only found in bacteria. Both types are composed of 24 identical subunits forming a 
spherical structure with the capacity to store about 5000 iron ions (Carrondo, 2003). 
Besides, bacterioferritins contain up to twelve heme groups of unknown function. 
Acquired heme molecules are either degraded by heme oxygenases to be used as 
an iron source (Zhu et al., 2000), or stored. Heme storage proteins are not known so 
far, but several proteins first considered to be heme oxygenases (e.g. HemS and 
ShuS) are now suspected to be heme storage proteins (Wilks, 2001). 
 
Fig. 5. Iron-loaded siderophore import. Ferrichrome is recognized by the outer membrane (OM) 
receptor FhuA. The β-strands in the front were deleted to visualize the cork structure. 
Ferrichrome binding induces conformational changes of the receptor, resulting in TonB-ExbB-
ExbD mediated displacement of the cork. Ferrichrome transport through the periplasm (PP) 
involves the periplasmic chaperone FhuD. A structural change of FhuD is predicted when it 
binds to the inner membrane (IM) permease FhuB. FhuC is an ATPase that provides the 
energy for transport of the siderophore across the inner membrane. Figure adapted from 
(Braun, 2001). 
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Regulation of the iron- and heme-uptake systems 
Most iron and heme uptake genes are negatively regulated by FeII-binding 
metalloproteins. The prototype of these molecules is the E. coli protein Fur (ferric 
uptake regulator) (Hantke, 1981). Iron-loaded Fur binds as a dimer to a 19-bp 
consensus sequence located near or within iron-regulated promoters (Baichoo and 
Helmann, 2002). Fur regulation also exists in B. fragilis, but the consensus sequence 
of the Fur-box differs from that in E. coli and remains to be elucidated (E.R. Rocha, 
personal communication). Fur-like repressors are characterized by a low affinity for 
FeII (Kd 10-5 M) (Wee et al., 1988). Because of this, a small change in the 
intracellular iron concentration may induce large changes in Fur iron load and 
therefore in the transcriptional level of Fur-regulated genes. Depending on the 
bacterial species, 50 to 100 genes are negatively regulated by Fur, including genes 
for iron and heme acquisition, acid resistance and virulence factors (McHugh et al., 
2003). All these types of genes can play important roles in an infection situation. 
 
Otto et al. have characterized a novel E. coli protein called Hemoglobin 
protease (Hbp). It belongs to the autotransporter type of proteins described below 
and is a 111 kDa secreted serine protease (Otto et al., 1998). In the extracellular 
environment, it can degrade hemoglobin by a so far unknown mechanism. 
Subsequently, it binds the released heme from that molecule and delivers it to a 
putative outer membrane receptor of E. coli and/or B. fragilis that still has to be 
identified. Based on what is described above, Hbp can be considered a hemophore, 
somewhat resembling the HxuA system. 
 
 
Coagulation and fibrinolysis 
 
Pathogenic bacteria often possess virulence factors that influence the 
balance between coagulation and fibrinolysis in the host organism. In the normal 
situation in the human body, there is a well-regulated balance between these two 
mechanisms responsible for the maintenance of the endothelial cell lining (reviewed 
by Norris, 2003). Upon minor or more extensive damage to the endothelium, platelets 
adhere to the subendothelium and activate the coagulation cascade (Stassen et al., 
2004). This cascade involves the activation of a range of inactive zymogens and 
cofactors by proteolytic cleavage (Fig. 6). Two main pathways are traditionally 
distinguished: the intrinsic or contact pathway and the extrinsic or tissue factor 
pathway. However, more recent evidence shows that these two pathways are not so 
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independent and that the main function of the intrinsic pathway may be to amplify the 
coagulation activation triggered by the extrinsic pathway (Hoffman, 2003; Norris, 
2003). Tissue factor is the only cofactor that is always present in an active form. 
Upon vascular injury, membrane bound tissue factor is exposed to plasma and can 
bind factor VII (Morrisey, 2001). This complex activates the cascade of blood clotting 
factors, starting with factor IX and X. These factors are activated to form  
 
 
Fig. 6. The coagulation cascade and the fibrinolytic pathway. The coagulation cascade shows 
both intrinsic and extrinsic activation, inhibitors (blocks) and feedback activation (dashed lines). 
Fibrin (gray box) is the endproduct of the coagulation cascade. ?a = activated form of factor ?, 
HMWK = high molecular-weight kininogen, CI-inh = CI-inhibitor, TF = tissue factor, TFPI = 
tissue factor pathway inhibitor, PL = phospholipids, Ca = calcium, AT = antithrombin, tPA = 
tissue plasminogen activator, uPA = urokinase plasminogen activator, PAI-I = plasminogen 
activator inhibitor I, TAFI = thrombin activatable fibrinolysis inhibitor, FDPs = fibrin degradation 
products. Figure adapted from (Norris, 2003). 
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factor IXa and Xa, respectively. The intrinsic pathway through factors XII and XI can 
also activate factor IX. Activated factor IX forms a complex with factor VIIIa, calcium 
and phospholipids and activates factor X to Xa. When factor Xa is bound to factor Va 
and a phospholipid membrane surface, inactive prothrombin is converted to α-
thrombin, a serine protease (Nesheim et al., 1979). Thrombin has multiple functions 
in haemostasis: the conversion of fibrinogen to fibrin, the activation of platelets, 
factors V, VIII and IX, and the activation of coagulation inhibitors (Brummel et al., 
2002). These multiple functions are possible because of the multiple binding sites on 
α-thrombin. Fibrin formation is a multistep process, starting with the cleavage of 
dimeric fibrinogen by thrombin to form soluble fibrin monomers. Non-covalent 
interactions result in the formation of fibres that aggregate to form a mesh. Finally, 
this network is stabilized by cross-linking induced by activated factor XIIIa (Weisel, 
1986). The coagulation pathways are tightly controlled with respect to place and time 
to avoid massive fibrin deposition. A series of anticoagulant proteins and cofactors 
bind to activated coagulation factors, limiting their period of activity. These include 
tissue factor pathway inhibitor (TFPI), antithrombin, CI inhibitor and the protein C 
anticoagulant pathway (Kisiel, 1979; Fuchs et al., 1982; Pixley et al., 1985; Broze, 
1995). 
Besides this negative regulation of coagulation, the fibrinolytic system acts to 
limit fibrin clot formation and dissolve fibrin clots (Fig. 6, lower part). Fibrin is 
degraded by the serine protease plasmin into fibrin degradation products (FDPs). 
Plasmin is formed by activation of plasminogen, a zymogen circulating in the 
bloodstream (Castellino, 1984). The major activator of plasminogen is tissue 
plasminogen activator (tPA), a serine protease produced by endothelial cells 
(Camiolo et al., 1971; Lijnen and Collen, 1995). Urinary type plasminogen activator 
(uPA) or urokinase can also activate plasminogen. This is important in tissues where 
plasmin degrades extracellular matrix proteins, facilitating migration of cells important 
for wound healing (Plow et al., 1999). The fibrinolytic system is negatively regulated 
by inhibition of plasmin function and inhibition of plasminogen activation. In plasma, 
plasmin is rapidly bound by α2-antiplasmin in an irreversible fashion (Wiman and 
Collen, 1978). Plasmin attached to fibrin is less rapidly bound by antiplasmin 
because fibrin already occupies the lysine binding sites of plasmin that are also used 
by antiplasmin. Plasminogen activation is inhibited by plasminogen activator inhibitor 
I (PAI-I) and others (Chandler et al., 1990). 
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Bacterial pathogenesis and haemostasis 
 
The finely tuned system of coagulation and fibrinolysis also plays an 
important role in the host defense against intra-abdominal infections. As described 
earlier, upon an infection, the balance between the two systems shifts in favor of 
coagulation. This results in the formation of peritoneal fibrin clots into which bacteria 
become trapped, which eventually results in abscess formation. Conversely, bacteria 
have been shown to actively interfere with the fibrinolytic system for their 
pathogenesis in several ways (Lähteenmäki et al., 2005). Several pathogenic species 
produce plasminogen activators (PAs), enhance plasminogen activation by host PAs, 
influence the production of host PAs or PA inhibitors (PAIs) or inhibit host 
antiplasmins (reviewed in Lähteenmäki et al., 2001). Also, various bacteria can 
immobilize plasminogen or plasmin on their cell surface, converting the cell into a 
proteolytic organism. This gives the bacteria the capability to dissolve fibrin clots in 
which they have become trapped and/or degrade basal membranes and extracellular 
matrix proteins to be able to cross tissue barriers and become invasive. When 
immobilized on the cell surface, host or bacterial plasminogen activators more easily 
activate plasminogen and bound plasmin is protected against rapid inactivation by α2-
antiplasmin. 
Various candidate receptors on the bacterial cell surface have been 
described in the last decade (those up to 2001 are listed in Lähteenmäki et al., 2001). 
Importantly, most bacterial plasminogen receptors have other, in many cases 
essential, functions such as adhesion, movement or metabolism. This complicates 
the research into these molecules, because specific mutations or deletions can often 
not be made. Well-characterized types of plasminogen receptors are the α-enolases. 
These proteins have an essential function in glycolysis or gluconeogenesis, 
catalyzing the interconversion between 2-phosphoglycerate and phosphoenol-
pyruvate. Recently it was discovered that α-enolase is also present on the cell 
surface of mammalian, fungal, nematode and bacterial cells, functioning as a 
plasminogen receptor (Redlitz et al., 1995; Pancholi and Fischetti, 1998; Bergmann 
et al., 2001; Jolodar et al., 2003; Jong et al., 2003). The plasminogen-binding site to 
α-enolase of Streptococcus pyogenes was thought to comprise the two C-terminal 
lysine residues (Derbise et al., 2004). However, the recently published crystal 
structure of S. pneumoniae α-enolase reveals that the enolase is present in an 
octamer in which the C-terminal lysines are shielded off from the molecular 
environment (Ehinger et al., 2004). Instead, an internal motif of nine amino acids 
(FYDKERKVY) that has been identified by the same authors earlier to be important 
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for plasminogen-binding, is exposed to the surface of the octamer (Bergmann et al., 
2003). Plasminogen-binding has been shown in vivo to be required for the efficient 
transmission and invasion of Borrelia burgdorferi, the causative agent of Lyme 
disease (Coleman et al., 1997). Others have identified a plasminogen-binding protein 
on the cell surface of B. burgdorferi (Hu et al., 1997). This protein also contains two 
C-terminal lysine residues but not the FYDKERKVY motif. 
Human plasminogen is a glycoprotein zymogen that is abundant in plasma 
(circa 2 µM). Its polypeptide is composed of a heavy chain (65 kDa), containing an N-
terminal peptide and five triple-disulfide bonded kringle (K) domains, and a light chain 
(25 kDa) containing the protease domain (Pollanen et al., 1991). The crystal 
structures of the individual K1, K4 and K5 domains reveal that the lysine binding site 
motifs are preformed and localized to the surfaces of the K domains (e.g. Chang et 
al., 1998). The binding of plasminogen to lysine-exposing molecules induces marked 
conformational changes of plasminogen (Andronicos et al., 2000; Lähteenmäki et al., 
2005), making it more accessible for plasminogen activators and at the same time 
protecting plasmin against inactivation by α2-antiplasmin. 
The role of plasminogen-binding by pathogens in bacterial peritonitis is so far 
not specifically investigated. In B. fragilis a protein of circa 60 kDa, now designated 
Pbp, has been found that may be responsible for plasminogen-binding to the 
bacterial cell surface (Otto et al., this laboratory). The α-enolase of B. fragilis has also 
been analyzed and it is not a plasminogen-binding molecule. The contribution of Pbp 
to the virulence of B. fragilis in peritonitis and the synergy with E. coli is currently 
under investigation. 
 
 
Autotransporter proteins 
 
The autotransporter secretion pathway 
An important class of virulence factors in Gram-negative bacteria is the class 
of the autotransporter proteins (Henderson and Nataro, 2001). The name relates to 
the fact that autotransporters carry all signals necessary for their targeting to and 
translocation across the inner and outer membranes within one (pre) protein (Fig. 7). 
No accessory periplasmic or outer membrane proteins appear to be needed. 
However, this concept has been challenged by recent findings as discussed below. 
The prototype of autotransporter proteins is the immunoglobulin A1 (IgA1) protease 
of Neisseria gonorrhoeae, described by Pohlner et al (Pohlner et al., 1987). The 169-
kDa IgA1 precursor encodes three functional domains: an N-terminal signal peptide 
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that directs inner membrane targeting and translocation, the secreted IgA1 protease 
and a C-terminal domain that directs translocation across the outer membrane. The 
authors proposed that the C-terminal domain encodes a pore-forming structure in the 
outer membrane that facilitates the transport of the protease. Since that time, many 
more proteins with this type of design have been described in various species of 
Gram-negative bacteria, all containing the modular structure of signal peptide, 
passenger domain and translocation unit in one preprotein (Jose et al., 
 
 
Fig. 7. Schematic overview of 
autotransporter secretion. The 
functional domains are the signal 
peptide, the passenger domain, 
the linker region and the β-domain. 
The latter two form the 
translocation unit. The complete 
pre-pro-protein is synthesized in 
the cytoplasm and translocated 
across the inner membrane 
through the Sec translocon. After 
cleavage of the signal peptide, the 
pro-protein travels through the 
periplasm and the β-domain 
inserts into the outer membrane as 
a pore. According to the classical 
model, the passenger domain is 
translocated through the β-barrel 
pore and cleaved off on the cell 
surface by either autoproteolysis or 
another protease. The arrowheads 
and scissors indicate the signal 
peptidase and protease cleavage 
sites. 
 
 
 
 
 
 
 
1995; Henderson and Nataro, 2001). The secretion pathway followed by the 
autotransporters has been termed the type V or Va secretion pathway by Henderson 
et al. (Henderson et al., 2000b). Nowadays, type V secretion also includes the 
General introduction 
 27 
related two-passenger secretion (TPS) pathway (or type Vb) and the AT-2 or type Vc 
system (Jacob-Dubuisson et al., 2001; Roggenkamp et al., 2003; Cotter et al., 2005). 
In the TPS pathway, the passenger domain (TpsA) and the translocation unit (TpsB) 
are produced by two different polypeptides instead of one. Therefore, this pathway 
needs a specific recognition event between the passenger and the translocator. 
Recognition is achieved by the addition of a conserved N-proximal module to the 
TpsA polypeptide, the TPS domain. The topology of the TpsB β-barrel appears to 
differ from that of the autotransporters by having 19 predicted amphipathic β-strands 
instead of 10 to 14 (see below). The AT-2 subfamily of autotransporters is defined by 
a short trimeric C-terminal translocation unit. After trimerization, a β-barrel pore 
consisting of 12 β-strands is formed in the outer membrane. In contrast to most 
conventional autotransporters, AT-2 proteins are not cleaved on the bacterial cell 
surface and they are generally involved in adhesion to extracellular matrix proteins or 
circulating host factors. A common property of all characterized type V proteins is 
that they are implicated to be bacterial virulence factors. Several reviews on type V 
and autotransporter secretion were published in 2004 (Desvaux et al., 2004; 
Henderson et al., 2004; Jacob-Dubuisson et al., 2004; Newman and Stathopoulos, 
2004). 
 
The signal peptide of autotransporters 
Analysis of the primary sequences of all known autotransporters reveals that 
they possess an N-terminal signal peptide that is typical for targeting of preproteins to 
the Sec translocon (Henderson et al., 1998). The signal peptides, typically about 25 
amino acids long, contain an N-domain with positively charged amino acids, an H-
domain containing hydrophobic amino acids and a short C-domain with a signal 
peptidase recognition site (Martoglio and Dobberstein, 1998). Interestingly though, 
several autotransporters contain a conserved N-terminal extension to the classical 
signal peptide, making it about twice as long as a general signal peptide (Fig. 8) 
(Henderson et al., 1998). Desvaux and Henderson describe the predicted presence 
of at least 80 proteins with extended signal peptides from completed genome 
sequences of Proteobacteria (Henderson et al., 2004). Notably, the extended signal 
peptides appeared to be exclusively associated with proteins larger than 100 kDa. 
The N-terminal extensions also contain a N- and H-domain that are enriched in 
charged and in hydrophobic residues, respectively. Conserved aromatic residues 
characterize the extended N-domain and the H-domain typically contains a glutamate 
residue. The “classical” N-domain in these proteins contains an unusual number of 
charged residues (Brunder et al., 1997). The biological function of the N-terminal 
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extension is not fully elucidated. Szabady et al. suggest a role in the transit of the 
passenger through the periplasm, based on their results with an N-terminally 
truncated construct (Szabady et al., 2005). In their experiments, a construct lacking 
the N-terminal extension was dissociated from the inner membrane faster than the 
wild type protein. They suggest that the extension might function as an inner 
membrane retention signal, allowing the translocation unit to insert into the outer 
membrane and preventing premature folding of the passenger in the periplasm. 
 
 
 
Fig. 8. The conserved N-terminal extension of a subset of autotransporters. Several 
autotransporters have a conserved extension of about 25 amino acids in front of the regular 
SecB-type signal sequence (bracket). The consensus sequence of the N-terminal extension is 
shown in the last line. Identical residues are depicted in black, similar residues in grey. N = N-
terminal part, H = hydrophobic part and C = C-terminal part of the SecB-type signal sequence. 
M = mature protein. The putative signal peptidase I cleavage site is indicated by the arrow. 
 
 
 
Inner membrane targeting of autotransporters 
Targeting to the Sec translocon in the inner membrane of E. coli (among 
others) can involve either a post-translational or a cotranslational route. The 
posttranslational route often involves the cytoplasmic chaperone SecB that targets 
the complete preprotein to translocon-associated SecA (Randall and Hardy, 2002). 
The cotranslational route involves recognition of the signal peptide by the Signal 
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Recognition Particle (SRP) that directs the ribosome-nascent chain complex directly 
to the translocon via the SRP receptor FtsY (Herskovits et al., 2000). A recently 
discovered pathway independent of the Sec translocon is the Twin-Arginine 
Translocation (Tat) pathway. This pathway is involved in the translocation of folded 
proteins across the inner membrane and recognizes signal peptides containing a 
typical twin-arginine motif. Twin-arginine motifs have not been found in 
autotransporters, therefore a role of the Tat pathway in the inner membrane 
translocation of autotransporters is unlikely. The work described in this thesis 
investigates the inner membrane targeting and translocation of the E. coli 
autotransporter Hbp, and it was found that Hbp is likely targeted to the membrane 
cotranslationally via SRP and translocated through the Sec translocon. The Shigella 
flexneri autotransporter IcsA also depends on the Sec translocon when expressed in 
E. coli, but under steady state conditions apparently not on SRP (Brandon et al., 
2003). Interestingly, Szabady et al. recently described the targeting of the E. coli 
autotransporter Pet and found targeting by SecB to the Sec translocon. Only when 
the N-terminal extension of the signal peptide was removed, the protein was rerouted 
into the cotranslational pathway (Szabady et al., 2005). 
 
Periplasmic transit of autotransporters 
Signal Peptidase I (LepB) cleaves the signal peptide from the 
autotransporter precursor during or after inner membrane translocation. A few 
exceptional autotransporters, like NalP (AspA) (Turner et al., 2002; van Ulsen et al., 
2003), carry a lipoprotein signal peptide and are subsequently cleaved by Signal 
Peptidase II. Between the translocation events at the inner and outer membranes, 
the autotransporter precursor molecule has to travel through the periplasm. 
Alternatively, secretion of the molecule may occur without the formation of 
periplasmic intermediates in one coupled inner/outer membrane translocation 
process. Periplasmic intermediates of autotransporters are generally not detected 
and most likely short-lived (Jacob-Dubuisson et al., 2004). Several controversial 
reports exist about the folding status of the autotransporters during the periplasmic 
transit and outer membrane translocation. Oliver et al. showed that the Bordetella 
pertussis autotransporter BrkA contains an internal chaperone sequence that is 
conserved in many autotransporters. They suggest that the passenger protein 
remains in an unfolded, translocation competent state during the periplasmic transit 
and that folding of the protein occurs at the bacterial surface (Oliver et al., 2003b). In 
contrast, Veiga et al. demonstrated the outer membrane translocation of a folded 
passenger domain, using a single-chain antibody as a heterologous passenger 
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molecule. Because of the dimensions of the (partially) folded passenger domain, they 
suggest that the passenger is not translocated through the small pore formed by the 
translocation unit, but through a central channel formed by a multimer of 
translocation units in the outer membrane (Fig. 9) (Veiga et al., 1999; Veiga et al., 
2002). The only genuine autotransporter passenger domain demonstrated to form 
disulfide bonds in the periplasm is that of Shigella flexneri IcsA (Brandon and 
Goldberg, 2001). 
 
 
 
 
Fig. 9. Oligomer model for autotransporter secretion. Multiple autotransporter translocation 
units (cylinders) insert as a ring-shaped complex in the outer membrane (OM). The passenger 
domains (dark ovals) are translocated from the periplasm (left) to the extracellular environment 
(right) through the central hydrophilic pore formed by the oligomeric complex. Figure taken from 
(Veiga et al., 2002). 
 
 
 
Translocation of autotransporters across the outer membrane 
The translocation unit of autotransporters consists of a short but essential 
linker region with a predicted α-helical structure and a β-core that presumably forms 
a β-barrel pore upon insertion in the outer membrane (Maurer et al., 1999; Oliver et 
al., 2003a). The pores are predicted to consist of 10 to 14 amphipathic β-strands 
connected by hairpin turns and loops (Jacob-Dubuisson et al., 2004). This original 
model was supported by the publication of the first crystal structure of an 
autotransporter translocation unit by Oomen et al. (Oomen et al., 2004). The 
translocation unit of the Neisseria meningitidis autotransporter NalP (AspA) has been 
isolated, refolded in vitro, crystallized and the structure was refined to 2.6 Å 
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resolution. The structure consists of a β-barrel formed by 12 antiparallel β-strands 
around a central cavity of circa 10 by 12.5 Å (Fig. 10). The pore was found to be 
occupied by an α-helix formed by the linker region as predicted. The cavity was 
shown to be hydrophylic with stretches of charged amino acids along the internal 
barrel wall. The dimensions of the pore and the presence of the α-helix in the β-barrel 
point towards a translocation mechanism in which the passenger is translocated 
through the β-barrel pore. The size of the pore is just wide enough to accommodate 
two extended polypeptide chains, allowing passing the protein only in an unfolded 
state. After translocation and cleavage of the passenger domain, the linker region 
accommodates an α-helix conformation and remains in the pore. Alternatively, the α-
helix inserts into the β-barrel pore only after translocation of the passenger through a 
larger oligomeric β-barrel channel. Taken together, more data is needed to elucidate 
the mechanism of periplasmic transit and outer membrane translocation of 
autotransporter passenger domains and to address the possibility of partial folding 
before translocation. 
 
 
 
Fig. 10. Crystal structure of the 
translocation unit of the N. 
meningitides autotransporter 
NalP. In the side view, 
aromatic residues flanking the 
membrane-embedded region 
are shown as ball-and-stick. In 
the top view, charged amino 
acids are shown as ball-and-
stick to indicate the hydrophylic 
nature of the barrel interior. 
Figure adapted from (Oomen 
et al., 2004). 
 
 
 
 
Folding of autotransporters 
The recent discovery of an autochaperone domain in the BrkA 
autotransporter suggests that the final folding of passenger molecules occur on the 
outside of the cell (Oliver et al., 2003b). This conserved C-terminal domain is present 
in several, but not all, autotransporters. The domain is important for folding of the 
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BrkA passenger, possibly by functioning as a chaperone, scaffolding the folding of 
the protein linked to it. In silico analysis of autotransporter passenger domains 
predicts that many possess a high degree of β-helical structure (Kajava et al., 2001; 
Yen et al., 2002). This might indicate that autotransporters generally adopt a 
conformation resembling that of pertactin, the first passenger domain of an 
autotransporter that was crystallized, although not completely (Emsley et al., 1996). 
In this thesis, the first complete crystal structure of an autotransporter passenger, 
Hbp, is described. This protein also has a β-helical backbone structure with several 
domains extruding from it. The process of folding of the mainly β-helical structured 
passenger domain on the cell surface might actually be the driving force for the outer 
membrane translocation (Klauser et al., 1992). According to Oliver et al., the correct 
folding of the passenger domain is supposed to depend on the autochaperone 
domain (Oliver et al., 2003b). A sequence homologous to the BrkA-like 
autochaperone domain is also found in Hbp. This C-terminal region has a remarkably 
high degree of structural homology to a similar domain in the pertactin crystal 
structure (Emsley et al., 1996) (J. Tame, personal communication). Interestingly 
though, the domain in Hbp contains only 4 out of the 9 highly conserved residues 
present in BrkA (Oliver et al., 2003b). Similar to this putative autochaperone function, 
a “junction region” at the C terminus of the Serratia marcescens PrtS passenger 
domain was identified that was necessary for correct folding of its passenger on the 
cell surface (Ohnishi et al., 1994). The sequence of this junction region is not 
homologous to that of the BrkA autochaperone domain but it is present in several 
PrtS homologues. Jacob-Dubuisson et al. propose that these subtilase-like 
autotransporters belong to a different structural group of autotransporters than the β-
helix passenger proteins such as Hbp (Jacob-Dubuisson et al., 2004). 
 
Outer membrane insertion of the β-barrel 
The outer membrane insertion of the β-barrel itself is still subject to debate. 
All autotransporters contain a conserved amino acid motif at the extreme C terminus 
that is specific for outer membrane proteins (e.g. Struyvé et al., 1991). The terminal 
amino acid is always phenylalanine or tryptophan, preceded by alternating 
hydrophylic and hydrophobic residues (Jose et al., 1995; Loveless and Saier, 1997). 
Deletion of the final three residues of the Haemophilus influenzae autotransporter 
Hap abolishes outer membrane insertion of the protein (Hendrixson et al., 1997). The 
traditional model proposes that the β-barrel structure spontaneously inserts itself in 
the outer membrane, without the assistence of accessory factors (hence the name 
autotransporter). The hydrophobic residues of the β-sheets will face the lipid bilayer, 
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while the alternating hydrophylic residues will face inwards and form the lining of the 
pore. This insertion process may be similar to the formation of porins in the outer 
membrane (Tamm et al., 2001). Additionally, other β-barrel forming outer membrane 
proteins, like OmpA and PhoE, have been shown to require lipopolysaccharide (LPS) 
and the periplasmic chaperone Skp for efficient outer membrane insertion (de Cock 
et al., 1999; Bulieris et al., 2003). Deletion of the skp gene does not fully prevent 
outer membrane insertion, indicating that other mechanisms of membrane insertion 
exist (Bulieris et al., 2003). Recently, Voulhoux et al. demonstrated the involvement 
of the highly conserved Omp85 protein in outer membrane insertion in Neisseria 
meningitidis (Voulhoux et al., 2003). Depletion of this protein resulted in the 
accumulation of unassembled forms of outer membrane proteins, including 
autotransporters. On the other hand, Genevrois et al. showed an involvement of 
Omp85 in lipid export to the outer membrane (Genevrois et al., 2003). Besides, the 
localization of several outer membrane proteins was not impaired upon Omp85 
depletion. The exact role of Omp85 in outer membrane protein insertion and the 
molecular mechanism involved remain to be investigated. Interestingly though, 
Oomen et al. even speculated about the possible direct involvement of Omp85 in the 
outer membrane translocation of passenger domains (Oomen et al., 2004). The 
passage of the passenger domain would then occur through a pore formed by 
Omp85 rather than by the translocation unit. Recently, Wu et al. identified a 
multiprotein complex required for the assembly of proteins in the OM of E. coli (Wu et 
al., 2005). A homologue of Omp85, YaeT, is part of this multiprotein complex. It is 
likely that this multiprotein complex is also required for the insertion of the β-barrels 
of autotransporters into the OM. 
 
Final processing of the autotransporter 
Once the passenger domain of the autotransporter is folded on the outside 
of the cell, several alternative processing steps have been demonstrated. The 
passenger domain may be cleaved from the translocation unit and released into the 
extracellular environment, as shown for E. coli Hbp, Pet and EspP (Brunder et al., 
1997; Eslava et al., 1998; Otto et al., 1998). Alternatively, the passenger may not be 
cleaved but remains attached to the β-barrel and extends into the environment, like 
Hia or Hsr (O'Toole et al., 1994; St Geme and Cutter, 2000). An intermediate form is 
also possible, in which the passenger domain is cleaved but remains non-covalently 
attached with the translocation unit, as is the case with AIDA-I and pertactin 
(Leininger et al., 1991; Benz and Schmidt, 1992). Interestingly, the cleavage between 
passenger and translocation unit can occur at various positions depending on the 
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autotransporter, ranging from well upstream of the linker region to within the 
predicted α-helix (Oliver et al., 2003a). This has important implications for the 
mechanism and cellular location of the cleavage. For several autotransporters, 
autoproteolytic cleavage involving the serine protease active site from the passenger 
has been demonstrated (Pohlner et al., 1987; Hendrixson et al., 1997; Serruto et al., 
2003). This event will likely only occur on the cell surface after folding of the 
passenger into its native conformation. Other autotransporters have been shown to 
be cleaved by the action of alternative proteases, like the Shigella flexneri 
autotransporter IcsA that is cleaved by the membrane protease IcsP (Egile et al., 
1997; Shere et al., 1997). When the cleavage site is located within the α-helical linker 
region, as for Hbp, the protease recognition site might not become available at the 
cell surface for surface proteases or autoproteolytic cleavage. In this case, a role for 
periplasmic proteases might also be invisaged, but this has not been investigated so 
far. The fate of the translocation unit after cleavage of the passenger is unclear. 
Studies on the translocation unit of pertactin P.69 from Bordetella pertussis indicate 
that the β-barrel structure is rather stable (Charles et al., 1994). On the other hand, 
studies in our lab on E. coli Hbp demonstrate that in a wild type Hbp-secreting E. coli 
strain EB1 hardly any translocation unit can be detected in the membrane (B.R. Otto, 
unpublished data). One might envisage that the accumulation of pore-forming outer 
membrane proteins without a plug domain could be detrimental for the cell because 
of potential massive leakage of ions through these open pores. The mechanism of 
regulation of the expression and degradation of translocation units requires further 
investigation. 
 
Functions of autotransporters 
As mentioned, autotransporters are virulence factors that are found in many 
Gram-negative pathogens (Yen et al., 2002). Although the overall structure of 
autotransporters is similar and they basically use the same secretion mechanism, 
individual passenger domains are very diverse in sequence and function (Henderson 
et al., 1998; Henderson and Nataro, 2001). The functions of autotransporters range 
from adhesin to protease and from lipase or esterase to mediator of intracellular 
motility. Phylogenetic relationships have been worked out and demonstrate the 
occurrence of horizontal gene transfer among evolutionarily separated species 
(Davis et al., 2001; Henderson and Nataro, 2001; Dutta et al., 2002; Henderson et 
al., 2004). A distinct class of autotransporters is formed by the serine protease 
autotransporters of the Enterobacteriaceae (SPATEs). Even though these proteins 
show significant homology (40-100% identity) and all contain a trypsin-type serine 
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protease motif, the proteins have specific and distinct functions which are adaptive 
for the particular niche occupied by the pathogen (Dutta et al., 2002). For example, 
EspC from enteropathogenic E. coli and Pet from enteroaggregative E. coli act as a 
toxin (Eslava et al., 1998; Mellies et al., 2001), EspP from enterohemorrhagic E. coli 
cleaves pepsin and human coagulation factor V (Brunder et al., 1997), and SepA 
from Shigella plays a role in tissue invasion (Benjelloun-Touimi et al., 1995). In our 
lab, Otto et al. have shown that enteropathogenic E. coli secretes Hbp that functions 
as a hemoglobinase and heme-binding protein (Otto et al., 1998). An essentially 
identical protein has been identified as a temperature-sensitive hemagglutinin (Tsh) 
in avian pathogenic E. coli (Provence and Curtiss, 1994). Recent results question the 
hemagglutinin activity of Tsh and demonstrate just like Hbp a proteolytic activity of 
this molecule (Kostakioti and Stathopoulos, 2004). Otto et al. also demonstrated that 
Hbp contributes to the synergism with B. fragilis in peritoneal infections by delivering 
heme to B. fragilis (Otto et al., 2002). No other autotransporters have been identified 
that contribute to synergy and abscess formation in intra-abdominal infections to 
date. 
 
 
Outline of this thesis 
 
The studies presented in this thesis describe the characterization of several 
proteins that are or may be involved in the pathogenic synergy between E. coli and 
B. fragilis in bacterial peritonitis. The protein Hbp is produced by the E. coli strain 
EB1 (O8-K43) and the proteins α-enolase P46 and Pbp are produced by the B. 
fragilis strain BE1. Both these strains have been isolated from a peritoneal abscess 
of a patient with a wound infection at the Academic Hospital of the Vrije Universiteit in 
Amsterdam (Verweij-van Vught et al., 1985). 
In 1998, Otto et al. described the discovery and initial characterization of the 
autotransporter protein Hbp from E. coli (Otto et al., 1998). The hbp gene has been 
cloned and further analysis showed that the purified protein degrades hemoglobin 
and subsequently binds the released heme (Otto et al., 1998; Tame et al., 2002). 
Later it has been demonstrated that Hbp is a true virulence factor, involved in the 
synergistic abscess formation and heme-dependent growth of B. fragilis (Otto et al., 
2002). In this thesis, the molecular properties of Hbp are characterized in more detail.  
In chapter 2, the targeting of the Hbp precursor to the inner membrane and 
its translocation across the inner membrane of E. coli is investigated. It is 
demonstrated that optimal processing of the precursor requires a functional SRP 
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pathway and Sec-translocon. SecB is not required for targeting of Hbp in vivo, but 
can compensate to some extent for the absence of SRP. These results give more 
insight into the mechanism of inner membrane targeting and translocation of 
autotransporters. 
In chapter 3 the crystal structure of the complete passenger domain of Hbp, 
refined to 2.2 Å resolution is presented. This is the first complete structure of an 
autotransporter passenger domain and the largest parallel β-helical structure solved 
to date. Based on the prediction that an overall β-helical architecture is common for 
autotransporters (e.g. Kajava et al., 2001), this structure may function as a homology 
model in the characterization of other autotransporters. 
In chapter 4, the translocation unit of Hbp is further characterized. In 2004, 
the crystal structure of the translocation unit of the Neisseria meningitidis 
autotransporter NalP has been published (Oomen et al., 2004). This was the first 
paper describing the structure of an autotransporter translocation unit. The 
translocation unit of Hbp has several similarities as well as differences with the NalP 
translocation unit. Besides a discussion of these differences and similarities, the 
chapter describes the first steps towards crystallization of the Hbp translocation unit. 
The following chapters describe the identification and characterization of two 
putative virulence factors from B. fragilis: P46 and Pbp. In chapter 5 the identification, 
cloning and partial characterization of the α-enolase P46 of B. fragilis is described. 
This functional α-enolase protein is upregulated under conditions of iron- or heme-
starvation. P46 is normally located mainly in the cytoplasm, but upon iron-depleted 
conditions it mainly localizes to the inner membrane. 
Finally, in chapter 6 the cloning and characterization of the plasminogen-
binding protein Pbp of B. fragilis is described. Pbp is a 60-kDa lipoprotein that is 
partially located on the cell surface where it can bind host plasminogen. This is the 
first study describing the functional characterization of a lipoprotein of B. fragilis, 
which may function as a plasminogen receptor on B. fragilis cells. 
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Abstract 
 
Hemoglobin protease (Hbp) is a hemoglobin-degrading protein that is 
secreted by a human pathogenic Escherichia coli strain via the autotransporter 
mechanism. Little is known about the earliest steps in autotransporter secretion, i.e. 
the targeting to and translocation across the inner membrane. Here, we present 
evidence that Hbp interacts with the signal recognition particle (SRP) and the Sec-
translocon early during biogenesis. Furthermore, Hbp requires a functional SRP 
targeting pathway and Sec-translocon for optimal translocation across the inner 
membrane. SecB is not required for targeting of Hbp but can compensate to some 
extent for the lack of SRP. Hbp is synthesized with an unusually long signal peptide 
that is remarkably conserved among a subset of autotransporters. We propose that 
these autotransporters preferentially use the co-translational SRP/Sec route to avoid 
adverse effects of the exposure of their mature domains in the cytoplasm. 
 
 
Introduction 
 
Hemoglobin protease (Hbp) is secreted by a human pathogenic Escherichia 
coli strain (Otto et al., 1998) and contributes to the pathogenic synergy between 
E. coli and Bacteroides fragilis in intra-abdominal infections (Otto et al., 2002). It 
represents the first described member of the serine protease autotransporters of 
Enterobacteriaceae (SPATE) group of autotransporter proteins (Henderson et al., 
1998).  
The key feature of an autotransporter is that it contains all the information for 
secretion in the precursor of the secreted protein itself (Henderson et al., 1998). 
Autotransporters comprise three functional domains: 1) an N-terminal targeting 
domain; 2) a C-terminal translocation domain; and, in between these two, 3) the 
passenger domain that is the actual secreted moiety. The C-terminal domain is 
supposed to form a β-barrel structure in the outer membrane that may form an 
oligomeric channel around a cavity to allow the passage of the passenger domain 
(Veiga et al., 2002). The N-terminal domain is thought to function as a signal peptide 
to mediate targeting to and translocation across the inner membrane.  
Compared with other signal peptides in E. coli, the putative signal peptide of 
Hbp is unusually long (Otto et al., 1998) (Fig. 1). Analogously, several other 
autotransporters are predicted to have long signal peptides (Henderson et al., 1998; 
Henderson et al., 2000a). All these signal peptides display a conserved domain 
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structure. The C terminus resembles a normal signal peptide with a basic N-terminal 
region, a hydrophobic core region, and a C-terminal consensus signal peptidase 
cleavage site. The N terminus forms a conserved extension, the function of which is 
not known (Fig. 1). 
 
 
 
Fig. 1. The signal peptide of Hbp has a conserved N-terminal extension. A schematic 
representation of the 52 amino acid-long signal peptide of Hbp is shown, indicating the 
probable signal peptidase cleavage site (arrow). The basic N-terminal (N), hydrophobic (H), 
and C-terminal (C) domains characteristic of typical signal peptides are indicated. M indicates 
the beginning of the mature region of Hbp. A comparison of the N-terminal extensions of 
several autotransporters possessing extended signal peptides is given together with a 
consensus sequence of the conserved domain. 
 
 
Most periplasmic and outer membrane proteins synthesized with a cleavable 
signal peptide are translocated through the Sec-translocon. The core translocase 
consists of the integral inner membrane proteins (IMPs) SecY, SecE, and SecG, 
which constitute an oligomeric complex homologous to the Sec61 channel complex in 
the endoplasmic reticulum (Manting and Driessen, 2000). The peripheral membrane 
ATPase SecA is unique to bacteria and catalyzes the actual polypeptide transfer 
through the translocase. Targeting to the Sec-translocon may occur after translation 
and often requires the cytosolic chaperone SecB. 
The Sec-translocon is also used for the membrane insertion of most IMPs 
that are synthesized with uncleaved, relatively hydrophobic signal peptides (de Gier 
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and Luirink, 2001). Targeting of IMPs to the Sec-translocon is not mediated by SecB 
but by the signal recognition particle (SRP) and its receptor, FtsY, in a co-
translational mechanism that resembles targeting to the Sec61 complex in the 
endoplasmic reticulum (Herskovits et al., 2000).  
Here we provide evidence that the long signal peptide of Hbp mediates 
targeting to the inner membrane via the SRP pathway. When the SRP pathway is 
compromised, SecB can prevent, to a certain extent, the mislocalization of pre-pro-
Hbp. Subsequent translocation across the inner membrane involves the Sec-
translocon. This is the first demonstration of the use of the co-translational SRP 
pathway for inner membrane targeting of an extracellular protein. 
 
 
Experimental procedures 
 
Bacterial Strains, Plasmids, and Media 
E. coli K12-strains and the plasmids used are listed in Table 1. E. coli strains 
were routinely grown in Luria-Bertani (LB) medium (Miller, 1992). Strains MM152 and 
HDB52 were grown in M9 medium (Miller, 1992). If required, antibiotics were added 
to the culture medium. 
 
Table 1. Bacterial strains and plasmids used in this study 
 
Strain / plasmid Relevant genotype Reference 
MC4100 F- araD139 ∆(argF-lac)U169 rpsL150 relA1 flb5301 ptsF25 rbsR (Casadaban, 1976) 
TOP10F’ F’{lacIq Tn10(TcR)} mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆M15 Invitrogen 
    ∆lacX74 deoR recA1 araD139 ∆(ara-leu)7697 galU galK  
    rpsL(StrR) endA1 nupG 
BL21 (DE3) F- ompT hsdSB (rB- mB-) gal dcm ∆(srl-recA)306::Tn10(TcR) (DE3) (Studier et al., 1990) 
HDB51 MC4100 ara+ secB+ zic-4901::Tn10 ffh::kan-1 λ(Para-ffh Apr) (Lee and Bernstein, 2001) 
HDB52 MC4100 ara+ secB::Tn5 zic-4901::Tn10 ffh::kan-1 λ(Para-ffh Apr) (Lee and Bernstein, 2001) 
HDB97 MC4100 malP::lacI ∆ara714 cps::lacZ mal+ (Lee and Bernstein, 2001) 
HDB107 MC4100 malP::lacI ∆ara714 cps::lacZ mal+ (Lee and Bernstein, 2001) 
    ∆lon510 ∆clpYQ1172::tet 
IQ85 secY24(ts) Tn10 thiA ∆lac araD rspL rspE relA (Shiba et al., 1984) 
IQ86 Tn10 thiA ∆lac araD rspL rspE relA (Shiba et al., 1984) 
MM152 MC4100 zhe::Tn10 malTC secB::Tn5 (Kumamoto and Beckwith, 1985) 
JARV16 MC4100 ∆tatA ∆tatE (Sargent et al., 1999) 
pET9-FtsY-A449 pET9, ftsY-A449 (Kusters et al., 1995) 
pACYC-Hbp pACYC184 (Orip15A), hbp (van Dooren et al., 2001) 
pC4MethssHbp pC4Meth, ss-Hbp this study 
pHB6.4-Hbp pBR322 (OriColE1), hbp this study 
pHB6.4-Hbp∆ss pBR322 (OriColE1), hbp∆ss  this study 
pHE12.6 pBR322 (OriColE1), hbp (Otto et al., 1998) 
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Reagents and Sera 
Restriction enzymes, the Expand long template PCR system and the Lumi-
light Western blotting substrate were obtained from Roche Molecular Biochemicals. 
All other chemicals were supplied by Sigma. Antiserum J40 raised against purified 
Hbp has been described previously (Otto et al., 2002). Antisera against β-lactamase, 
OmpA/OmpC, trigger factor (TF)/SecA, and SufI were gifts from J.-M. van Dijl, J.-W. 
de Gier, W. Wickner, and T. Palmer, respectively. 
 
Plasmid Construction 
For cross-linking of nascent Hbp, we constructed pC4MethssHbp, which 
encodes the 110 N-terminal amino acid residues of Hbp fused to a C-terminal 4× 
methionine tag and a three amino acid linker sequence to improve labeling efficiency. 
The construct was obtained by PCR using pHE12.6 as a template and the primers 
Hbp-EcoRI-for (5'-GCCGGAATTCTAATATGAACAGAATTTATTCTCTTC-3' with the 
EcoRI restriction site in boldface) and Hbp-BamHI-rev (5'-GCGGGATCCACCGATTT-
CCGAATCCACA-3' with the BamHI restriction site in boldface). The PCR fragment 
was cloned EcoRI/ BamHI into pC4Meth (Valent, 1997). To construct plasmid 
pHB6.4-Hbp∆ss, the signal peptide coding region of hbp was removed from plasmid 
pHB6.4-Hbp using the Exsite PCR-based, site-directed mutagenesis kit (Stratagene). 
The plasmid pHB6.4-Hbp is derived from pHE12.6 (Otto et al., 1998). The primers 
used were Hbp-NheI-for (5'-CTTGCTAGCGTCAATAATGAACTCGGGTATC-3' with 
the NheI restriction site in boldface) and Hbp-BglII-rev (5'-CTGATTTTATTTTTCTCA-
GGAGTAATTAAAAATGAAGAGATCTAAG-3' with the BglII restriction site in 
boldface). Upon ligation of the linear DNA, the last three bases from each end 
constitute a HindIII restriction site. The resulting plasmid encodes the Hbp protein 
without its signal peptide but with six extra N-terminal amino acids (MKRSKL) and 
two altered amino acids (GT  AS) at the start of the mature Hbp region. 
 
In Vitro Transcription, Translation, Targeting, and Cross-linking 
Truncated mRNA was prepared as described previously (Scotti et al., 2000) 
from HindIII linearized pC4MethssHbp. In vitro translation, targeting to inverted 
membrane vesicles (IMVs), cross-linking with DSS, and carbonate extraction of 
nascent Hbp were carried out as described (Scotti et al., 2000). The samples were 
either analyzed directly by 15% SDS-PAGE or immunoprecipitated first using 4-fold 
the amount used for direct analysis. 
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Pulse-Chase Experiments 
For Ffh depletion studies, strains HDB51 and HDB52 were grown overnight 
in M9 containing 0.1% casaminoacids (Difco), 0.2% fructose, and 0.2% L-arabinose, 
washed in the same medium lacking L-arabinose, and diluted to an OD660 of 0.004 in 
M9 containing fructose (0.2%) and either L-arabinose (0.2%) or glucose (0.2%). Cells 
were grown to an OD660 of ~0.3 before labeling. Depletion of Ffh was verified by 
Western blotting. The temperature-sensitive SecY mutant strains IQ85 and its 
isogenic wild type strain IQ86 were grown overnight at 30 °C in LB medium, diluted 
into fresh medium to an OD660 of 0.02, and grown to an OD660 of 0.3. Growth was 
then continued at 30 or 42 °C for 3 h. For overexpression of a dominant lethal ftsY 
allele, strain BL21(DE3) harboring pET9-FtsY-A449 was grown overnight at 37 °C in 
M9 medium with 0.2% glycerol as a carbon source and diluted into fresh medium to 
an OD660 of 0.03. When cells reached an OD660 of 0.2, 40 µM isopropyl-1-thio-β-D-
galactopyranoside (IPTG) was added to induce FtsY-A449 expression, and growth 
was continued for 15 min. To inhibit SecA functioning in MC4100, 3 mM NaN3 was 
added 3 min prior to labeling. In all experiments, 2.4 OD660 units of cells were washed 
and diluted into 3 ml of M9 medium containing appropriate sugars and a mixture of 
18 amino acids except methionine and cysteine. After recovery for 15-45 min at 
30, 37, or 42 °C as indicated, cells were pulse labeled for 1 min by the addition of 
10 µCi/ml [35S]methionine and chased for various times by adding cold methionine 
(2 mM). To stop the chase, cells were rapidly cooled in ice water and centrifuged at 
4 °C for 2 min at 8,000 × g. Supernatants were precipitated with trichloroacetic acid 
and subjected directly to 8-15% SDS-PAGE. Cell pellets were first lysed and 
subjected to immunoprecipitation using anti-Hbp and anti-OmpA serum essentially as 
described (Luirink et al., 1992). 
 
Western Blotting 
For analysis of steady-state levels of Hbp, E. coli strains harboring an hbp 
expression plasmid were grown to an OD660 of 0.5. Aliquots were removed from the 
cultures and centrifuged (1 min at 16,000 × g). The culture supernatants were 
trichloroacetic acid precipitated. Equivalent amounts of cells and supernatant were 
analyzed by Western blotting. Blots were developed by enhanced 
chemiluminescence using Lumi-light Western blotting substrate. 
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Sample Analysis 
Radiolabeled proteins were visualized by phosphorimaging using a 
Amersham Biosciences PhosphorImager 473 and quantified using the ImageQuant 
quantification software from Amersham Biosciences. Chemiluminescent Western 
blots were analyzed using the Fluor-S MultiImager and Multianalyst software (Bio-
Rad). 
 
 
Results 
 
Hbp That Lacks Its Signal Peptide Is Not Secreted and Degraded in the Cytosol 
Hbp is synthesized in a pre-pro form (148 kDa) (Otto et al., 1998). The N-
terminal signal peptide is cleaved during passage of the pre-pro-Hbp through the 
inner membrane, leaving the pro-Hbp (142 kDa) in the periplasm. The C-terminal β-
barrel domain is cleaved from the pro-Hbp at the outer membrane and mediates the 
transfer of the mature Hbp (111 kDa) into the culture medium. To analyze the role of 
the Hbp signal peptide, it was deleted from the pre-pro-Hbp, and the consequences 
for maturation and secretion were analyzed by Western blotting of cell samples and 
culture supernatants using Hbp-specific antibodies (Fig. 2A). As expected, deletion of 
the signal peptide (∆ss) prevented secretion of mature Hbp into the medium. Only a 
small amount of pro-Hbp∆ss was detected in the cells. In contrast, most wild-type 
pre-pro-Hbp was processed to mature Hbp, which was either secreted or remained 
cell-associated as observed previously (Otto et al., 1998). In addition, some pre-pro- 
or pro-Hbp accumulated in the cells. 
 
We next investigated the reason for the low expression level of pro-Hbp∆ss. 
It has been observed previously that secreted proteins and IMPs that fail to be 
translocated across or inserted into the inner membrane are prone to proteolytic 
degradation (Bernstein and Hyndman, 2001). To investigate this possibility, Hbp∆ss 
was expressed in strain HDB107, which lacks the major cytoplasmic proteases Lon 
and ClpYQ (Bernstein and Hyndman, 2001). Pulse-chase labeling was employed to 
compare the stability of Hbp∆ss species in strain HDB107 and its isogenic parental 
strain HDB97 (Fig. 2B). Hbp∆ss remained almost completely stable for at least 
10 min in HDB107, whereas only limited amounts were detected in HDB97 after a 10-
min chase. In fact, relatively little Hbp∆ss was detected in HDB97 even when 
samples were analyzed directly after pulse labeling.  
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Fig. 2. A, the signal sequence of Hbp is required for secretion. Strain Top10F', harboring 
pHB6.4-Hbp (wt, wild-type) or pHB6.4-Hbp∆ss, was grown to an OD660 of 0.5 and split in cells 
and supernatant (sup). Samples corresponding to 0.1 OD660 unit were subjected to 8% SDS-
PAGE and Western blotting using anti-Hbp serum. B, the proteases Lon and/or ClpYQ are 
involved in degradation of precursor Hbp in the cytosol. HDB97 (wild-type) and HDB107 (lon-, 
clpYQ-), harboring pHB6.4-Hbp∆ss, were grown to mid-log growth phase, radiolabeled with 
[35S]methionine for 1 min, and chased for the times indicated. The cell samples were 
immunoprecipitated using anti-Hbp serum and subjected to SDS-PAGE. The numbers below 
the lanes show the relative quantified amount of pro-Hbp. Lanes 1-6, HDB97 cells; lanes 7-12, 
HDB107 cells. pro, pro-Hbp (142 kDa); mature, mature Hbp (111 kDa). 
 
 
These data indicated that Hbp requires its signal peptide for targeting to the 
inner membrane and, consequently, for secretion of mature Hbp. Mislocalized pro-
Hbp is rapidly degraded by the cytoplasmic proteases Lon and/or ClpYQ. 
 
Nascent Hbp Interacts with SRP, Trigger Factor, SecA, and SecY in Vitro 
To investigate the molecular interactions of the atypical Hbp signal peptide 
in the cytoplasm and the membrane, we used an in vitro cross-linking assay. A 
radiolabeled Hbp translation intermediate of 117 amino acid residues was generated 
by in vitro translation of truncated mRNA in a homologous cell-free translation system 
developed previously in our laboratory (Scotti et al., 2000). Because the truncated 
RNA does not contain a stop codon, the nascent chain remains associated with the 
ribosome, and the signal peptide is exposed outside the ribosome that covers ~35 C-
terminal amino acids. Translation was carried out in the presence of purified IMVs to 
allow targeting and membrane insertion. Subsequently, interactions of the nascent 
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Hbp were fixed by using the membrane-permeable, lysine-specific cross-linking 
reagent DSS. Finally, the samples were extracted with sodium carbonate to separate 
membrane integrated from the soluble and peripheral membrane proteins.  
Approximately 30% of the synthesized nascent Hbp was detected in the 
carbonate pellet (Fig. 3, quantification data not shown). Given the relatively low 
intrinsic efficiency of the E. coli in vitro translocation system, this result indicated that 
nascent Hbp is properly targeted and inserted into the membrane and remains 
anchored via its signal peptide that is not cleaved at this nascent chain length. In the 
untargeted (carbonate soluble) fraction, a cross-linking product of ~60 kDa appeared  
 
 
Fig. 3. Nascent Hbp interacts with 
TF, SRP and SecA. The 117-mer 
Hbp was synthesized in the 
presence of IMVs. After translation, 
samples were either treated with 
DSS (lanes 2-4 and 6 and 7) or 
mock treated (lanes 1 and 5) and 
subsequently extracted with 
carbonate (supernatant (sup), lanes 
1-4; pellet, lanes 5-7). DSS-treated 
fractions were immunoprecipitated 
using antiserum against TF, Ffh, 
and SecA (lanes 3, 4, and 7). The 
translation products at 30 kDa 
present in lanes 5 and 6 represent 
the peptidyl-tRNA form of nascent 
Hbp. Cross-linked products and 
nascent chains (NC) are indicated. 
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that could be immunoprecipitated using serum directed against Ffh, the protein 
component of the SRP (Fig. 3, lane 4). The molecular mass of this product is 
consistent with the combined molecular mass of Ffh (50 kDa) and the Hbp 117-mer 
(13 kDa). The cross-linking to Ffh is remarkably strong considering the low 
abundance of the SRP in the translation lysate, suggesting that it represents a 
functional interaction. Weaker cross-linking products of slightly higher molecular 
mass were immunoprecipitated using anti-TF serum (Fig. 3, lane 3). TF (54 kDa) 
cross-linked to nascent chains often migrates at varying positions (Valent, 1997). The 
membrane-integrated nascent Hbp was primarily cross-linked to SecA (102kDa) (Fig. 
3, lane 7). In addition, a very faint cross-linking smear was observed at ~46 kDa that 
contained SecY, as evident from long exposures of immunoprecipitated samples (not 
shown). 
Together, the cross-link patterns are reminiscent of those found with the 
nascent IMPs FtsQ and leader peptidase I (Lep) (Valent, 1997; Houben et al., 2000; 
Scotti et al., 2000). Both FtsQ and leader peptidase I are targeted by the SRP to the 
Sec-translocon (de Gier et al., 1996; Urbanus et al., 2001). Apparently, nascent Hbp 
can be targeted to the inner membrane and inserts close to the Sec-translocon. The 
unprecedented strong cross-linking to Ffh, considering the extremely low abundance 
of Ffh in the translation lysate, suggests a high affinity of the Hbp signal peptide for 
the SRP and, consequently, a role for the SRP in the targeting of Hbp. 
 
Hbp Requires the SRP for Optimal Processing and Secretion in Vivo 
We investigated whether the interaction of nascent Hbp with the SRP 
observed in vitro reflects a dependence on the SRP targeting pathway for processing 
and secretion of the full-length protein in vivo. Strains that are conditional for the 
expression of targeting factors were used in pulse-chase experiments to analyze the 
effects on the kinetics of processing as described above. Furthermore, spent medium 
of the pulse-chase samples was analyzed to monitor the secretion of mature Hbp in 
time.  
Under normal conditions, N-terminal processing appeared to be very fast, 
and pre-pro-Hbp could only be detected in the pulsed sample (Fig. 4A, lane 7) as has 
been observed for many pre-secretory proteins such as OmpA (see also Fig. 4C, 
lane 4). However, C-terminal processing of Hbp is much slower. Under the 
expression conditions used, not all pro-Hbp was converted into mature Hbp even 
after 1 h of chase (Fig. 4A, lane 12). The actual release of mature Hbp into the culture 
medium is even slower, appearing prominently only after 1 h of chase (Fig. 4B, lane 
12). Depletion of Ffh resulted in an accumulation of pre-pro-Hbp in the cells (Fig. 4A, 
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left panel). The amount of secreted mature Hbp after 60 min of chase, but not the 
kinetics of the secretion of mature Hbp, appeared affected upon depletion of Ffh (Fig. 
4B, left panel). As a control, the processing of OmpA was hardly influenced (Fig. 4C, 
left panel), which is in agreement with its requirement for SecB rather than SRP for  
targeting (Kumamoto and Beckwith, 1985). In an alternative approach to analyzing 
the role of the SRP-targeting pathway in Hbp secretion, the effect of overexpression 
of FtsY-A449 was investigated. This mutant SRP receptor has a reduced GTP-
binding capacity as a result of an amino acid substitution in the fourth GTP-binding 
consensus element (Kusters et al., 1995). Moderate overexpression of FtsY-A449 
has been shown to compromise SRP-mediated protein targeting (Kusters et al., 
1995). Hbp processing and, consequently, also secretion appeared to be impaired 
upon moderate overexpression of FtsY-A449 as opposed to the non-induced 
expression level (Fig. 4, D and E). OmpA processing was not affected under these 
conditions (Fig. 4F). 
To examine whether the other major targeting factor, SecB, is also involved 
in Hbp targeting, Hbp was expressed in strain MM152, which lacks SecB, and in its 
isogenic wild-type strain, MC4100. Pre-pro-Hbp did not accumulate in the SecB 
minus strain, nor was the secretion of mature Hbp affected (Fig. 4, G and H). As a 
control, pre-OmpA accumulated at early chase times in strain MM152. Apparently, 
SecB is not necessary for efficient targeting of Hbp per se. 
We next considered the possibility that the residual processing and secretion 
of Hbp under Ffh-deficient conditions is due to alternative targeting via SecB. 
Consistent with this explanation, the expression of Hbp in a double mutant strain 
(SecB knockout, Ffh conditional) showed a much stronger secretion phenotype upon 
Ffh depletion than the single (Ffh conditional) mutant (Fig. 4, J and K, left panels). 
The secretion defect was greatly reduced in cells that express Ffh (Fig. 4, J and K, 
right panels), again suggesting that SecB is not required for the targeting of Hbp 
under normal conditions. The accumulation of pre-pro Hbp under these conditions at 
early chase times remains unexplained but may be related to adverse effects of the 
unnatural control of Ffh expression from the arabinose promoter. Interestingly, a 
similar but opposite additive effect is observed for OmpA. When the preferred 
targeting factor, SecB, is absent, processing is impaired (Fig. 4L, right panel). 
Additional depletion of Ffh completely blocks residual OmpA processing (Fig. 4L, left 
panel). 
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Fig. 4. The SRP-pathway is required for efficient targeting of Hbp. A-C, depletion of Ffh inhibits 
processing and secretion of Hbp. HDB51 (Para-ffh secB+) harboring pACYC-Hbp was grown in 
M9 medium without (-ara) or with L-arabinose (+ara). Cells were radiolabeled with 
[35S]methionine for 1 min and chased for the times indicated. Panel A shows Hbp 
immunoprecipitated from cell samples. Panel B shows trichloroacetic acid-precipitated proteins 
from the supernatant (sup), and panel C shows OmpA immunoprecipitated from cell samples. 
D-F, overexpression of mutant FtsY inhibits the processing and secretion of Hbp. BL21(DE3) 
harboring pET9-FtsY-A449 and pACYC-Hbp was grown in M9 medium. At an OD660 of 0.2, the 
expression of FtsY-A449 was induced with 40 µM isopropyl-1-thio-β-D-galactopyranoside for 
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15 min or left uninduced as indicated. Samples were processed and displayed as described 
above. G-I, inactivation of SecB does not affect processing and secretion of Hbp. MM152 
(secB-), and MC4100 (wt) harboring pHE12.6 were grown in M9 medium. Samples were 
processed and displayed as described above. J-L, inactivation of SecB aggravates the effects 
of depletion of Ffh on the processing and secretion of Hbp. HDB52 (Para-ffh secB-) harboring 
pACYC-Hbp was grown in M9 medium without (-ara) or with L-arabinose (+ara). Samples were 
processed and displayed as described above. Prepro, pre-pro-Hbp (148 kDa); pro, pro-Hbp 
(142 kDa); mature, mature Hbp (111 kDa). 
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Together, these results suggested that Hbp requires the SRP pathway for 
optimal targeting to the inner membrane. Although SecB is not essential for targeting 
per se, it can apparently compensate to a certain extent for depletion of the SRP. 
 
Hbp Requires SecA and SecY for Efficient Processing and Secretion in Vivo 
Two main types of translocons mediate the transfer of proteins across the 
inner membrane, namely the Sec-translocon (Manting and Driessen, 2000) and the 
Tat-translocon (Berks et al., 2000). We investigated the role of these translocons in 
the secretion of Hbp in vivo using the pulse-chase approach described above.  
A temperature-dependent conditional secY mutant strain was used to 
deplete the cells for functional Sec-translocons. At the non-permissive temperature, 
processing of the control Sec substrate OmpA was severely impaired in this strain as 
compared with its parental wild-type strain (Fig. 5C). Likewise, pre-pro-Hbp 
accumulated in the secY Ts cells (Fig. 5A, left panel), indicating that translocation of 
Hbp across the inner membrane proceeds through the Sec-translocon. 
To study the role of SecA, its ATPase activity was perturbed with azide. 
Under the conditions used, processing of OmpA was almost completely inhibited (Fig. 
5F, left panel). Again, pre-pro-Hbp accumulated in the cells, indicating that 
translocation of Hbp is dependent on SecA (Fig. 5D, left panel). A similar 
dependence on functional SecA was observed when a temperature-dependent 
conditional secA mutant strain was used (data not shown). 
The Tat-translocon is used by a subset of preproteins that are folded prior to 
translocation (Berks et al., 2000). Tat substrates carry an essential twin arginine motif 
in their signal peptide just upstream of the hydrophobic domain. Although the Hbp 
signal peptide does not fully comply with this motif, it does contain two consecutive 
arginine residues upstream of the hydrophobic core region. This feature prompted us 
to investigate a possible role of the Tat-translocon using a strain that lacks TatA and 
TatE, rendering it completely unable to translocate Tat substrates. This double 
mutant strain showed normal kinetics of processing and secretion of Hbp whereas 
processing of the known Tat substrate SufI was completely blocked, arguing that the 
Tat-translocon is not involved in secretion of Hbp (data not shown).  
Together, the data suggest that Hbp uses the Sec-translocon for transfer 
across the inner membrane consistent with the in vitro cross-link data (Fig. 3). SecA 
appears to be required to drive the translocation process. 
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Fig. 5. The Sec-translocon is required for efficient translocation of Hbp. A, inactivation of SecY 
inhibits processing and secretion of Hbp. IQ85 (secY24 ts) and IQ86 (wt, wild-type), harboring 
pHE12.6, were grown at 30 °C to an OD660 of 0.3 and shifted to 42 °C for 3 h. Samples were 
processed and displayed as described in the legend to Fig. 4. B, inhibition of SecA functioning 
with azide inhibits processing and secretion of Hbp. MC4100 (wild-type), harboring pHE12.6, 
was grown at 37 °C in M9 medium. Three minutes prior to labeling, 3 mM NaN3 was added to 
inhibit the ATPase activity of SecA as indicated. Samples were processed and displayed as 
described in the legend to Fig. 4. 
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Discussion 
 
In the present work, we have addressed the question how the 
autotransporter Hbp is targeted to and translocated across the inner membrane. Both 
in vitro cross-linking and in vivo pulse-chase labeling experiments point to the use of 
a co-translational targeting and translocation mechanism involving the targeting factor 
SRP and the Sec translocation machinery. This is the first example of an extracellular 
protein that can be targeted by the SRP. Interestingly, in the absence of a functional 
SRP pathway, part of the mistargeted Hbp is rescued by SecB, underscoring the 
inherent flexibility of protein targeting in E. coli (Kim et al., 2001).  
What are the features in the Hbp signal peptide that determine SRP 
binding? Previous work in our group has demonstrated that the SRP preferentially 
interacts with relatively hydrophobic signal peptides such as those that are present in 
IMPs (Valent, 1997). However, the hydrophobic core region at the C terminus of the 
Hbp signal peptide is not particularly hydrophobic. Interestingly, the Hbp signal 
peptide is relatively long (52 amino acids) and appears to contain an N-terminal 
extension that precedes a "classical" signal peptide (Fig. 1). It is attractive to 
speculate that the N-terminal extension plays a role in the recognition by the SRP 
either directly or indirectly by presenting the hydrophobic core in a favorable 
conformation or by recruiting other factors that increase the affinity of the Hbp signal 
peptide for the SRP. It is worth mentioning that the only other known example of a 
secreted protein that makes use of the SRP for targeting, SecM, is also synthesized 
with a long signal peptide that comprises an N-terminal extension and a moderately 
hydrophobic core region (Sarker et al., 2000). SecM is a regulatory protein that 
functions in the secretion-responsive control of SecA expression. In wild-type cells, 
SecM is translocated to the periplasm where it is rapidly degraded (Nakatogawa and 
Ito, 2001).  
Alternatively, the N-region (KCVHKSVRR) between the hydrophobic core 
and the N-terminal extension might be important for SRP recognition of the Hbp 
signal peptide. Compared with other signal peptides in Gram-negative bacteria, this 
region is more basic. Interestingly, the crystal structure of the SRP has revealed an 
unusual RNA-protein interface that is thought to constitute the signal peptide binding 
groove (Batey et al., 2000). It has been suggested that the protein moiety of the 
interface interacts with the hydrophobic core of the signal peptide, whereas the RNA 
is responsible for recognizing the basic N-domain. Following this reasoning, a more 
basic N-domain might compensate for a less hydrophobic core region in SRP 
binding. These possibilities are currently being investigated.  
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Translocation of autotransporters across the inner membrane has been 
proposed to involve the N-terminal signal peptide and occur via the Sec-pathway, 
which is also used by periplasmic and outer membrane proteins (Henderson et al., 
1998). Consistent with this proposal, our data suggest that the Sec-translocon 
receives and translocates the nascent Hbp. In this respect, Hbp resembles IMPs like 
leader peptidase I, FtsQ, and MtlA (de Gier and Luirink, 2001). An accessory 
translocon component, YidC, is specifically involved in membrane integration of these 
IMPs but not in the translocation of secretory proteins (Samuelson et al., 2000; Scotti 
et al., 2000)1. We have not observed any cross-linking of nascent Hbp with YidC. 
Moreover, depletion of YidC did not affect processing and secretion of Hbp (data not 
shown). Apparently, YidC is dispensable for the reception of Hbp at, as well as the 
translocation of Hbp across, the inner membrane-embedded Sec-translocon.  
It is not unlikely that other members of the autotransporter family follow the 
same pathway of targeting and translocation across the bacterial inner membrane. 
Many autotransporters carry signal peptides of similar length and domain structure 
(Henderson et al., 1998). The N-terminal extension in these signal peptides is 
remarkably conserved, as is the basic character of the N-domain. In addition, 
substrates of an analogous secretion system, the "two-partner secretion" (TPS) 
pathway in which the β-barrel domain is present in a separate protein, also possess 
signal peptides that are conserved with members of the classical autotransporter 
family (Henderson et al., 2000a). One of these substrates, the HMW1 adhesin from 
Haemophilus influenzae that carries a 68 amino acid-long signal peptide was shown 
to require SecA and SecE for maturation and secretion (Grass and St Geme, 2000).  
What would be the benefit of co-translational translocation for 
autotransporters? For Hbp, it might prevent degradation or premature folding of Hbp 
in the cytoplasm. Hbp that lacks its signal peptide appeared to be vulnerable to 
degradation by cytoplasmic proteases. It should be noted that both the 
autotransporter and two-partner secretion families comprise many virulence factors 
such as hemagglutinins, hemolysins, cytolysins, and proteases (Henderson et al., 
2000a) that may be harmful when expressed in the cytoplasm of the pathogenic 
bacterium. Furthermore, the autotransporters are relatively large molecules with a 
typical domain structure. The passenger domain that is expressed in the cytoplasm 
may fold into a conformation that is incompatible with translocation through the Sec-
translocon, even when the β-barrel domain is still being synthesized. 
 
                                            
1 E. N. G. Houben, personal communication. 
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Abbreviations 
 
The abbreviations used are: Hbp, Hemoglobin protease; IMP, inner 
membrane protein; IMV, inverted membrane vesicle; SRP, signal recognition particle; 
DSS, 2,2-dimethyl-2-silapentanesulfonic acid; TF, trigger factor; TPS, two-partner 
secretion. 
 
  
 
 
Chapter 3 
 
 
 
Crystal structure of Hemoglobin 
protease, a heme binding 
autotransporter protein from 
pathogenic Escherichia coli 
 
Ben R. Otto, Robert Sijbrandi, Joen Luirink, Bauke Oudega, 
Jonathan G. Heddle1, Kenji Mizutani1, Sam-Yong Park1, and 
Jeremy R. H. Tame1 
 
 
1 Protein Design Laboratory,Yokohama City University, Tsurumi, Yokohama, Japan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Published in The Journal of Biological Chemistry 280 (2005): 17339-17345 
 
© 2005 The American Society for Biochemistry and Molecular Biology, Inc. 
Chapter 3 
 56 
Abstract 
 
The acquisition of iron is essential for the survival of pathogenic bacteria, 
which have consequently evolved a wide variety of uptake systems to extract iron 
and heme from host proteins such as hemoglobin. Hemoglobin protease (Hbp) was 
discovered as a factor involved in the symbiosis of pathogenic Escherichia coli and 
Bacteroides fragilis, which cause intra-abdominal abscesses. Released from E. coli, 
this serine protease autotransporter degrades hemoglobin and delivers heme to both 
bacterial species. The crystal structure of the complete passenger domain of Hbp 
(110 kDa) is presented, which is the first structure from this class of serine proteases 
and the largest parallel β-helical structure yet solved. 
 
 
Introduction 
 
Autotransporters (ATs) are virulence proteins produced by a variety of 
pathogenic bacteria, including several types of Escherichia coli associated with 
severe, even fatal, diarrhea and urinary tract infections. An increasing number of 
these proteins have been discovered over the last decade, and a large body of 
research is now devoted to these proteins and their different roles in various 
diseases. ATs have evolved a unique export mechanism, the type V pathway 
(Henderson et al., 2000b; Henderson et al., 2004). Initially the protein is synthesized 
with an N-terminal leader peptide directing the protein to the periplasm via the signal 
recognition particle (SRP) (Sijbrandi et al., 2003). Once across the inner membrane, 
the C-terminal domain forms a β-barrel structure within the outer membrane, allowing 
the passenger domain to escape to the external medium, where it is released 
proteolytically from the cell (Pohlner et al., 1987; Klauser et al., 1993; Jose et al., 
1995). Recently the crystal structure of a translocator (membrane) domain of an AT 
has been solved (Oomen et al., 2004). AT passenger domains are generally more 
than 100 kDa in size and vary widely in sequence and function but include a group of 
closely related serine proteases, the SPATE family (serine protease autotransporters 
of the Enterobacteriaceae). These proteins are found only in pathogenic bacteria, but 
their precise roles remain unknown (Henderson and Nataro, 2001; Dutta et al., 2002). 
The SPATE family includes EspC from enteropathogenic E. coli (Stein et al., 1996), 
EspP from enterohemorrhagic E. coli (Brunder et al., 1997), plasmid-encoded toxin 
(Pet) from enteroaggregative E. coli (Eslava et al., 1998), Sat from uropathogenic E. 
coli (Guyer et al., 2000), Tsh and Vat from avian pathogenic E. coli (Provence and 
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Curtiss, 1994; Parreira and Gyles, 2003), and Pic and SepA from Shigella flexneri 
(Benjelloun-Touimi et al., 1995; Henderson et al., 1999). These AT proteins are 
associated with a number of serious, possibly life-threatening diseases affecting 
millions world-wide. Tsh and Vat are essential virulence factors in avian diseases that 
cost the poultry industry millions of dollars annually. SPATE proteins do not appear to 
have conserved or even related functions (Henderson and Nataro, 2001; Dutta et al., 
2002). Vat has vacuolating activity, and Pet enters eukaryotic cells to disturb the 
cytoskeletal system. As essential proteins in pathogenesis, SPATE proteins are key 
drug targets and potential routes to vaccines. Knowledge of the molecular structure is 
a first step toward understanding their mechanisms and hopefully how they may be 
inactivated. We have solved the crystal structure of the passenger domain of 
Hemoglobin protease (Hbp), an AT involved in bacterial synergy in the development 
of peritonitis.  
Peritonitis is an inflammation of the peritoneal cavity and may develop into a 
life-threatening condition through the formation of persistent abscesses, which leak 
pathogenic bacteria into the general circulation (Aldridge, 1995; Farthmann and 
Schöffel, 1998). This common complication of invasive surgery then results in septic 
shock and multiorgan failure with mortality rates well in excess of 50%. These 
abscesses are difficult to treat with antimicrobial therapy, and usually require surgical 
intervention. It is frequently found that pathogenic E. coli and the strictly anaerobic 
Bacteroides fragilis occur together in intra-abdominal abscesses, the combination 
surviving better than either species alone (Rotstein et al., 1989a; Otto et al., 2002). B. 
fragilis is a common member of the normal human gut flora, but it is also a significant 
opportunistic pathogen (Aldridge, 1995; Farthmann and Schöffel, 1998). It promotes 
fibrin deposition by the host, which localizes the bacteria and prevents systemic 
spread, but also provides an environment where the bacteria can escape attack by 
the immune system. In return, E. coli helps to supply both species with heme 
scavenged from hemoglobin (Hb). Hbp was discovered as the protease secreted by 
E. coli, which degrades Hb and binds heme (Otto et al., 1998; Otto et al., 2002). The 
hbp gene is located on a large episome, pColV-K30, which also encodes an 
aerobactin-dependent iron uptake system (Williams, 1979). Hbp is highly expressed 
by E. coli during peritonitis and plays a key role in bacterial synergy with B. fragilis. 
Adding Hbp and heme to cultures of B. fragilis was shown to stimulate growth, and 
mice immunized with Hbp showed no abscess formation when subsequently 
challenged with mixed E. coli/B. fragilis cultures. Hbp therefore appears to be a useful 
target in the treatment and prevention of peritonitis. We have determined the crystal 
structure of Hbp with the longer term view of producing inhibitors, vaccines, or other 
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treatments for peritonitis and other diseases caused by SPATE proteins. From this 
first molecular model of an AT, we have constructed homology models of other ATs 
to observe both common and unique features of these proteins. 
 
 
Materials and Methods 
 
Protein Purification and Crystallization 
The cloning of Hbp has been described previously (Otto et al., 1998). E. coli 
strain DH5α harboring plasmid pACYC-Hbp was grown to an A600 of 0.6 in MA 
medium, and the supernatant was collected and concentrated. Following 1000-fold 
concentration by ultrafiltration, the protein was purified by gel filtration in 10 mM Tris-
HCl, pH 8.0, 300 mM sodium chloride. Apo-Hbp was crystallized by the published 
method (Tame et al., 2002). 4 mg/ml protein was crystallized using the hanging drop 
method using 0.1 M sodium acetate, pH 4.6, 200 mM ammonium sulfate, 10% 
glycerol, and 15–20% polyethylene glycol 6000. 
 
Data Collection and Processing 
Multi-wavelength x-ray data were collected at beam line 45XU-PX, SPring8, 
Harima, Japan. Native data were collected at beam line BL5 of the Photon Factory, 
Tsukuba, to a resolution of 2.2 Å. All data were indexed and integrated using 
HKL2000 and scaled with the program SCALEPACK (Otwinowski and Minor, 1997). 
The crystals are in space group P6122 with unit cell dimensions of a = b = 114.86 Å, c 
= 437.05 Å, with one molecule per asymmetric unit and a solvent content of 65%. 
 
Structure Determination and Refinement 
The structure of Hbp was solved by MAD (multiple-wavelength anomalous 
dispersion) using selenomethionine-containing protein. Phase determination and 
refinement were performed using the programs SOLVE and RESOLVE (Terwilliger 
and Berendzen, 1999; Terwilliger, 2003). 12 Se sites were located out of 14 
expected. The 3.0-Å resolution electron density map obtained from RESOLVE was of 
sufficient quality to permit unambiguous chain tracing without further refinement of 
the heavy atom sites. After model building using the programs O (Jones et al., 1991) 
and Turbo (Roussel and Cambillau, 1989), initial refinement was carried out with 
XPLOR (Brunger, 1996) and final refinement with REFMAC (Collaborative 
Computational Project, 1994; Murshudov et al., 1999) using the 2.2-Å resolution 
native data. Solvent molecules were placed at positions where spherical electron-
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density peaks were found above 1.5 σ in the 2Fo – Fc map and above 3.0 σ in the Fo 
– Fc map and where stereochemically reasonable hydrogen bonds were allowed. The 
final model extends from the N terminus (residue 1 of the mature protein) to residue 
1048, the C-terminal residue of the passenger domain. The Ramachandran plot has 
86% of the residues in the most favorable regions and none in disallowed regions. A 
summary of the data collection and refinement statistics is given in Table 1. The final 
model and structure factors have been deposited in the Protein Data Bank (PDB, 
1WXR). 
 
Table 1. Data collection and refinement statistics 
 
Space group, unit cell dimensions (Å)   P6122, a = b = 114.86, c = 437.05 
Wavelength (Å) peak inflection remote 
Resolution range (Å)  50.0-3.0 50.0-3.0 50.0-3.0 
Reflections (measured/unique)  214,532/33,539 242,451/34,130 232,344/33,910 
Completeness (overall/outer shell, %)a 95.4/88.5 98.8/92.6 96.0/87.7 
Rmerge (overall/outer shell, %)a 10.2/21.2 8.3/18.3 8.5/18.8 
Redundancy (overall)  6.4 7.1 6.9 
Mean <I/σ(I)> (overall) 7.8 8.9 8.3 
Phasing (20.0-3.0 Å)   
Mean FOMc after SOLVE phasing  0.33 
Refinement statistics   
  Refinement resolution (Å) 30.0-2.20   
  Reflections (measured/unique) 525,426/81,279  
  Completeness (overall/outer shell, %)a 92.3/70.8   
  Rmerge (overall/outer shell, %)a,b  5.8/31.8   
  Redundancy (overall)  6.5    
  Mean <I/σ(I)> (overall) 11.0    
  σ cut-off/reflections used 0.0/81,279  
  R-factord/free R-factor (%)b 20.3/24.3   
  R.m.s.d. bond lengths/bond angles (Å) 0.016/1.7   
  Water molecules 399    
  Average B-factor (protein/water, Å2) 35/33 
Ramachandran plot 
  Residues in most favorable regions (%) 86.1    
  Residues in additionally allowed regions (%)  12.9 
  Residues in generously allowed regions (%) 1.0   
     
a Completeness and Rmerge, are given for overall data and for the highest resolution shell 
(overall/the highest resolution shell).The highest resolution shells for the MAD data and native 
data are 3.11-3.0 Å and 2.28-2.20 Å, respectively. 
b Rmerge = Σ Ii – <I>/Σ Ii ; where Ii is intensity of observation and <I> is the mean value for that 
reflection. 
c Figure of merit (FOM) = Fbest/F. 
d R factor = Σ||Fo(h) – Fc(h)||/ΣhFo(h); where Fo and Fc are the observed and calculated 
structure factor amplitudes, respectively. The free R-factor was calculated with 5% of the data 
excluded from the refinement. 
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Results 
 
The overall structure of the protein is shown in Fig. 1. The most striking 
feature is the right-handed β-helical C-terminal tail which extends from residue 260 
onwards, forming three parallel β-sheets. This is highly similar to pertactin (PDB 
1DAB) (Emsley et al., 1996) and the N terminus of filamentous hemagglutinin (PDB 
1RWR) (Clantin et al., 2004), both adhesins from Bordetella pertussis. Pertactin is 
the only AT structure refined to date, one of only a dozen or so right-handed parallel 
β-helix protein structures so far solved. The first was the pectate lyase PelC (PDB 
1AIR), and a number of different pectate lyase structures are now known (Jenkins 
and Pickersgill, 2001). The pectate lyase superfamily members are a functionally 
eclectic mix including P22 tailspike protein (PDB 1TYU), chondroitinase B (PDB 
1DGB) and insect cysteine-rich antifreeze protein (PDB 1EZG). All share a similar 
pattern of repeats of about 25 amino acid residues which form one turn of the right-
handed helix. Each turn creates three β-strands which form extended β-sheets with 
neighboring turns. The core of this region is generally but not exclusively 
hydrophobic. The leucine-rich repeat family is another group of protein structures 
formed from repeated sequence motifs, but these include an α-helix in each turn and 
are found to be highly curved into horseshoe shapes. The pectate lyase superfamily 
forms a much straighter superhelix. The shape of Hbp was previously determined to 
low resolution using a combination of small-angle x-ray scattering and analytical 
ultracentrifugation (Scott et al., 2002). The crystal structure shows a slightly straighter 
structure than the model from small-angle x-ray scattering, possibly due to greater 
flexibility in solution. 
The Hbp model includes 24 turns of right-handed β-helix, compared with 16 
in pertactin, the longest parallel β-helix known to date. Hbp is highly reminiscent of 
pertactin, but less regular and slightly kinked in the centre. It also has a large N-
terminal globular domain, and a smaller domain of 75 residues (481-556) about half-
way long the β-helix, as well as decorative loops where the polypeptide chain departs 
from the helical stem. The extra surface features make the length of Hbp (1048 
residues) almost twice that of pertactin (539 residues). The extended hydrophobic 
core is largely but not exclusively filled with aliphatic side chains (Fig. 2, A and B). 
The N-terminal region close to the serine protease domain has a higher proportion of 
buried aromatic residues. Very few polar residues point into the hydrophobic core, 
but Ser780 is one exception (Fig. 2, B). Other SPATE proteins generally have 
threonine at this position. Unlike the pectate lyases there are no regular “stacks” of 
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Fig. 1. A stereo ribbon diagram showing the overall structure of the entire passenger region of 
Hbp. Helices and strands are colored red for the protease domain (domain 1, residues 1-256) 
and green for the chitinase b-like domain (domain 2, residues 481-556). The β-strands in the 
parallel β-helix are colored dark blue. Residues 950-1048 (the C terminus of the mature 
protein) are colored light blue. This region is required for transport of the passenger domain 
through the membrane pore created by the C-terminal region of the complete protein. 
 
 
identical residues packed in layers within the core, but a row of asparagine residues 
is found forming an extended hydrogen bonding chain on the surface of the β-helix 
(Fig. 3). Overall the electron density for the model is very clear, but model building 
became increasingly difficult towards the C terminus. LAFIRE, a model fitting and 
rebuilding program using local correlation of electron density,1 was essential in 
assembling the last 100 residues of the model. Details of the program may be found 
at: http://altair.sci.hokudai.ac.jp/g6/Research/Lafire_English.html. There are several 
breaks in the final electron density maps in this region where short loops cannot be 
modeled. The C-terminal region from residue 950 to the end is a conserved domain 
found among AT proteins believed to assist folding after passage through the C-
terminal pore domain (Oliver et al., 2003b).  
Residues 1-256 of the model form a clearly separate domain (domain 1 in  
 
                                            
1 M. Yao, unpublished program. 
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Fig. 2. A, a slice through 
the β-helix showing the 
hydrophobic core. The 
backbone is shown as a 
green ribbon, and 
hydrophobic side chains 
are shown in pink. B, the 
2mFo - DFc electron 
density map, shown in 
stereo and contoured at 
1.3σ, showing a cross-
section through the β-
helix. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. An orthogonal 
view to Figure 2B of the 
final 2mFo - DFc electron 
density map, at the 
same contour level, 
showing a stack of 
asparagine residues on 
the surface of the β-
helix (colored red), 
which are hydrogen 
bonding through their 
side chains. These 
asparagines are not 
conserved among AT 
sequences, which have 
a variety of hydrophilic 
side chains at equivalent 
positions. 
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Fig. 1), including six β-strands rolled into a barrel-like structure, with several long β-
hairpins over its surface. The N-terminal glycine residue is deep within the structure, 
close to the bottom of the barrel. Folding of the domain can clearly only occur after 
the signal peptide has been removed. The glycine N atom hydrogen bonds to Asp206, 
which also interacts with Arg140 and the main-chain of Gly144. An α-helix (Leu245-
Asp255) connects this domain to the β-helical stem. Searching the PDB for structural 
homologues with DALI (Holm and Sander, 1993, 1995) revealed that the N-terminal 
domain is highly similar to bovine trypsin (PDB 5PTP), which gave a Z-score of 17.5 
(scores above 2.0 are considered significant). The 162 residues matched showed 
20% sequence identity to Hbp, and could be fitted with rmsd 2.5 Å over the main 
chain. The Cα traces are overlaid in Fig. 4A. Other proteases gave rather poorer 
scores. Overlaying trypsin on the model of Hbp gave an excellent match of the 
catalytic triad (Ser195, His57 and Asp102) of trypsin with Ser207, His73 and Asp101 of Hbp 
(Fig. 4B). Comparing the active sites, Hbp misses a loop (Ser93 to Asp101 in trypsin) 
just prior to the essential aspartate. In trypsin this loop includes Leu99, which contacts 
Trp215, one of the residues that forms antiparallel β-sheet interactions with the 
substrate polypeptide. Trp215 in trypsin is changed to alanine (Ala229) in Hbp, making 
the active site of Hbp much more open. At the bottom of the specificity pocket, which 
accommodates the residue preceding the scissile bond, trypsin has an aspartate 
(Asp189), which leads to the preference for Lys and Arg residues at the S1 position. 
Chymotrypsin and elastase have serine in this position, but Hbp has tyrosine (Tyr201). 
Among the trypsin/chymotrypsin family, Pro225 is very highly conserved from bacteria 
to man, but Hbp misses a loop just before this residue and the nearest equivalent is 
Gly237. Hbp is also unusual in having an asparagine residue at the position equivalent 
to glycine 226 in trypsin. Thus, although the fold of the N-terminal domain is close to 
trypsin, it also has unique features not seen in other serine proteases. The active site 
suggests broad substrate specificity with a preference for hydrophobic side chains in 
the specificity pocket. The very open active site presumably helps Hbp to attack 
folded globular proteins such as Hb, but more work is required to determine its 
functional properties as a protease. Low resolution electron density maps calculated 
using data collected with crystals soaked with two serine protease inhibitors, tosyl 
phenylalanine chloromethyl ketone (TPCK) and tosyl lysine chloromethyl ketone 
(TLCK), show peaks of density close to the active site serine, suggesting the 
protease is still active at pH 4.6 (data not shown). 
Sequence alignments of SPATE family members shows the sequence 
GDSGSPL to be highly conserved between Gly205 and Leu211 (Fig. 5). vat, an AT 
gene found in a pathogenicity island of avian pathogenic E. coli Ec222, has a slightly 
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altered sequence, ATSGSPL, which may be related to its vacuolating activity 
(Parreira and Gyles, 2003), but it maintains both the active site serine (Ser207) and 
Ser209, which hydrogen bonds to the carbonyl oxygen of Asp206 to make the turn 
carrying Ser207. The N-terminal Gly1 lies close to the active site serine and hydrogen 
bonds to the side chain of Asp206. This strongly suggests the enzyme can only 
become active after the leader peptide is removed. All SPATE proteins tested show 
proteolytic activity, but with different substrate specificities, suggesting different 
functions (Dutta et al., 2002). Replacement of the active site serine of Pet (a SPATE 
from enteroaggregative E. coli) with isoleucine did not prevent release of the 
passenger domain from the C-terminal pore, but did eliminate all cytotoxic effects 
(Navarro-Garcia et al., 2001). Comparing the sequences of various ATs shows that 
Tyr201 in the specificity pocket of Hbp is preserved in Pic and SepA, whereas Pet and 
Sap have leucine (Fig. 5). The sequence alignment also suggests that EspC has 
glutamate at this position, which presumably would affect substrate preference 
strongly. Using the N domain structure of Hbp, a homology model of Pet protease 
domain was built using SwissModel (Schwede et al., 2003). From this a second 
homology model of Sat protease domain was also constructed. The weaker 
sequence conservation between Hbp and Sat prevented a model of the latter being 
built more directly. These homology models show no unexpectedly loose packing or 
unfavorable geometry, indicating that each protein has identical connectivity, with 
minor differences in loop regions, in the N-terminal protease domain. 
The N-terminal domain makes extensive contact with the β-helical stem of 
Hbp, but given its globular shape the contact region with the roughly cylindrical β-
helix is long and narrow. Many N domain contacts are found between Asp108 and 
Val114. For example, Arg106 makes buried hydrogen bonds to the carbonyl oxygen 
atoms of Asn301 and Gly303. The main hydrophobic contact is provided by Leu110, 
which is buried at the interface. Arg106 and Lys109 are very strongly conserved among 
ATs, the latter forming a salt bridge with Asp367. Arg441 and Asp49, both well 
conserved, make another bond between the N-terminal protease domain and the β-
helix. These contacts, and the preservation of key glycines in the sequences of ATs, 
suggest that these proteins share a very similar structure over the first half of the 
protein.  
Residues 481-556 of Hbp make a small separate domain (domain 2 in Fig. 
1), the main-chain returning to the β-stem close to the point of departure. DALI found 
only one notable match, to the chitin binding domain (ChBD) of chitinase b (PDB 
1E15). This domain consists of only 49 residues folded into three antiparallel β- 
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Fig. 4. A, a stereo overlay of the Cα trace of bovine trypsin (blue) and the serine protease 
domain of Hbp (red). The Cα of the catalytic serine (Ser207) is shown as a green sphere. 
Trypsin (PDB 5PTP) was matched to Hbp by least-squares fitting residues 16-19 (1-4), 21-24 
(15-18), 26-32 (49-55), 42-60 (58-76), 63-69 (78-84), 79-93 (85-99), 101-114 (100-113), 118-
127 (114-123), 129-132 (128-131), 134-146 (136-148), 147-152 (156-161), 153-165 (163-175), 
176-183 (177-184), 184-187 (186-189), 188-202 (200-214), 224-231 (236-243), 234-245 (244-
255). These 648 main-chain atoms selected by DALI have a root mean square deviation of 
2.5 Å, and a maximum deviation of 8.2 Å. B, the 2mFo - DFc electron density map contoured at 
1.3σ over the catalytic site of the serine protease domain, showing the catalytic serine (Ser207) 
and a water molecule hydrogen bonded to it. Tyr201, the residue in the specificity pocket, is 
seen on the lower left. 
 
 
strands connected by long loops. ChBD fitted the 481-556 loop of Hbp with a Z score 
of 3.6 over 44 residues, with 16% sequence identity. Not surprisingly, the surface 
aromatic groups of ChBD presumed to bind chitin are altered in Hbp, but the 481-556 
loop has a different cluster of aromatic residues which appear to form a binding 
pocket of some sort. Tyr510 and Tyr526 point into solvent and are highly exposed (and 
make crystal contacts with a neighboring molecule). The nearby Trp492, Tyr506 and 
Phe527 make a hydrophobic pocket open to solvent. The 481-556 domain is quite 
different to any known heme-binding site, and a mutant in which this domain is 
deleted shows identical heme binding to the wild-type protein (Fig. 6). Possibly its 
function is docking to the bacterial receptor proteins, but these have yet to be 
identified. Using residues 250-615 from the Hbp model, a homology model of the 
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same region could be built (again using SwissModel) for Pic. Key residues such as 
Glu538 and Arg554, which hold domain 2 against the β-helix by a salt bridge, are 
preserved in Pic. Sequence alignment of ATs shows that Pet, Sat and EspC among 
others do not have this domain. 
 
 
 
Fig. 5. A sequence alignment of Hbp with other members of the SPATE family, covering the N-
terminal protease domain. Conservative mutations are shown in red, and residues common to 
all of the six compared sequences are shown in white on red. The UNIPROT reference 
numbers for the sequences are O88093 (Hbp), Q8CWC7 (Pic), Q8VSL2 (SepA), P77070 
(EspC), Q6KD43 (Sat), and O68900 (Pet). Secondary structure elements of Hbp are shown 
over the alignment. The conserved regions show strong correlation to these structural 
elements, with the exception of the catalytic region GDSGS. The side-chain four residues 
upstream from this sequence sits in the specificity pocket (Tyr201 in the case of Hbp). 
 
 
Residues 608-644 of Hbp form a long discursive loop projecting from the β-
helix, which also forms close contacts with the N domain. Thr616-Ala626 form an α-
helix, but this probably requires hydrophobic contact with the N domain residues Tyr9  
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Fig. 6. Heme binding by Hbp. PCR was 
used to create an Hbp mutant (called “Gdel-
2”) missing domain 2 by linking Ala481 to 
Asn556 with a glycine residue. Purified native 
Hbp and Hbp(Gdel-2) (20 pmol) were 
incubated with different concentrations of 
heme and subsequently subjected to 
nondenaturing gel electrophoresis as 
described previously (Otto et al., 1998). 
Heme containing proteins were visualized by 
tetramethyl benzidine staining. The upper 
panel shows the tetramethyl benzidine 
stained gel; lanes 1 to 3, Hbp incubated with 
0, 50 or 100 pmol of heme, respectively. 
Heme binding, shown by the dark band, is 
unchanged in the mutant. Lanes 4 to 6, 
Hbp(Gdel-2) incubated with the different 
amounts of heme. The lower panel shows 
the Coomassie-stained gel of Hbp and 
Hbp(Gdel-2). The lower molecular weight of 
the mutant is apparent. 
 
 
and Met158 in order to form. The 608-644 loop has no hydrophobic core of its own to 
suggest it is a stable independent fold. Because other ATs show no homology to Hbp 
in this region, it may be the heme binding site. Residue 629 is histidine, which is the 
most common residue bonding to heme groups, but the structure does not readily 
suggest how heme might bind. Repeated attempts to co-crystallize Hbp with heme or 
soak the crystals were unsuccessful, and mutagenesis is now underway to test the 
function of this region. The charge distribution over the molecular surface shows a 
concentration of negative charge on one face of the molecule, centered around the 
interface between the β-helix and domain 1 (Fig. 7). Further mutagenesis is required 
to determine whether this negatively charged patch is involved in heme transport.  
Sequence similarity among ATs shows an increase again towards the C-
terminal region of the passenger proteins. Glycines 868 and 875 in turns of Hbp are 
completely preserved, as are Met886 and Trp891. The β-helix structure is broken at the 
conserved Ala979/Pro980, which mark a change in the direction of the polypeptide 
chain. Breaks in the electron density prevented modeling residues 913-918, 937-941 
and 1024-1031. Despite the sequence conservation over the last 140 residues, these 
gaps in the Hbp model prevented making homology models of this region. The 
pattern of preserved residues matches very well interactions seen in the Hbp  
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Fig. 7. Surface charge of 
Hbp. The molecular 
surface of the protein, 
colored by electrostatic 
charge (red, negative; 
blue, positive). Color 
saturation corresponds to 
an electron energy of ±20 
kBT. 
 
 
 
 
 
 
 
structure however, and the C-terminal region of other ATs presumably show a very 
similar fold. Key residues include Trp1015, which is buried and forms a hydrogen bond 
through its indole side chain to make a turn in the protein backbone. 
Hbp has been shown to cross the inner membrane by the signal recognition 
particle (SRP)-dependent pathway (Sijbrandi et al., 2003), but the precise 
mechanism of transport across the outer membrane of the cell remains unclear. 
Several different proposals have been made, including the suggestion that 
autotransporters form a multimeric pore in the outer membrane (Veiga et al., 2002). 
Recently the structure of the pore-forming domain of NalP has been solved, showing 
that it is in fact a monomer, a 12-stranded β-barrel blocked by an N-terminal α-helix 
(Oomen et al., 2004). The pore diameter, roughly 10–12 Å, is insufficient to allow 
passage of folded proteins and suggests that only extended polypeptides can pass 
through. This appears incompatible with the idea that the passenger domain is 
threaded through from its C-terminal end (the hairpin model), because the pore 
would then have to accommodate two stretches of polypeptide simultaneously. An 
alternative model is that the N terminus of the passenger domain is threaded through 
the pore, but, because other protein domains fused to the pore domain are also 
transported, there is no evidence of sequence-specific interactions that target the N 
terminus to the pore. Oomen and colleagues have suggested that the passenger 
domain may instead pass though the pore of the Omp85 complex, and that the name 
“autotransporter” is in fact a misnomer (Oomen et al., 2004). From the crystal 
structure of Hbp described here, it is clear that the C-terminal domain (residues 950-
1048) of the mature protein is more flexible and mobile than the N-terminal protease 
domain. This is consistent with the prediction that the C-terminal domain plays a key 
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role in passage across the outer membrane. On the other hand, because the N-
terminal glycine of the mature protein is buried within the structure, the protease 
domain cannot fold properly until the signal peptide is removed, and this may provide 
a mechanism for keeping the protein in a readily transported form. 
 Tsh (temperature-sensitive hemagglutination), a SPATE found in avian 
pathogenic E. coli, has only two amino acid changes compared to Hbp (Provence 
and Curtiss, 1994; Stathopoulos et al., 1999; Dozois et al., 2000), but Hbp showed 
no hemagglutination activity in tests (Otto et al., 1998). Recently this result has been 
confirmed for Tsh. The two mutations, Lys157  Gln and Thr790  Ala, are both on the 
protein surface. Lys157 is roughly 18 Å from the active site, but replacement with 
glutamine seems unlikely to alter the functional behavior of the protein greatly. Hbp 
and Tsh are therefore essentially identical, suggesting that Tsh too is a hemoglobin 
protease. If so, then the name “Tsh” seems redundant, and we suggest the name 
“Hbp” be used exclusively in future. Tsh has been shown to bind red blood cells, 
hemoglobin, fibronectin, and collagen IV (Kostakioti and Stathopoulos, 2004). It 
remains to be tested which of these are bound by domain 2. 
 
 
Discussion 
 
Hbp was first purified from E. coli EB1, a strain isolated from an intra-
abdominal wound infection (Otto et al., 1998). Without Hbp, E. coli and B. fragilis are 
unable to form abscesses and are more readily cleared from the site of infection by 
the immune system, presumably due to iron limitation. Although a great deal is 
known about iron uptake by pathogens through siderophores, very few bacterial 
heme uptake systems have been characterized in molecular detail. The best 
understood is the HasA protein of Serratia marcescens for which a crystal structure 
has been refined to 1.9 Å (Arnoux et al., 1999). Hbp has a quite different fold, and is 
over five times larger. Much of the biology involving Hbp remains to be elucidated. 
No surface protein from either E. coli or B. fragilis has yet been identified which can 
interact with Hbp and receive heme from it, yet these must presumably exist given 
the known effects of the protein on these bacteria under conditions of iron limitation. 
B. fragilis up-regulates expression of a number of proteins under iron-limiting 
conditions (Otto et al., 1998), and these are currently being examined as possible 
receptors for Hbp. 
One functional role of Hbp is to remove heme from Hb and supply it to 
bacteria growing within the body. The crystal structure shows a novel trypsin-like 
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serine protease domain that is well conserved among the SPATE family. The overall 
β-helix architecture is also common to the ATs, but different loops and domains 
carried by this stable fold appear to give the proteins distinctive functional properties. 
Hbp does not have a sequence motif or structural domain which resembles a known 
heme binding site. Further heme binding studies with mutants of Hbp and other ATs 
are currently underway to determine how heme interacts with Hbp. 
Homology models of other ATs based on the Hbp structure described here 
will hopefully be useful in designing new experiments to test their functional roles and 
find ways to block their activity. Hbp may be a convenient vehicle for presenting 
peptides for antibody and vaccine production, by inserting them in place of domain 2. 
Domain 2 itself may well allow us to produce a clinically useful vaccine to reduce 
substantially the occurrence of severe peritonitis. 
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Abstract 
 
Hemoglobin protease (Hbp) is an autotransporter protein produced by some 
pathogenic Escherichia coli species. Autotransporters are found in a variety of Gram-
negative bacteria and have a common mechanism of secretion: a N-terminal signal 
sequence for translocation across the inner membrane and a C-terminal 
translocation unit necessary for translocation across the outer membrane. The 
translocation unit is composed of a predicted α-helical linker region and a β-core 
believed to form a β-barrel pore in the outer membrane to allow export of the 
passenger domain. A DNA construct was made encoding a full length Hbp in which a 
thrombin cleavage site for controlled cleavage replaced the natural cleavage site in 
the linker region. A histidine-tag was added to the linker region to facilitate 
purification of the protein. The complete recombinant Hbp pro-protein was expressed 
in E. coli and recovered from the outer membrane fraction. The histidine-tag and the 
thrombin cleavage site were found to be inaccessible for binding to a Ni2+-charged 
chelating column and thrombin, respectively, which points to a localization of the 
linker region within the β-barrel pore. The translocation unit of Hbp was also 
expressed in E. coli without a signal peptide, resulting in the accumulation of the 
protein in the cytoplasm in the form of inclusion bodies. After solubilization of the 
inclusion bodies in urea, the protein was refolded in vitro by dilution in the presence 
of detergent. Refolding resulted in pure protein that was heat-modifiable. Circular 
dichroism spectroscopy revealed a high content of β-strand in agreement with the 
prediction of a β-barrel structure. A β-barrel topology model for the Hbp translocation 
unit is proposed. 
 
 
Introduction 
 
Outer membrane proteins (OMPs) are integral membrane proteins found in 
the outer membranes of Gram-negative bacteria, chloroplasts and mitochondria. All 
bacterial OMPs of which the structure has been determined have β-barrel 
transmembrane domains composed of an even number of β-strands (Schulz, 2003). 
Most bacterial OMPs are involved in transport processes for (bio-) molecules into 
and/or out of the cell. Other OMPs have diverse functions like adhesins, proteases, 
phospholipases or structural proteins (Mogensen et al., 2005). 
Bacterial OMPs that are involved in the secretion of proteins into the 
extracellular environment can be part of various types of secretion pathways (Lee 
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and Schneewind, 2001; Henderson et al., 2004). These secretion pathways differ 
markedly in their composition and complexity. In some pathways (for instance type I 
and type III), proteins are translocated in one step across the inner and outer 
membrane, without a periplasmic intermediate. The type I system is quite simple, 
consisting of only three proteins (Gentschev et al., 2002), while the type III system 
consists of more than 20 proteins (Cheng and Schneewind, 2000). Other pathways 
first translocate the secretory protein across the inner membrane and subsequently 
translocate the periplasmic intermediate in a second step across the outer 
membrane. Here too, simple systems exist, like the type V secretion system, as well 
as more complex systems like type II, which consists of at least 12 proteins 
(Sandkvist, 2001). The type V secretion system comprises type Va, the 
autotransporter pathway, type Vb, the two-partner secretion system, and type Vc, the 
trimeric autotransporter (AT-2) pathway (Cotter et al., 2005). Several extensive 
reviews on type V and autotransporter secretion have been published recently 
(Desvaux et al., 2004; Henderson et al., 2004; Jacob-Dubuisson et al., 2004; 
Newman and Stathopoulos, 2004).  
The type Va or the autotransporter pathway can probably be considered as 
the most simple secretion mechanism, because the autotransporter protein itself 
contains most of the elements that are necessary for its secretion. The secreted 
functional protein, termed the passenger domain, is preceded by an N-terminal signal 
sequence that mediates targeting to and translocation across the inner membrane 
through the Sec translocon (Sijbrandi et al., 2003). Following the passenger is a C-
terminal translocator domain that is necessary for translocation across the outer 
membrane (Pohlner et al., 1987). This translocator domain consists of a predicted 
outer membrane β-barrel forming structure preceded by a linker domain (Konieczny 
et al., 2001; Oliver et al., 2003a). The current models for outer membrane 
translocation predict that the passenger is translocated to the cell surface either in an 
unfolded state through a pore formed by the β-barrel translocation domain (Oliver et 
al., 2003b), or (partially) folded through an oligomeric ring formed by multiple barrels 
(Veiga et al., 2002). The autotransporter β-barrels are predicted to consist of 10 to 14 
amphipathic transmembrane β-strands connected by hairpin turns and loops (Jacob-
Dubuisson et al., 2004). Recently, the first crystal structure of an autotransporter 
translocator domain was published (Oomen et al., 2004). The translocation unit of the 
Neisseria meningitidis autotransporter NalP (AspA) was shown to consist of a β-
barrel formed by 12 antiparallel β-strands around a central cavity. This pore was 
occupied by an α-helix that was formed by the linker region. The dimensions of the 
pore, circa 10 by 12.5 Å, and the presence of the helix in the barrel point towards a 
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translocation mechanism by which the passenger is translocated through the β-barrel 
pore. 
Also quite recently, the first complete crystal structure of an autotransporter 
passenger domain, of the Escherichia coli Hemoglobin protease (Hbp), was 
published (Otto et al., 2005). Hbp is a serine protease autotransporter that is involved 
in the pathogenic synergy between E. coli and Bacteroides fragilis in human intra-
abdominal infections (Otto et al., 1998; Otto et al., 2002). The secreted passenger 
degrades hemoglobin and binds heme, which is probably delivered to both bacterial 
species. The structure of the passenger domain of Hbp was resolved to 2.2-Å 
resolution and shows a somewhat globular N-terminal protease domain followed by a 
very large right-handed β-helical structure with several smaller domains or loops 
protruding from this backbone.  
In this chapter, the translocator domain of Hbp is studied in more detail. The 
final goal is to resolve the crystal structure of the Hbp translocator to gain more 
insight in the mechanism of passenger translocation and to be able to compare the 
similarities and differences between several autotransporter translocator domains. 
The purification process, as well as the in vitro folding of the Hbp translocator domain 
is described, and a model for the predicted topology of the translocation unit is 
presented. 
 
 
Materials and methods 
 
Bacterial strains, plasmids and media 
The Escherichia coli strain Top10F’ (Invitrogen) and the plasmid pACYC184 
(Chang and Cohen, 1978) were routinely used in cloning procedures. The E. coli 
strain BL21AI (Invitrogen) and the plasmid pET11a (Novagen) were used for 
subcloning and controlled expression of β-barrel inclusion body constructs. The E. 
coli strain BL21(DE3)omp8 (a gift from R. Koebnik) (Prilipov et al., 1998) was used 
for expression and purification of the construct pACYC-HbpThromHisBarrel. The E. 
coli strains were routinely grown in Luria-Bertani (LB) medium (Miller, 1992). 
Appropriate antibiotics were added to the culture medium. For culturing of the strain 
BL21(DE3)omp8, the chemically defined MA medium was used (Miller, 1992). 
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Table 1. Plasmids used in this study 
pACYC-Hbp (Otto et al., 2002) 
pACYC-HbpHisBarrel (this study) 
pACYC-HbpThromHisBarrel (this study) 
pET11a (Novagen) 
pET11a-βHbp 
encodes residues 1102 to 1377, starts at amino acid +2 after 
natural cleavage site, introducing mutation Leu1102Met 
(this study) 
pET11a-β13Hbp 
encodes residues 1088 to 1377, starts 13 amino acids 
upstream of natural cleavage site at Met1088 
(this study) 
pET11a-β25Hbp 
encodes residues 1076 to 1377, starts 25 amino acids 
upstream of natural cleavage site, introducing mutation 
Arg1076Met 
(this study) 
 
 
General methods 
Recombinant DNA techniques were carried out as described (Sambrook et 
al., 1989). DNA sequencing was carried out using the Big Dye Terminator Cycle 
sequencing kit on an ABI Prism 310 automated sequencer (Perkin Elmer). Bound 
antibodies were visualized on immunoblots by chemiluminescence. The (relative) 
intensity of protein bands from both chemoluminescent blots and Coomassie-stained 
gels were quantified using a FluorS MultiImager with the Multi-Analyst software 
package (BioRad). 
 
Polyclonal antibodies and reagents 
Goat anti-rabbit HRP-conjugated antibodies used for immunodetection were 
obtained from BioRad. For Western blotting, anti-β-barrel antiserum raised against 
purified β-barrel was used. Restriction enzymes, the Expand long template PCR 
system, Complete EDTA-free protease inhibitors and the Lumi-light western blotting 
substrate were obtained from Roche Molecular Biochemicals. IPTG was purchased 
from Anatrace. The zwitterionic detergent SB3-12 was obtained from Fluka. Acidic 
impurities from SB3-12 were removed as described (Kramer et al., 2000). Sigma 
Chemicals supplied all other chemicals. 
 
Construction of plasmids 
The T7 expression system was used for IPTG-arabinose inducible 
expression of β-barrel inclusion bodies (Studier et al., 1990). The β-barrel from the 
hbp gene was amplified by PCR using the plasmid pACYC-Hbp as template DNA. 
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Primers used were the BarNdeI primer (5’-CATTGCATATGAACAAACGCATGGGC-
GATTTG-3’, with the NdeI restriction site in boldface letters) and the BamHI primer 
(5’-TATAACCTAGGTCTCTACACAAGTCCTCAATC-3’, with the BamHI restriction 
site in boldface letters). Constructs encoding 13 or 25 extra amino acids in front of 
the β-barrel were also constructed using the primers Bar13NdeI (5’-CCTGTG-
CATATGCACATCAGCTATAACAACTTCCATC-3’ with the NdeI restriction site in 
boldface letters) or Bar25NdeI (5’-CTTCCCATATGAACGACGGCCAGGGTAAG-
GTG-3’ with the NdeI restriction site in boldface letters) in combination with the 
BamHI primer. The three fragments were cloned into pET11a using the created NdeI 
and BamHI restriction sites, resulting in the plasmids pET11a-βHbp, pET11a-β13Hbp 
and pET11a-β25Hbp. 
A histidine tag was introduced at the N-terminal side of the Hbp β-barrel in 
the full-length construct by nested PCR using pACYC-Hbp as template DNA. In the 
first amplification rounds, the primers used were the gap4,10for primer (5’-
GAACTCAACACTGACCAGTAC-3’) which anneals just upstream of the natural KpnI 
restriction site in the Hbp passenger domain and the HisβBarRev primer (5’-
ATGGTGGTGATGGTGATGGCGTTTGTTCAGGTTGTTAACTTCAGTGATGAAGTT-
GTTATAGC-3’ with the His-tag in boldface letters) for the first fragment and the 
HisβBarFor primer (5’-CATCACCATCACCACCATATGGGCGATTTGAGGGATAT- 
TAATGGCGAAGCCGGTACGTGGG-3’ with the His-tag in boldface letters) and the 
BamHI primer for the second fragment. Both fragments were used together as 
template DNA in the second amplification round using the gap4,10for primer and the 
BamHI primer. Using the KpnI and BamHI restriction sites, the fragment was inserted 
into the corresponding sites of pACYC-Hbp, resulting in the plasmid pACYC-
HbpHisBarrel. 
This plasmid was then used to make a construct encoding Hbp, in which a 
thrombin cleavage site for controlled cleavage replaced the natural cleavage site 
between passenger domain and translocation unit. This thrombin-cleavable His-
tagged construct was also made by nested PCR. In the first amplification rounds, the 
primers used were the gap4,10for primer and the ThromBbarRev primer (5’-
ACTACCGCGTGGCACCAGGTTGTTATAGCTGATGTGCATGAATGTGGCGGCA-
GCCTTACCCTG-3’ with the thrombin cleavage site in boldface letters) for the first 
fragment and the ThromBbarFor (5’-CTGGTGCCACGCGGTAGTAACCTGAAC- 
AAACGCCATCACCATCACCACCATATGGGCGATTTG-3’ with the thrombin 
cleavage site in boldface letters) primer and the BamHI primer for the second 
fragment. Both fragments were used together as template DNA in the second 
amplification round using the gap4,10for primer and the BamHI primer. Using the 
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KpnI and BamHI restriction sites, the fragment was inserted into the corresponding 
sites of pACYC-HbpHisBarrel, resulting in the plasmid pACYC-HbpThromHisBarrel. 
All constructed plasmids were sequenced to check for second site 
mutations. 
 
Purification of native translocator domain from the outer membrane 
Native Hbp translocator domain was purified from the outer membrane of E. 
coli BL21(DE3)omp8 (pACYC-HbpThromHisBarrel) over-expressing full length Hbp 
with a thrombin cleavage site between the passenger domain and the β-barrel to 
cleave off the β-barrel in vitro. Cells were cultivated in 4 L MA medium at 37 °C to an 
OD660 of circa 0.6. Cells were harvested, washed and resuspended in 40 ml buffer K 
(50 mM triethanolamine-HAc, 250 mM sucrose and 1 mM EDTA, pH 7.5). The whole 
procedure was carried out on ice or at 4 °C. Complete EDTA-free protease inhibitors, 
1 mM EDTA, DNase and RNase were added and the cells were lysed using a French 
pressure cell. The cellular debris was removed by centrifugation at 11.000 rpm in a 
Sorvall SS34 rotor for 5 min (twice). A total membrane preparation was obtained by 
ultracentrifugation of the lysate at 165.000 × g for 90 min. The membrane pellet was 
washed in 50 mM Tris-HCl, pH 8.0. Inner membrane proteins were selectively 
removed by dissolving the membranes in 10 ml 50 mM Tris-HCl, pH 8.0 with 0.2% 
sodium-sarkosyl for 1 h. An outer membrane enriched protein fraction was obtained 
by ultracentrifugation at 300.000 × g for 20 min. Outer membrane proteins were 
extracted from the membranes by incubation for 1 h at room temperature in 4 ml 50 
mM Tris-HCl, pH 8.0 with 1% Triton X-100. Undissolved material was removed by 
ultracentrifugation at 300.000 × g for 20 min at room temperature. The buffer for the 
dissolved proteins was exchanged into Tomp buffer (20 mM Tris-HCl, 125 mM NaCl, 
2.5 mM CaCl2 and 0.5% SB3-12, pH 8.0) using a HiTrap desalting column 
(Amersham Biosciences). The β-barrel was cleaved from the full length Hbp protein 
using the introduced thrombin cleavage site. The 8 ml sample was incubated 
overnight with circa 90 µg of human α-thrombin (Haematologic Technologies). The 
protein sample was diluted 2.5 times in 20 mM Tris-HCl, pH 8.0 and loaded on a 
HiTrap DEAE column (Amersham Biosciences) equilibrated in 20 mM Tris-HCl, 50 
mM NaCl, pH 8.0 with 0.2% SB3-12. Bound proteins were eluted from the column 
using a linear gradient to 500 mM NaCl. Samples taken during the procedure were 
analysed by SDS-PAGE and Coomassie staining. 
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Isolation of inclusion bodies 
 For production of inclusion bodies, E. coli BL21AI cells harboring plasmids 
pET11a-βHbp, pET11a-β13Hbp or pET11a-β25Hbp, encoding three versions of the 
Hbp translocator domain, were grown in 4 L LB medium at 37 °C. At OD660 = 0.4, 
expression was induced with 0.2% arabinose and 1 mM IPTG for 2 h. Cells were 
harvested and resuspended in 60 ml 50 mM Tris-HCl and 2 mM EDTA, pH 8.0. 
DNase was added and the suspension was lysed using a French pressure cell. Then 
1/10 volume 1% Triton X-100 was added and the suspension was incubated at 30 °C 
for 20 min. The sample was centrifuged at 20.000 × g for 10 min at 4 °C. Repeated 
washing and centrifugation steps purified the pellet fraction containing the inclusion 
bodies. The pellet was first washed in ice-cold 50 mM Tris-HCl (pH 8.0) containing 
100 mM NaCl, 1 mM EDTA and 1% NP-40. Then the pellet was washed in ice-cold 
50 mM Tris-HCl (pH 8.0) containing 100 mM NaCl and 1 mM EDTA. Subsequently, 
the pellet was washed in ice-cold 50 mM Tris-HCl (pH 7.0) containing 1 M urea. 
Finally, the pellet was resuspended in 4 ml ice-cold 20 mM Tris-HCl (pH 7.0) 
containing 0.1 M glycine. The purity and concentration of the translocator domain 
containing inclusion bodies was analyzed by SDS-PAGE and Coomassie staining. 
 
In vitro refolding of translocator domain inclusion bodies 
For small scale refolding experiments, 1 mg of translocator domain 
containing inclusion bodies was centrifuged at 20.000 × g for 15 min. The 
supernatant was removed and the inclusion bodies were unfolded in 100 µl buffer A 
(20 mM sodium phosphate (NaH2PO4 / Na2HPO4), 100 mM glycine, pH 7 to which 
solid urea was added to 8 M). The sample was incubated O/N on a shaker at room 
temperature. The non-dissolved material was pelleted by ultracentrifugation at 
300.000 × g for 1 h. Unfolded protein was refolded by rapid dilution at room 
temperature in 900 µl buffer B (20 mM sodium phosphate (NaH2PO4 / Na2HPO4), 1 M 
NaCl, 0.5% SB3-12, pH 7.0). Refolding was allowed to occur over a period of 3 days 
at 37 °C while the sample was standing still. Aggregates were removed by 
centrifugation at 20.000 × g for 15 min. To be able to record CD spectra, the refolded 
protein samples were dialyzed against buffer C (20 mM sodium phosphate (NaH2PO4 
/ Na2HPO4), 100 mM NaCl, 0.2% SB3-12, 80 mM urea, 1 mM glycine, pH 7.0) for 3 h. 
Subsequently, the samples were centrifuged at 20.000 × g for 15 min and 
concentrated 2-3 times using a Microsep microconcentrator (Pall Life Sciences). CD 
spectra were recorded at room temperature on a Jasco J-600 spectropolarimeter. 
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Results 
 
For a fast and easy purification procedure of the Hbp translocator domain 
under native conditions, a construct was prepared containing two modifications in the 
predicted α-helical linker region (Fig. 1). The natural cleavage site of Hbp (between 
Asn1100 and Asn1101) was replaced by a thrombin cleavage site for controlled 
cleavage of the passenger from the translocator domain. Also, a histidine tag was 
introduced near the N-terminal end of the translocator domain sequence to facilitate 
the purification of the translocator domain. 
 
 
Fig. 1. A, Partial amino acid sequence of wild type Hbp (bottom) and the HbpThromHisBarrel 
construct (top), indicating the transition between the passenger and the translocation unit, 
consisting of the linker region and the predicted β-barrel. At the bottom, the C-terminal end of 
the passenger domain (passenger), the α-helical linker region (linker) and the N-terminal end of 
the predicted β-barrel (random coil, followed by a β-strand) are indicated schematically for the 
wild type protein. C = random coil, H = α-helix, E = β-strand, as predicted by the PSIPRED 
algorithm (http://bioinf.cs.ucl.ac.uk/psipred/). In the wild type sequence, the natural cleavage 
site is indicated by the arrow marked Hbp? since Hbp is presumed to be responsible for the 
cleavage reaction. In the HbpThromHisBarrel construct, the introduced thrombin cleavage site 
(boldface letters) is indicated by the arrow marked Thrombin. The introduced histidine tag in 
this construct is also indicated (boldface letters). B, Partial amino acid sequence of the 
inclusion body constructs β-0, β-13 and β-25 Hbp. All sequences start at their respective N-
termini. Mutated amino acids with respect to the wild type Hbp sequence are shown in boldface 
letters. 
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This construct (pACYC184-HbpThromHisBarrel) was introduced into E. coli 
BL21(DE3)omp8 cells for high expression of the modified Hbp. This strain is lacking 
eight major outer membrane proteins, thereby creating more available space in the 
outer membrane for accumulation of Hbp translocator domain molecules. Cells 
expressing this construct were collected and after cell lysis, a total membrane pellet 
was obtained by ultracentrifugation. Inner membrane proteins were selectively 
removed by incubation of the membranes in 0.2% sodium sarkosyl and 
recentrifugation. In this way, a crude outer membrane pellet was obtained, that was 
dissolved in 1% Triton X-100 to extract the outer membrane proteins from the 
membranes (Fig. 2, lanes 1-8). Subsequently, thrombin was added to the outer 
membrane proteins in order to cleave the translocator domain from the Hbp protein 
using the introduced thrombin cleavage site. The buffer in which the outer membrane 
proteins were dissolved was changed into a thrombin cleavage buffer, and thrombin 
cleavage was allowed to take place overnight. As shown in Fig. 2 (lane 9), the pro-
Hbp (translocator domain plus passenger domain) form of 142 kDa was still present 
in the thrombin treated sample and no accumulation of translocator domain (ca. 32 
kDa) was detectable. Only when the concentration of the detergent SB3-12 was 
increased to at least 1%, the translocator domain was cleaved off. However, this was 
probably due to (partial) unfolding of the protein, as the CD spectrum that was 
recorded for this sample did not show a β-fold conformation (data not shown). 
 
 
Fig. 2. Purification and thrombin cleavage of the HbpThromHisBarrel construct. Samples taken 
at different steps during the purification and thrombin cleavage procedures were resolved on an 
11% SDS-PAGE gel and stained with Coomassie. Relative molecular weight markers are 
indicated on the left of the figure, and the position of pro-Hbp in the gel is indicated on the right. 
The contents of the lanes are indicated above the figure and further explained in the text. 
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In another approach, the pro-Hbp was first purified using the histidine tag 
and then cleaved with thrombin. However, despite several attempts, the pro-Hbp did 
not bind to a Ni2+-charged chelating column (data not shown). These results suggest 
that both the thrombin cleavage site and the histidine tag are not accessible in the 
isolated and native protein possibly due to a localization of these sites halfway inside 
the channel.  
In an alternative approach, the translocator domain was expressed inside 
the E. coli cytoplasm in the form of inclusion bodies. Three different constructs for 
translocator domain proteins of various lengths were made. The β-0 construct 
encodes a translocator domain that starts just one amino acid after the natural 
cleavage site of Hbp. The β-13 construct starts 13 amino acids upstream of the 
natural cleavage site and the β-25 construct starts 25 amino acids upstream the 
natural cleavage site. The latter two variants contain a larger part (β-13) or even the 
complete (β-25) predicted α-helical linker (Fig. 1). The constructs were introduced 
into E. coli BL21AI cells for the production of inclusion bodies. After culturing and 
induction for 2 h, the cells were harvested and analyzed. Analysis of cells under a 
phase contrast light microscope clearly showed the inclusion bodies in the β-0 and β-
13 expressing cells, but hardly any inclusion bodies in the cells with expression the 
β-25 construct. The inclusion bodies were isolated and purified. The purity and 
concentration of the translocator domain containing inclusion bodies were analysed 
by SDS-PAGE and Coomassie staining (Fig. 3A). In accordance with the 
observations under the light microscope, only small amounts of β-25 protein were 
detected in the inclusion body preparations. 
Equal amounts of protein from all three inclusion body preparations were 
unfolded overnight in 8 M urea. After removal of non-dissolved material by 
centrifugation, the unfolded proteins were allowed to refold by rapid ten-fold dilution 
in refolding buffer containing 1 M NaCl and 0.5% SB3-12. The β-25 protein did not 
dissolve well in 8 M urea, but it was found in the pellet material after the 
centrifugation step. It appeared that the β-25 protein was mainly present in the 
membranous material that still contaminated the inclusion bodies. Because of the 
lack of proper inclusion body formation the β-25 construct was not further used.  
Samples from the refolded β-0 and β-13 proteins were analyzed on an 11% 
native PAGE gel. The samples were applied either in a non-denaturing loading buffer 
or in SDS loading buffer after boiling them (Fig. 3B). For both proteins, folded as well 
as unfolded forms are visible in the native condition (lanes 1 and 2). Intriguingly, the 
folded forms of both proteins run at a similar position in the gel, below the 31-kDa  
 
Chapter 4 
 82 
 
Fig. 3. Purification and in vitro folding of translocator domain inclusion bodies. A. Equal 
amounts of purified inclusion bodies from the β-0, β-13 and β-25 inclusion body constructs 
were boiled in SDS-solubilization buffer and resolved on an 11% SDS-PAGE gel. B. Analysis of 
the refolding of the β-0 and β-13 proteins. Equal amounts of protein were dissolved and 
unfolded in buffer containing 8 M urea and subsequently refolded by rapid 10-fold dilution in 
buffer without urea containing 1 M NaCl and 0.5% SB3-12. Samples were taken in native 
sample buffer and resolved on an 11% native PAGE gel, or in SDS-solubilization buffer, boiled 
at 95°C and resolved on the same native gel. C. Effect of dialysis on the refolded proteins. The 
refolded material was dialyzed against a low-salt buffer. Samples before and after dialysis were 
resolved on an 11% native PAGE gel. n.d. = not dialyzed. d. = dialyzed. The positions of folded 
and unfolded proteins and of possible dimers are indicated between panels B and C. Relative 
molecular weight markers are indicated on the left of panels A and B. All gels were stained with 
Coomassie. 
 
 
protein marker. Besides monomeric forms around 30 kDa, some possible protein 
dimers were visible. The proteins were confirmed to be translocator domain proteins 
by western blotting using anti-translocator domain antibodies. When the refolded 
samples were boiled in SDS, the folded forms completely disappeared (lanes 3 and 
4). For the β-13 protein an extra band appeared at the position of the β-0 protein, 
which is probably partially or incorrectly folded protein.  
To be able to record circular dichroism (CD) spectra of the refolded proteins, 
the protein samples were dialyzed to lower the salt concentration. Some precipitation 
occurred during the dialysis, and the samples were centrifuged to remove all 
precipitated protein. When protein samples before and after dialysis were compared 
on native PAGE, it appeared that the unfolded proteins were quite specifically 
removed upon dialysis, while the folded proteins remained in solution (Fig. 3C). This 
step increased the folding efficiency to above 80 or 90% as quantified from the 
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Coomassie stained gels. CD spectra were recorded for the refolded, dialyzed protein 
samples to determine if the refolded proteins had a β-folded conformation as 
expected. Although impurities or buffer components disturbed the measurements 
below 200 nm, the minimum of the ellipticity around 218 nm clearly indicated a β-
folded content for both proteins (Fig. 4). 
 
 
 
Fig. 4. CD spectra of refolded Hbp translocation units. Spectra were recorded for the refolded 
and dialyzed β-0 (solid line) and β-13 (broken line) constructs. The ellipticity (θ) on the vertical 
axis is in arbitrary units. 
 
 
Discussion 
 
This study describes the purification, in vitro folding and preliminary 
characterization of the translocation unit of the E. coli autotransporter Hbp. The Hbp 
translocation unit is predicted to consist of a short α-helical linker region of circa 32 
amino acids, followed by a β-barrel structure forming a pore in the outer membrane. 
First an attempt was made to purify the translocation unit by using a mutant construct 
in which the naturally occurring cleavage site of Hbp was replaced by a thrombin 
cleavage site. In this way, complete 142 kDa pro-Hbp molecules were expected to 
accumulate in the outer membranes of E. coli cells expressing this construct. The 
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idea was then to cleave off the passenger domain from the predicted β-barrel 
structure by the addition of purified thrombin to the reaction mixture. Pro-Hbp did 
accumulate in the outer membranes and did have its passenger domain exposed at 
the cell surface (data not shown), but it was not possible to cleave off the passenger 
domain with thrombin under native conditions. Only when a high concentration of 
detergent was present, cleavage was observed. Similarly, a histidine tag that was 
introduced close to the thrombin cleavage site appeared to be unavailable for binding 
to a Ni2+-charged affinity column under native conditions. These observations led to 
the conclusion that both the thrombin cleavage site and the histidine tag are not 
exposed to the buffer/solvent in the pro-Hbp molecule. This might be related to the 
positioning of both sites within the predicted α-helical linker region or shielding by 
LPS or other membrane proteins. When an α-helix is indeed formed in Hbp, which is 
analogous to the α-helix in the NalP crystal structure and is positioned in the β-barrel 
pore, then the thrombin cleavage site and the histidine tag are predicted to be 
located inside the pore structure. 
In another attempt to obtain intracellular inclusion bodies a translocator 
domain without a signal sequence was constructed. Constructs encoding the Hbp 
translocation unit of three different lengths were used. The shortest construct starts 
just one amino acid C-terminal to the natural cleavage site of Hbp. The longest 
version starts 25 amino acids upstream of the natural cleavage site and 
encompasses the complete predicted α-helical linker region. The middle construct (β-
13) starts in between the former two and encodes about two-third of the predicted α-
helix. Hardly any inclusion bodies were formed in cells producing the β-25 construct. 
When 8 M urea was added to preparations containing the β-25 construct, the protein 
did not dissolve and was recovered in a membranous pellet after centrifugation. 
Possibly, the β-25 translocation unit may partly insert into or stick to the inner 
membranes of the cells. Experiments testing the heat-modifiability of this β-25 protein 
on native PAGE gels indicated that this mutant protein was quite stable, although it 
probably did not acquire its native conformation (data not shown). 
High amounts of proteins were easily obtained from the β-0 and β-13 
constructs. These proteins unfolded well and solubilized easily in 8 M urea. A high 
percentage of refolding was observed after dilution. Interestingly, upon dialysis 
against a low salt buffer, unfolded protein precipitated, thereby increasing the overall 
refolding efficiency. When CD spectra were recorded for these samples, the 
minimum at 218 nm clearly indicated a high β-strand content. Taken together, these 
results point towards a native β-barrel conformation for the refolded proteins encoded 
by the β-0 and β-13 constructs. 
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Fig. 5. Topology model for the Hbp translocation unit. Amino acids in β-strands are indicated in 
long rectangles, in α-helix as hexagonals and in loops or random coils as circles. The 
periplasmic turns and extracellular loops of the barrel are assigned as T and L, respectively. 
The natural cleavage site between passenger and translocator is indicated by the arrow, the C-
terminal residues of the passenger are indicated in grey. The model is based on the crystal 
structures of NalP and the Hbp passenger domain and on predictions by the PSIPRED and 
PRED-TMBB (http://bioinformatics.biol.uoa.gr/PRED-TMBB/) algorithms. 
 
 
The purified and refolded Hbp translocation units will be used for crystallization 
studies to resolve the crystal structure of the Hbp translocation unit. Because the 
crystal structure of the passenger domain of Hbp is already known (Otto et al., 2005), 
the complete Hbp structure would then be known, crystallized as two separate 
entities. Furthermore, the crystal structure of the Hbp translocation unit can be 
compared with that of NalP, so far the only known structure of an autotransporter 
translocation unit (Oomen et al., 2004). Based on the crystal structure of the NalP 
translocation unit and secondary structure predictions by the PSIPRED (McGuffin et 
al., 2000) and PRED-TMBB (Bagos et al., 2004) algorithms, a topology model for the 
translocation unit of Hbp has been developed (Fig. 5). Like NalP, in the model, Hbp 
contains 12 antiparallel β-strands forming a pore and an α-helical linker spanning the 
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membrane. Using the program Deep View / Swiss-Pdb Viewer (Guex and Peitsch, 
1997), a homology model for the three-dimensional structure of the Hbp translocation 
unit was devised, based on the crystal structure of the NalP translocation unit (Fig. 
6). The crystal structure itself will have to reveal whether the α-helix occupies the 
pore, like in NalP, or whether it is located outside the barrel. In contrast to NalP, the 
major part of the helix in Hbp remains connected to the passenger domain after 
cleavage from the translocation unit (depicted in Fig. 1A and 5). In case the α-helix 
will be found within the barrel, a model can be developed in which passenger domain 
translocation proceeds through the β-barrel pore. This translocation process could be 
either N terminus first (the threading model) (Oomen et al., 2004) or C terminus first 
(the hairpin model) (Pohlner et al., 1987; Henderson et al., 1998). The major 
unresolved issue for the threading model is the mechanism of targeting of the N 
terminus of the passenger domain to the pore. The hairpin model has the problem  
that the pore diameter appears not to be large enough to accommodate two 
 
 
 
 
Fig. 6. Homology model for the three-dimensional structure of the Hbp translocation unit in 
comparison with the NalP translocation unit (PDB indentifier 1UYN shown here). Homology 
modelling was carried out using the Deep View / Swiss-Pdb Viewer program 
(http://www.expasy.org/spdbv/), in which the primary sequence of Hbp was manually aligned 
with the NalP primary sequence. The three-dimensional structure of the Hbp translocation unit 
was subsequently treaded unto the two NalP crystal structures (PDB identifiers 1UYN and 
1UYO). Note that loop 5 (L5) is not completely resolved in the NalP crystal structure, but the 
loop is present in the Hbp model. Front and top views are shown for both proteins. 
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stretches of extended polypeptide simultaneously (Oomen et al., 2004; Otto et al., 
2005). Alternatively, in case the α-helix does not occupy the pore, the multimer 
model for passenger domain translocation as proposed by Veiga et al. (Veiga et al., 
2002), will be the most probable model. However, because the membrane interface 
of the NalP translocation unit is hydrophobic, the central pore of a multimer is likely to 
be filled with outer membrane lipids. To date, translocation through a multimeric pore 
has only been observed for non-native passenger molecules. As an alternative to the 
multimer model or the models in which translocation takes place through the pore, 
Oomen et al. postulated a model involving the conserved Omp85 protein (Oomen et 
al., 2004). Autotransporter secretion has been shown to (partially) depend on Omp85 
(Voulhoux et al., 2003), but more experiments are needed to elucidate the role of this 
protein in autotransporter secretion, as Omp85 might also facilitate the outer 
membrane insertion of the translocation unit itself. In this respect it is noteworthy that 
a homologue of Omp85, YaeT, was recently found to be present in a multiprotein 
complex required for the assembly of outer membrane proteins in E. coli (Wu et al., 
2005). Another component of this complex, the lipoprotein YfgL, is involved in a 
homeostatic control mechanism that coordinates the overall assembly process of the 
outer membrane (Wu et al., 2005). This complex may very well be required for the 
insertion of autotransporter translocation units in the outer membrane. It is expected 
that the crystal structure of the Hbp translocation unit will contribute to the knowledge 
about the mechanism of autotransporter passenger domain translocation across the 
outer membrane. 
 
 
Acknowledgments 
 
We would like to thank Jessica Sipkens, Edwin van Bloois and Hugo Groot 
for their scientific contribution to this project.  
Chapter 4 
 88 
 
 
  
 
 
Chapter 5 
 
 
 
Characterization of an iron-regulated 
α-enolase of Bacteroides fragilis 
 
 
 
Robert Sijbrandi, Tanneke Den Blaauwen1, Jeremy R.H. Tame2, 
Bauke Oudega, Joen Luirink and Ben R. Otto 
 
 
1 Department of Molecular Cytology, Swammerdam Institute for Life Sciences, 
University of Amsterdam, Amsterdam, The Netherlands 
2 Protein Design Laboratory, Yokohama City University, Tsurumi, Yokohama, Japan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Published in Microbes and Infection 7 (2005): 9-18 
 
© 2004 Elsevier SAS. All rights reserved. 
Chapter 5 
 90 
Abstract 
 
This study describes the identification, cloning and molecular 
characterization of the α-enolase P46 of Bacteroides fragilis. The Gram-negative 
anaerobic bacterium B. fragilis is a member of the commensal flora of the human 
intestine but is also frequently found in severe intra-abdominal infections. Several 
virulence factors have been described that may be involved in the development of 
these infections. Many of these virulence factors are upregulated under conditions of 
iron- or heme-starvation. We found a major protein of 46 kDa (P46) that is 
upregulated under iron-depleted conditions. This protein was identified as an α-
enolase. α-Enolases in several Gram-positive bacteria and eukaryotic cells are 
located at the cell surface and function as plasminogen-binding proteins. Localization 
studies demonstrated that P46 is mainly located in the cytoplasm and partly 
associated with the inner membrane (IM). Under iron-restricted conditions, however, 
P46 is localized primarily in the IM fraction. Plasminogen-binding to B. fragilis cells 
did occur but was not P46 dependent. A 60-kDa protein was identified as a putative 
plasminogen-binding protein in B. fragilis. 
 
 
Introduction 
 
Bacteroides fragilis is a Gram-negative obligate anaerobic bacterium of the 
colon and a common member of the normal human gut flora, but it is also a 
significant opportunistic pathogen. This bacterium is the most frequently isolated 
anaerobic species from human intraperitoneal and intra-abdominal infections 
(Aldridge, 1995; Farthmann and Schöffel, 1998). These types of infection due to an 
abdominal trauma or surgery are a serious clinical problem, especially when 
abscesses are formed (Aldridge, 1995; Farthmann and Schöffel, 1998; Hall et al., 
1998). Intra-abdominal infections are polymicrobial in nature and especially, B. 
fragilis and Escherichia coli are often isolated from the abscesses (Farthmann and 
Schöffel, 1998; Hall et al., 1998). The molecular mechanism of the pathogenesis in 
these infections is poorly understood. Bacterial factors include the capsular 
polysaccharide of B. fragilis, which promotes the formation of abscesses to shelter 
the microorganisms from circulating host defense mechanisms (Tzianabos et al., 
1993), the secretion by B. fragilis of short-chain fatty acids that inhibit the killing of E. 
coli by neutrophils (Rotstein et al., 1989b) and the secretion of the heme-scavenger 
protein Hbp by E. coli, which makes heme accessible for bacterial growth to both E. 
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coli and B. fragilis (Otto et al., 1998; Otto et al., 2002). Nearly all bacterial virulence 
factors are tightly regulated with their expression linked to various environmental 
signals. Some parameters that affect virulence factor regulation include temperature, 
pH, osmolarity, carbon source availability and iron levels (Finlay and Falkow, 1997). 
In this study, we searched for virulence factors of B. fragilis regulated by iron. An 
iron-regulated α-enolase was found and characterized. 
α-Enolase is a cytosolic enzyme that catalyses the conversion of 2-
phosphoglycerate into phosphoenolpyruvate. It is therefore essential for the 
degradation of carbohydrates via glycolysis and other catabolic pathways as well as 
for glucose synthesis via gluconeogenesis. A remarkable feature of α-enolase is that 
this enzyme is also part of RNA-degradosomes, multienzyme complexes in the inner 
membrane (IM) involved in the processing of mRNAs (Carpousis et al., 1994). These 
degradosomes enable the bacterium to respond efficiently on the dynamic fluctuation 
of environmental signals. 
Interestingly, several α-enolases have been shown to possess plasminogen-
binding activity. For plasminogen-binding, α-enolase has to be cell-surface exposed. 
This unexpected feature has recently been described for several bacterial, fungal, 
nematode and human α-enolases (Redlitz et al., 1995; Pancholi and Fischetti, 1998; 
Bergmann et al., 2001; Jolodar et al., 2003; Jong et al., 2003). Conversion of 
surface-bound plasminogen into plasmin by bacterial or host plasminogen activators 
changes the bacterium into a proteolytic and invasive organism (Parry et al., 2000; 
Lähteenmäki et al., 2001). Thus, α-enolase might carry out different functions, 
depending on its subcellular localization. 
Here we report the identification and characterization of the α-enolase P46 
of B. fragilis. The expression of this protein appeared to be iron-regulated, subcellular 
redistribution of P46 occurred under iron limitation, and the enzyme did not show 
plasminogen-binding activity. A 60-kDa outer membrane (OM) protein appeared to 
be a plasminogen-binding protein in this microorganism. 
 
 
Materials and methods 
 
Bacterial strains, plasmids and media 
The clinical isolate B. fragilis BE1 (Verweij-van Vught et al., 1986) was used 
as a source of chromosomal DNA for cloning and PCR experiments and for 
functional studies on the P46 α-enolase. E. coli TOP10F’ (Invitrogen) and the 
plasmid pACYC184 (Chang and Cohen, 1978) were used in routine cloning 
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procedures (Sambrook et al., 1989). E. coli BL21AI (Invitrogen) and the plasmid 
pET16b (Studier et al., 1990) were used for subcloning and controlled expression of 
p46. The E. coli strains were routinely grown in Luria–Bertani (LB) medium (Miller, 
1992). Appropriate antibiotics were added to the culture medium. B. fragilis BE1 was 
maintained on 5% horse blood agar plates (no. 2 agar; Oxoid) and cultured 
anaerobically in BM medium (Verweij-van Vught et al., 1986) in the presence of 
50 µg/ml kanamycin and 20 µg/ml nalidixic acid (Sigma Chemicals) as the standard 
medium. Anaerobiosis was achieved using the Anaerogen system from Oxoid. 
Where indicated, 15 µM hemin, 125 µM 2,2′-bipyridyl or 150 µM Fe(II)SO4 was added 
to the culture medium. 
 
General methods 
Recombinant DNA techniques were carried out as described (Sambrook et 
al., 1989). DNA sequencing was carried out using the Big Dye Terminator Cycle 
sequencing kit on an ABI Prism 310 automated sequencer (Perkin–Elmer). The N-
terminal amino acid sequence of proteins was determined by a gas phase sequencer 
(model 470A; Applied Biosystems), which was coupled to an on-line high-
performance chromatograph. Bound antibodies were visualized on immunoblots by 
chemiluminescence (Roche Molecular Biochemicals). The (relative) intensity of 
protein bands from both chemoluminescent blots and Coomassie-stained gels were 
quantified using a FluorS MultiImager with the Multi-Analyst software package 
(BioRad). 
 
Polyclonal antibodies and reagents 
Goat anti-human plasminogen antibodies and human plasminogen used in 
plasminogen-binding assays were purchased from Haematologic Technologies. 
Rabbit anti-goat HRP-conjugated antibodies and goat anti-rabbit HRP-conjugated 
antibodies used for immunodetection were obtained from Santa Cruz Biotechnology 
and BioRad, respectively. For Western blotting, anti-P46 antiserum raised against 
purified histidine-tagged P46 (His-P46) was used. Rabbits were injected with a 
mixture of 50% of native and 50% of denatured His-P46 protein (Agrisera, Sweden). 
IgG fractions were purified from the anti-P46 antiserum and anti-Hbp antiserum (Otto 
et al., 2002) by protein A affinity chromatography (Amersham Biosciences). The IgG 
fractions were conjugated to FluoReporter Oregon Green 488 (Molecular Probes) 
and used for immunofluorescence microscopy. Anti-P44 antiserum was used to 
identify a 44-kDa iron-repressible OM protein of B. fragilis (Otto et al., 1990). 
Restriction enzymes, the Expand long template PCR system, Complete EDTA-free 
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protease inhibitors and the Lumi-light Western blotting substrate were obtained from 
Roche Molecular Biochemicals. Sigma Chemicals supplied all other chemicals. 
 
Cloning of the α-enolase gene 
The coding sequence of p46 was amplified by PCR using chromosomal DNA 
from B. fragilis BE1 as template. The primers used were the Frag46kDa-forward 
primer 5′-CTAACAAGCTTATTAATAGTGATTCTTCCGCTTCC-3′, introducing a 
HindIII site (boldface letters) 40 bp upstream of the putative promoter of p46 (see 
Fig. 1) and the Frag46kDa-reverse primer 5′-CGCGCGGATCCTAACCTTTTATCA-
TGCTATGCTATCATG-3′, introducing a BamHI site (boldface letters). The complete 
gene, including its own promoter, was cloned into pACYC184 using the created 
HindIII and BamHI sites. The plasmid pACYC-46kDa was introduced into E. coli 
TOP10F’.  
The T7 expression system was used for IPTG-arabinose-inducible 
expression of p46 (Studier et al., 1990). The p46 gene was amplified by PCR using 
the plasmid pACYC-46kDa as template DNA. Primers used were the Bf46kDa-
forward primer 5′-ACAAGAGAAACATATGAAAATAGAA-3′, with the NdeI restriction 
site in boldface letters and the Frag46kDa-reverse primer. The p46 gene was cloned 
into the expression vector pET16b using the created NdeI and BamHI sites. This 
vector allows N-terminal fusion to a cleavable histidine-tagged sequence. Plasmid 
pET16b-46kDa was introduced into E. coli BL21AI for an IPTG- and arabinose-
inducible expression of p46. Both plasmids pACYC-46kDa and pET16b-46kDa were 
sequenced to check for second site mutations. 
 
Purification of the P46 α-enolase 
Strain BL21AI(pET16b-46kDa) over-expressing the N-terminal 10His-tagged 
P46, was cultivated in 4 L of LB-medium for the isolation of P46. Cells were induced 
with 1 mM IPTG and 0.2% arabinose for 1 h at an OD660 of 0.3. The cells were 
harvested, resuspended in a phosphate-buffered saline solution (PBS), containing 
500 mM NaCl, 50 mM imidazole and protease inhibitors and lyzed using a French 
pressure cell. The obtained cell lysate was loaded on a Ni2+-charged HiTrap chelating 
column (Amersham Biosciences), washed at 100 mM imidazole and eluted in reverse 
flow using a gradient to 250 mM imidazole. Peak fractions were pooled and 
concentrated to 3.5 mg/ml with a centrifugal concentrator. Glycerol was added to 8% 
(v/v) before storage at minus 80 °C. 
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Subcellular localization of α-enolase in B. fragilis 
To determine the location of P46 in B. fragilis, cells were fractionated into 
their subcellular compartments by using sucrose density centrifugation techniques 
(Kotarski and Salyers, 1984; Otto et al., 1988). The advantages of this separation 
procedure are the high yields and purity of the different fractions and the absence of 
detergents. Cell lysates were obtained from iron-restricted and iron-unrestricted 
cultures (1200 OD660 units) by passing the cells through a 23-gauge needle and a 
French pressure cell. The cell lysate was loaded onto two-step gradients of 70% and 
37% of sucrose and centrifuged at 140,000 × g for 1 h. The upper fraction including 
the 10–37% interface was collected and run on a 37% sucrose cushion. The fraction 
above the cushion contains an enrichment of IM and soluble proteins. Membranes 
and soluble proteins were separated from each other by ultracentrifugation at 
270,000 × g for 5 h. The IM-enrichment fraction was then loaded onto a 30–60% 
sucrose step gradient and centrifuged at 140,000 × g for 16 h to purify the IM. The 
buoyant densities of the fractions were calculated from the refractive index by 
refractometry. IM were found at a buoyant density of 1.14 g/cm3. Material in the 37% 
and 70% fraction of the first two-step gradients was pelleted into a 57% sucrose 
cushion to obtain an enrichment of OM. The OM-enrichment fraction was loaded on a 
40–70% sucrose step gradient and centrifuged at 140,000 × g for 16 h to purify the 
OM. OM proteins fractionated at a buoyant density of 1.22 g/cm3. Fractions of 
interest were pooled, diluted 1:1 with PBS and centrifuged at 270,000 × g for 5 h. 
The membrane pellets were resuspended in 40% sucrose in PBS and stored at –
80 °C. To separate integral IM proteins from peripheral ones, purified IM vesicles 
were treated with 0.18 M Na2CO3 (pH 11.3) for 15 min on ice. The membrane 
fractions containing integral membrane proteins were collected by ultracentrifugation 
(10 min, 115,000 × g). The pellet and supernatant fractions contained the integral 
and peripheral IM proteins, respectively. 
 
α-Enolase activity 
For the measurement of α-enolase activity, a direct enzyme assay was used, 
as described (Pancholi and Fischetti, 1998). The assay was carried out at 37 °C in 
1 ml reaction buffer, 5 µg of purified His-P46 or P46, from which the histidine tag had 
been cleaved off, and concentrations of 2-PGE from 0 to 6.0 mM were used. The 
absorbance at 240 nm was recorded at 11-s intervals for 198 s. The initial rates of 
conversion were calculated from the resulting curves, using the extinction coefficient 
for phosphoenolpyruvate (PEP) as calculated by Pancholi and Fischetti (εm = 1164 
per M (Pancholi and Fischetti, 1998)). The kinetic determinants KM and Vmax were 
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estimated from the curve obtained by fitting the datapoints to the equation V = 
VmaxS/(S + KM) using the program KaleidaGraph (Synergy Software). 
 
Immunofluorescence microscopy 
Experiments were carried out essentially as described (den Blaauwen et al., 
2003), with the following modifications. IgG fractions from anti-P46 and control anti-
Hbp antisera were conjugated to FluoReporter Oregon Green 488 (Molecular 
Probes). The intracellular pool of P46 was visualized by permeabilization of the cells 
prior to antibody incubation. The cells were permeabilized by treatment with 0.1% 
Triton X-100 in PBS for 45 min at room temperature, washing three times with PBS 
and subsequent treatment with 400 µg/ml lysozyme and 5 mM EDTA in PBS for 
45 min at room temperature. Untreated cells were used to detect P46 localized at the 
cell surface. Incubation with the conjugated antibodies was overnight instead of 
60 min. After washing, the cells were resuspended in PBS for microscopic analysis. 
 
Identification of plasminogen-binding proteins 
A blot overlay assay (Bergmann et al., 2001) and an enzyme-linked 
immunosorbant assay (ELISA) (Konieczny et al., 2000) were used to identify 
plasminogen-binding proteins of B. fragilis. For the blot overlay assay, equal amounts 
of protein from several subcellular fractions were separated on an 11% SDS-
polyacrylamide gel and blotted electrophoretically onto PVDF membrane (Immobilon-
P, Millipore). The membranes were blocked with 4% skimmed milk powder in PBS for 
30 min before the binding reaction. The blots were incubated with human 
plasminogen (1 µg/ml) for 2 h, washed with PBS and then incubated with anti-human 
plasminogen for 2 h. After washing, the blots were probed with rabbit anti-goat HRP-
conjugated antibody (Santa Cruz Biotechnology) for 1 h. The probed blots were 
washed two times with PBS, incubated with Lumilight substrate and exposed to 
Kodak X-Omat AR film. Afterwards, the blot was stained with Coomassie Brilliant 
Blue to identify the bands visualized on film. An ELISA was carried out to detect 
surface-exposed plasminogen-binding proteins of B. fragilis. Serial dilutions of iron-
restricted and iron-unrestricted BE1 cells (initial OD660-units of 0.088) were coated to 
the wells of a microtiter plate. After coating of the cells, 4% skimmed milk powder in 
PBS containing 0.07% Tween 80 was applied to block unbound places. Plasminogen 
(1 µg/ml) was added to the wells, the cells were washed after 2 h of incubation, and 
the amount of cell-bound plasminogen was measured using an anti-plasminogen 
antibody. Absorbance at 450 nm was measured in a FLUOstar Galaxy (BMG 
Labtechnologies) plate reader and plotted in a graph. 
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Genbank accession numbers 
The obtained sequences of p46 and p60 were deposited in the 
EMBL/GenBank nucleotide database under accession number AJ495857 and 
AJ786264, respectively. 
 
 
Results 
 
The P46 protein is iron-regulated 
B. fragilis upregulates the production of several proteins in the cell in 
response to the iron-restricted conditions imposed by the host (Otto et al., 1990). 
These iron-regulated proteins may be involved in the pathogenesis of an intra-
abdominal infection by B. fragilis. SDS-PAGE protein profiles from cells grown under 
iron-depleted and normal conditions were compared. A prominent protein band with 
an approximate molecular mass of 46,000 was discovered under iron-depleted 
conditions. 
The iron-regulated expression of P46 was assayed with B. fragilis BE1 cells 
cultured under different iron-restricted conditions. Hemin or iron(II)sulfate were added 
to standard BM2-medium as additional sources of heme and excess of iron, while the 
iron-chelator 2,2′-bipyridyl was used to achieve iron-depleted conditions (Otto et al., 
1988; Otto et al., 1994). Total cell lysates were subjected to SDS-PAGE, and the 
expression levels of P46 were visualized by Coomassie staining and immunoblotting 
with specific anti-P46 antiserum (Fig. 1). As shown in lane 3 of Fig. 1, depletion of 
iron from the medium increased the levels of P46 by two- to threefold. Addition of 
iron(II)sulfate to the iron-depleted medium completely reversed this effect (Fig. 1; 
lane 4), which was not the case with the addition of equal concentrations of Cu-, Mg-, 
Mn- or ZnSO4 (data not shown). Addition of extra hemin or iron to the iron-
unrestricted medium did not completely abolish the expression of the P46 protein 
(Fig. 1, lane 2 and 5). Depletion of heme from the standard medium also resulted in 
two- to threefold increased levels of P46 (data not shown). 
Similar growth and expression experiments were carried out with E. coli 
TOP10F’(pACYC-46kDa) harboring cloned p46 under control of its own promoter 
(see below). Although expression levels were low compared to B. fragilis, the same 
upregulation of P46 expression was observed under iron-depleted conditions (data 
not shown). 
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Fig. 1. Iron-regulated expression of 
P46. SDS-PAGE profile (top) and 
Western blot analysis (bottom) of cell 
lysates from B. fragilis BE1 cells. Cells 
were grown in the presence or absence 
of 15 µM hemin, 125 µM bipyridyl (BPD) 
and/or 150 µM FeSO4, as indicated. The 
arrow indicates the position of P46 in 
the Coomassie-stained gel. Anti-P46 
antibodies were used for the detection 
P46. 
 
 
 
 
 
 
 
 
 
In previous studies (Otto et al., 1988), we characterized a 44-kDa iron-
repressible OM protein. This molecule is probably part of a heme-binding protein 
complex in the OM of B. fragilis (Otto et al., 1990; Otto et al., 1994). Immunoblot 
experiments with P46 and P44 antisera (Otto et al., 1990) showed that these two 
iron-repressible proteins co-migrate more or less at the same position in SDS-PAGE 
and can only be distinguished from each other using specific antisera. P46 is present 
in both iron-depleted and control cells, while P44 is exclusively expressed under iron-
restricted conditions (data not shown). Surprisingly, P44 appears to have a slightly 
higher molecular weight than P46 in the immunoblot assay. Another important 
difference between the two molecules is that P44 is an OM protein (Otto et al., 1988), 
whereas P46 is not (see below). 
 
The molecular characterization of P46 
Analysis of the P46 protein revealed the NH2-terminal amino acid sequence 
MKIEKITGGEILD. A protein versus translated DNA BLAST in the B. fragilis shotgun 
reads database (http://www.sanger.ac.uk/Projects/B_fragilis/) resulted in a 92% 
confidentiality hit (MKIEKITGREILD). The open reading frame (ORF) found encodes 
a putative 426-amino acid protein with a deduced monomer molecular weight of 
46.4 kDa. A protein BLAST search with the putative protein sequence in the NCBI 
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sequence database (http://www.ncbi.nlm.nih.gov/BLAST/) revealed a significant 
homology to bacterial α-enolases, a family of proteins involved in carbohydrate 
transport and metabolism. The identity between the putative B. fragilis protein and 
the α-enolase from the closely related Bacteroides thetaiotaomicron was 93% and 
with the Gram-positive Staphylococcus aureus α-enolase 72%. An NCBI Conserved 
Domain Search revealed a 97% alignment with α-enolase conserved domains. 
These results indicated that P46 is most likely an α-enolase. 
The nucleotide sequence up- and downstream of the p46 gene was further 
analyzed (Fig. 2). In total, five ORFs were detected, which encode putative proteins 
larger than 100 amino acids, all in the same direction as the α-enolase gene. The 
predicted products of these ORFs were subjected to a protein BLAST search. An 
ORF located directly upstream of the α-enolase gene encodes a putative 221-amino  
 
 
 
 
Fig. 2. Organization of ORFs of the 4692-bp contig. Part of the B. fragilis chromosome is 
indicated in a linear fashion. The positions of several HindIII, NcoI and PstI sites are indicated. 
Arrows in all six frames indicate the ORFs. The p46 gene encodes an α-enolase. The putative 
promoter and Shine-Dalgarno sequences and start codon of p46 are depicted above the 
diagram. The ORFs in the same direction as p46 and longer than 200 bp are numbered. The 
orf1 gene encodes a CrcB-like protein, the orf2 product belongs to the pentapeptide repeat 
protein and/or acetyltransferase family, and orf5 encodes a putative glycosyltransferase. No 
homologues were found for ORF 3 and 4. The sequence data of this contig can be found in the 
database of The Welcome Trust Sanger Institute (http://www.sanger.ac.uk). 
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acid protein with significant homology to the quinolone-resistance protein, Qnr (Tran 
and Jacoby, 2002). This putative protein belongs to the pentapeptide repeat protein 
family and/or acetyltransferase family. Further upstream, an ORF was found  
encoding a putative 127-amino acid protein with homology to an integral membrane 
protein that belongs to the CrcB protein family. This protein, which has been reported 
to be involved in chromosome condensation and overexpression in E. coli, leads to 
camphor resistance (Hu et al., 1996). Downstream of the p46 gene, are situated two 
ORFs which encode putative proteins without significant homology to known 
proteins. Further downstream is an ORF possibly encoding a 258-amino acid 
glycosyltransferase with significant homology to ArnC. This protein has also been 
shown to be necessary for polymyxin resistance in Salmonella typhimurium (Gunn et 
al., 1998). 
Analysis of the DNA sequence directly in front of the α-enolase gene 
revealed a putative promoter sequence and Shine–Dalgarno sequence that could 
potentially function as transcription and translation signals (Fig. 2). The p46 gene 
was cloned and expressed in E. coli for further investigations, and the cloned gene 
was sequenced to check for second site mutations. Minor differences found between 
the nucleotide sequences of p46 and the α-enolase of B. fragilis NCTC9343 
(http://www.sanger.ac.uk/Projects/B_fragilis/) did not result in amino acid differences. 
 
 
 
 
 
 
 
Fig. 3. Purification of His-tagged P46. E. coli 
BL21AI(pET16b-46kDa) was used to overexpress the 
histidine-tagged α-enolase. His-P46 was purified from the 
lysate of these cells by affinity chromatography using a 
Ni2+-charged chelating column. Samples from the total cell 
lysate (lane 1), flow through fraction (lane 2) and eluted 
fractions (lane 3) were subjected to SDS-PAGE and 
Coomassie staining. The position of His-tagged P46 in the 
gel is indicated on the right. The amount of purified protein 
obtained from 1 L culture was circa 6.5 mg. 
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α-Enolase activity of P46 
The sequence of the P46 protein reveals similarity with known α-enolases. A 
direct enzyme assay was used to analyze the expected activity (Pancholi and 
Fischetti, 1998). P46 was purified to homogeneity by affinity chromatography (Fig. 3). 
For this purpose a histidine tag was introduced at the N terminus of the molecule. 
Due to the introduction of the histidine tag, P46 migrated at an apparent molecular 
weight of ±49 instead of ±46 kDa in SDS-PAGE. The results of the enzyme reaction 
rates were analyzed in Michaelis–Menten plots and fitted to the equation V = 
VmaxS/(S + KM) (Fig. 4). A Michaelis–Menten coefficient (KM) of 2.1 × 10–4 M and a 
Vmax of 42 mM/min per mg were calculated. Similar results were obtained with P46 
without a His-tag. The obtained values are in agreement with those found for other α-
enolases (Kitamura et al., 2004). 
 
 
 
Fig. 4. α-Enolase activity of P46. Enzyme kinetics of purified His-P46. Activity was determined 
according to the direct enzyme assay (Pancholi and Fischetti, 1998). The conversion-rate (V) of 
2-PGE (S) to PEP was measured at 240 nm using 5 µg of P46 and various concentrations of 2-
PGE (0–6.0 mM). Measurements were performed for 3 min, but only the initial reaction rates 
were used for calculation. Data from two independent experiments were plotted by the method 
of Michaelis–Menten and fitted to the equation V = Vmax·S/(S + KM). This fit yielded the kinetic 
parameters KM = 2.1 × 10–4 M and Vmax = 4.2 × 10–2 M/min per·mg. 
 
 
P46 is not cell-surface exposed 
α-Enolases are generally known as cytosolic enzymes. However, several 
studies have indicated a cell-surface localization for α-enolases of both prokaryotic 
and eukaryotic origin despite the lack of a cleavable signal sequence (Redlitz et al., 
1995; Bergman et al., 1997; Pancholi and Fischetti, 1998; Bergmann et al., 2001). 
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P46 also lacks a cleavable signal sequence. Immunodetection of P46 on intact cells 
of B. fragilis by immunofluorescence microscopy was carried out to assess the 
possible surface localization of P46. 
IgG fractions from anti-P46 antiserum were covalently linked to a fluorescent 
label and used as a probe for the detection of putative cell-surface-localized P46. 
Permeabilization of cells with the detergent Triton X-100 made the intracellular pool 
of α-enolase accessible to the fluorescently labeled antibody (Fig. 5). The iron-
depleted cells that were not permeabilized showed a very weak fluorescence signal 
in the immunofluorescence microscopy experiments. The fluorescence signal of the 
iron-depleted cells was slightly higher than in control cells. Notably, the extent of the 
 
 
 
 
 
Fig. 5. Immunofluorescence microscopy of B. fragilis cells. Iron-restricted and iron-unrestricted 
BE1 cells were fixed with formaldehyde and glutaraldehyde immediately after culturing. To 
visualize intracellular P46, cells were permeabilized with Triton X-100, lysozyme and EDTA 
prior to immunolabeling (top panels). Non-permeabilized cells were used to detect P46 on the 
cell surface (middle panels). To measure background binding of fluorescent antibody to the 
cells, a non-related antiserum (anti-Hbp) was used in an equal concentration and degree of 
labeling of the fluorescent probe (lower panels). The brightness of the immunofluorescence 
pictures of non-permeabilized cells was enhanced with respect to the permeabilized cells. 
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fluorescence signal did not exceed the background signal elicited by a non-related 
fluorescently labeled antibody. In contrast, the permeabilized cells showed high 
levels of fluorescence over the entire cross-section of the cells, suggesting P46 is 
located intracellularly and can only be accessed upon permeabilization. The amount 
of internal P46 was significantly higher in the iron-depleted cells than in the control 
cells (Fig. 5), confirming the iron-repressible expression of P46. In conclusion, these 
results, plus the finding that P46 is not present in the OM of B. fragilis (see below), 
indicated that P46 is not cell-surface localized in B. fragilis. 
 
Redistribution of the subcellular localization of P46 under iron-restricted conditions 
To determine where P46 is localized in the cell, the subcellular distribution of 
this protein in B. fragilis was analyzed using cells that were grown under conditions of 
excess hemin or iron limitation. IM and OM were separated by sucrose gradient 
centrifugation. The cytoplasmic marker enzymes lactate dehydrogenase (LDH) and 
glucose-6-phosphate dehydrogenase (G6PDH) were used to measure the possible 
contamination of the membrane fractions with cytoplasmic proteins. The purified IM 
and OM fractions were hardly contaminated by cytoplasmic proteins (6% and 2.5%, 
respectively). All fractions were analyzed by SDS-PAGE followed by protein staining 
or Western blotting using P46 antiserum. The P46 protein was clearly present in the 
IM fractions and in the cytoplasm of iron-depleted and iron-unrestricted cells and is 
almost absent in the OM fractions of these cells (Fig. 6A; lanes 3, 4, 7 and 8). The 
trace amount of P46 found in the OM is most likely due to contamination of the 
purified membranes with cytosolic P46, as it does not exceed this contamination 
(Fig. 6A; lanes 4 and 8). Together, these results strongly suggested that P46 is 
located in the cytoplasm and IM but not in the OM. The iron-depleted cells contained 
twice the amount of P46 detected in control cells (Fig. 6A; lanes 1 and 5). 
Furthermore, the P44 iron-regulated OM protein is clearly visible in the OM fraction 
from iron-depleted cells in the Coomassie-stained gel (Fig. 6A, lane 8). Strikingly, 
under iron-limited conditions, a redistribution of P46 to the IM fraction occurred 
(Fig. 6B). A comparable ratio of P46 (±40%) is detected in the soluble and IM 
fractions of control cells. In contrast, iron-depleted cells contained proportionally 
more P46 in the IM (64%) than in the soluble fraction (26%). To determine whether 
P46 is an integral or peripheral IM protein, IM vesicles were subjected to Na2CO3 
extraction. Peripheral IM proteins are removed from the membrane by Na2CO3  
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Fig. 6. Subcellular localization of P46. A, SDS-PAGE profile (top) and Western blot analysis 
(bottom) of the different cellular fractions of strain BE1. Cells were grown in the presence of 
15 µM hemin (Iron+ cells) or 125 µM bipyridyl (Iron– cells). Membrane fractions were isolated 
using sucrose gradients as described in Section 2. Equal amounts of protein were loaded in 
each lane. C: cell lysate, S: soluble protein, IM: inner membrane fraction, OM: outer membrane 
fraction. Anti-P46 antibodies were used as probe in the blotting experiments. The arrow 
indicates the position of P46 in the Coomassie-stained gel. For the quantification of the relative 
amounts of P46 in the different cellular compartments, the detected amount of P46 in cell 
lysate from iron-unrestricted cells was set at 100%. B, the cellular distribution of P46 in iron-
restricted and -unrestricted cells. The distribution of P46 in the cell was quantified by setting 
both the amounts of P46 in the lysates from iron-restricted and -unrestricted cells at 100%. 
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treatment, in contrast to integral IM proteins. Ultracentrifugation of the Na2CO3-
treated membrane vesicles separate the released proteins from the pelleted 
membranes. P46 was only found back in the supernatant, indicating that P46 is not 
an integral IM protein (data not shown). 
 
Plasminogen-binding to intact B. fragilis cells and OM proteins 
Recent studies have suggested that α-enolases from eukaryotic and 
prokaryotic cells possess plasminogen-binding activity (Redlitz et al., 1995; Bergman 
et al., 1997; Pancholi and Fischetti, 1998; Bergmann et al., 2001). Plasminogen 
binds to surface-exposed α-enolase and is subsequently activated to plasmin by host 
or bacterial activators. Specific plasminogen-binding motifs have been characterized 
in α-enolases (Pancholi and Fischetti, 1998; Bergmann et al., 2001; Bergmann et al., 
2003; Derbise et al., 2004). The P46 α-enolase of B. fragilis is very likely not cell-
surface localized (see above), and analysis of the primary structure of this molecule 
did not reveal any plasminogen-binding motif. In particular, P46 does not possess a 
C-terminal lysine residue. Thus, P46 is probably not a plasminogen-binding protein. 
Regardless of this fact, B. fragilis cells were tested for their ability to bind 
plasminogen. 
B. fragilis cells were grown under iron-restricted and iron-unrestricted 
conditions. Serial dilutions of the cells were coated onto a microtiter plate. After 
incubation with human plasminogen (1 µg/ml), the amount of bound plasminogen 
was measured using an anti-plasminogen antibody. The B. fragilis cells showed a 
dose-dependent plasminogen-binding activity (Fig. 7A). The plasminogen-binding 
activity was similar for both normal and iron-depleted cells, indicating that the 
synthesis of the plasminogen receptor is not iron-regulated. 
A blot overlay assay was used to identify possible candidates responsible for 
the interaction with human plasminogen. Subcellular fractions from B. fragilis cells 
grown under normal or iron-depleted conditions were subjected to SDS-PAGE, 
electroblotted to PVDF membranes, which were subsequently incubated with 
plasminogen (1 µg/ml), and probed with anti-plasminogen antibodies to identify 
bound plasminogen (Fig. 7B). Interaction of plasminogen with an OM protein of circa 
60 kDa was observed (Fig. 7B; lanes 4 and 5). The expression of this 60-kDa protein 
is not iron-regulated. Weaker plasminogen-interacting OM protein bands of 50 kDa 
and a double protein band of circa 40 kDa were detected in this blot overlay assay. 
The expression of the 40-kDa protein seemed to be iron-regulated (Fig. 7B; lanes 4 
and 5). Purified P46 protein did not show any interaction with plasminogen in this  
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Fig. 7. Plasminogen-binding activity. A, plasminogen-binding by intact BE1 cells. Twofold serial 
dilutions of iron-restricted cells (dashed line) and of iron-unrestricted cells (solid line) were 
coated onto a microtiter plate and incubated with plasminogen (1 µg/ml). Cell-bound 
plasminogen was detected with anti-plasminogen antibodies. Each value is a mean of 
triplicates. B, immunodetection of plasminogen-binding activity by B. fragilis OM proteins. 
Plasminogen-binding to B. fragilis cellular fractions and purified P46 (1 µg) was assayed using 
a blot overlay assay. Total cell lysate (T), the soluble fraction (S) and outer membranes (OM) 
isolated from cells grown under different iron conditions were subjected to SDS-PAGE and 
electroblotted onto PVDF membrane. The membrane was incubated with plasminogen. Bound 
plasminogen was probed with anti-plasminogen antiserum and visualized by 
chemoluminescence. Afterwards the blot was stained with Coomassie to visualize the protein 
bands and the position of P46. The positions on the blot of P46 and the plasminogen-binding 
OM protein (arrow) are indicated. 
 
 
assay. The prominent protein band of 60 kDa was treated with trypsin and analyzed 
by mass spectrometry. Analysis of the observed peptide masses revealed an OM 
protein with homology to proteins with unknown function in related organisms. In 
conclusion, B. fragilis cells are able to bind plasminogen. This plasminogen-binding 
activity is not P46 dependent but likely dependent on a 60-kDa OM protein. 
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Discussion 
 
This study showed that the B. fragilis α-enolase P46 is upregulated and 
intracellularly redistributed under iron- and heme-limited conditions. The enzyme has 
a monomer molecular weight of 46 kDa, contains α-enolase-conserved domains and 
shows enzyme kinetics similar to those of other α-enolases (Kitamura et al., 2004). 
The iron-regulated expression of the α-enolase is probably important under 
conditions of infection. Depending on its subcellular localization, α-enolase carries 
out different functions. It might be involved in cell-surface plasminogen-binding or in 
proper RNA processing and decay in the IM (Liou et al., 2001), or in the cytoplasm, it 
might be necessary for sufficient ATP production under iron-restricted conditions 
(Heithoff et al., 1997). 
In Gram-positive bacteria and eukaryotic cells, α-enolase may act as a cell-
surface receptor for plasminogen (Redlitz et al., 1995; Pancholi and Fischetti, 1998; 
Bergmann et al., 2001; Jolodar et al., 2003; Jong et al., 2003; Derbise et al., 2004). 
Bound plasminogen is converted into the protease plasmin by host or bacterial 
plasminogen activators, allowing bacteria to acquire surface-associated proteolytic 
activity (Lähteenmäki et al., 2001). To assess the possible surface exposure of P46, 
immunofluorescence microscopy and subcellular localization experiments were 
carried out. The results of these experiments clearly showed that P46 is not present 
in the OM or at the cell surface. In addition, P46 did not show any plasminogen-
binding activity, which is consistent with the lack of plasminogen-binding motifs in this 
molecule. The consensus motif FYDKERKVYD and C-terminal lysine residues in α-
enolases are crucial for plasminogen-binding activity (Pancholi and Fischetti, 1998; 
Bergmann et al., 2001; Bergmann et al., 2003; Derbise et al., 2004). Screening of 
bacterial α-enolases on the presence of these motifs revealed that none of the known 
α-enolases from Gram-negative bacteria contains such motifs. Thus, it seems that 
the surface expression of plasminogen-binding α-enolase is restricted to Gram-
positive bacteria. 
In E. coli, α-enolase is part of RNA-degradosomes, multicomponent IM 
complexes involved in RNA processing and decay (Carpousis et al., 1994). 
Degradosomes consist of α-enolase, a polyphosphate kinase, the endonuclease 
RNase E, a polynucleotide phosphorylase and helicase RhlB. The degradosomes 
are associated with the cytoplasmic membrane via the N-terminal region of RNase E 
(Liou et al., 2001). α-Enolase binds to a specific region of the cytoplasmic 
membrane-bound RNase E molecule. However, significant amounts of α-enolase 
and other proteins of the multienzyme complex remain separated from the 
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membrane. We showed that P46 is not cell-surface exposed nor present in the OM. 
The next step in our study was to determine whether P46 might be located in the IM 
of B. fragilis. We found that P46 is located both in the cytoplasm and in the IM of B. 
fragilis. Remarkably, under iron-limited conditions, P46 is mainly present in the IM. 
This is the first evidence that the subcellular location of α-enolase varies, depending 
on the amount of available iron. The nature of the interaction between the IM and 
P46 is not known. It is tempting to speculate that the subcellular redistribution of P46 
is due to an interaction between an IM-bound RNase E and P46 and that IM-
associated P46 is part of RNA-degradosomes, especially under iron-limited 
conditions. 
The higher expression of P46 under iron-limited conditions could also be 
necessary for sufficient ATP production. In B. fragilis, the maximum energy from 
glucose is obtained under heme-unrestricted conditions. At low concentrations of 
heme in vivo, glycolysis and the lactate and malate metabolism are the only sources 
of ATP (Macy et al., 1978; Chen and Wolin, 1981). In an abscess, lactate may be the 
predominant carbon and energy source and glucose may be limiting. To compensate 
to some extent for the lower gain of energy from glucose, a higher expression of α-
enolase could be a way to generate sufficient ATP. 
We demonstrated that the expression of P46 is iron-regulated. Iron-regulated 
genes are often preceded by a Fur-box sequence to which the regulatory Fur protein 
can bind (Baichoo and Helmann, 2002). The Fur-binding site overlaps the promoters 
of iron-regulated genes. Iron acts as a corepressor with Fur at sufficient 
concentrations of iron. The active Fur-iron complex binds to the Fur-binding site and 
prevents transcription. No sequence related to a consensus Fur-box sequence was 
detected in the promoter region of p46. Additionally, the expression of P46 under its 
own promoter is iron-regulated in both B. fragilis and E. coli. However, a complete 
repression of P46 was not possible under high iron conditions, which is consistent 
with the essential role of α-enolase in glycolysis. These results suggest that the 
expression of P46 is Fur independent. 
This study showed that B. fragilis cells bound plasminogen to their surface. 
An OM protein of 60 kDa (P60) binds plasminogen in a blot overlay assay and is 
likely responsible for the plasminogen-binding activity of the B. fragilis cells. Analysis 
of the primary structure of this molecule reveals a signal-peptide sequence 
containing a motif for lipid attachment. This suggests that P60 is likely a membrane 
lipoprotein. Furthermore, P60 does possess a C-terminal lysine residue. However, 
P60 lacks a plasminogen-binding consensus motif, as described for Gram-positive 
bacteria. 
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In summary, we have shown that the B. fragilis α-enolase P46 is upregulated 
and intracellularly redistributed under iron- and heme-limited conditions. This 
mechanism is probably essential to survive at the site of an infection, because it 
guarantees an efficient ATP production and a dynamic regulation of the processing 
and decay of mRNAs under stressful conditions. The plasminogen-binding activity by 
B. fragilis cells is not P46 dependent but highly likely depends on a 60-kDa OM 
protein. Further studies will be directed at the characterization of this 60-kDa protein 
and the nature of the interaction between the IM and P46.  
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Abstract 
 
The cloning and preliminary characterization of a possible plasminogen-
binding protein (Pbp) of Bacteriodes fragilis is described. The Gram-negative 
anaerobic bacterium B. fragilis is a member of the commensal flora of the human 
intestine, but is also frequently found in severe intra-abdominal infections. Several B. 
fragilis virulence factors have been described that may be involved in the 
development of these infections. A B. fragilis protein of circa 60 kDa was identified as 
a putative plasminogen-binding protein. The corresponding gene was now cloned, its 
sequence was analyzed using various computer programs and the subcellular 
localization of the protein (Pbp) was investigated. Pbp was found in the outer 
membrane fraction of B. fragilis cells and also in outer membranes of E. coli cells 
expressing the protein. Protease accessibility studies gave the first indications for a 
cell-surface location of the protein. In overlay experiments Pbp was able to bind 
plasminogen, but C-terminally His-tagged Pbp did not. Primary sequence analysis 
suggested that Pbp is a lipoprotein. Pbp-like proteins were also found in various 
other Bacteroides strains and clinical isolates. The role of this potential B. fragilis 
virulence factor in pathogenicity is discussed. 
 
 
Introduction 
 
B. fragilis is a Gram-negative anaerobic bacterium that is a member of the 
commensal gut flora in humans. However, it can be an important opportunistic 
pathogen that is frequently isolated from human intra-abdominal infections (Aldridge, 
1995; Farthmann and Schöffel, 1998). These infections are a common complication 
of invasive surgery or the result of abdominal trauma in which the gut microflora 
enters the abdominal cavity (Hall et al., 1998). In these infections, persistent 
abscesses are often formed which leak pathogenic bacteria into the general 
circulation, resulting in septic shock and multi-organ failure. It is frequently found that 
pathogenic E. coli and B. fragilis occur together in these abscesses, the combination 
surviving better than either species alone. These polymicrobial abscesses are usually 
difficult to treat with antimicrobial therapy and pose a serious clinical problem. The 
molecular mechanism underlying the pathogenesis of these infections and the way in 
which formation of abscesses is initiated is only partially understood. Several putative 
virulence factors involved in peritonitis have been described. These include the 
capsular polysaccharide of B. fragilis, a secreted hemoglobin protease by E. coli and 
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secreted short-chain fatty acids and hemolysins of B. fragilis. The capsular 
polysaccharide of B. fragilis promotes the formation of fibrin clots by the host 
(Tzianabos et al., 1993), providing an environment where the bacteria are protected 
against circulating factors from the immune system. E. coli cells involved in peritonitis 
often secrete a hemoglobin protease (Hbp) that is capable of degrading hemoglobin. 
This protein can also bind the released heme from hemoglobin, which is then 
delivered to both E. coli and B. fragilis, facilitating their growth (Otto et al., 1998; Otto 
et al., 2002). The secretion of short-chain fatty acids by B. fragilis inhibits killing by 
neutrophils (Rotstein et al., 1989b). In B. fragilis as many as nine functional 
hemolysin homologues have been found (E.R. Rocha and C.J. Smith, unpublished 
observations). In addition, B. fragilis displays hemolytic activity in an iron-regulated 
manner (B.R. Otto, unpublished observations). 
Plasminogen-binding to the bacterial cell surface may also contribute to the 
pathogenesis of peritonitis. Plasminogen-binding properties have recently been 
described for a range of bacterial species. Conversion of surface-bound plasminogen 
to plasmin changes the bacterium into a proteolytic organism capable of degrading 
fibrin and extracellular matrix proteins (Parry et al., 2000; Lähteenmäki et al., 2001). 
Binding of plasminogen to the cell surface could therefore be an important virulence 
factor involved in pathogenic synergy in intra-abdominal infections. Several bacterial 
cell-surface receptors for plasminogen have been identified. In Gram-positive 
bacteria, α-enolase is often present on the cell surface as a plasminogen-binding 
protein (Pancholi and Fischetti, 1998; Bergmann et al., 2001). However, we have 
recently shown that in B. fragilis α-enolase is only present intracellularly and does not 
possess plasminogen-binding capability (Sijbrandi et al., 2005). There are only a few 
reports describing plasminogen-binding proteins in Gram-negative bacteria. In 
Borrelia burgdorferi, a 70 kDa plasminogen-binding protein has been isolated (Hu et 
al., 1997), and in Helicobacter pylori, two homologous cell-surface proteins were 
characterized that could bind plasminogen: PgbA (50 kDa) and PgbB (60 kDa) 
(Jonsson et al., 2004). 
It has been reported recently that B. fragilis cells possess plasminogen-
binding activity. In an overlay assay, a 60 kDa protein was identified as a possible 
plasminogen-binding protein (Sijbrandi et al., 2005). In this study, the 60 kDa protein, 
referred to as Pbp for Plasminogen-binding protein, was further investigated. The pbp 
gene was cloned and sequenced, the subcellular location of the pbp gene product 
was studied, and its plasminogen-binding property was confirmed in an overlay 
assay using (semi) denatured proteins. In addition, indications were obtained that in 
other Bacteriodes subspecies Pbp-like proteins are present. 
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Materials and methods 
 
Bacterial strains, plasmids and media  
Clinical isolates of 26 different strains of Bacteroides subspecies, all isolated 
from extra-intestinal infections, were used in this study. All strains, except B. fragilis 
ATCC23745, were isolated from hospitalized patients in The Netherlands and 
identified with a BBL Minitek Numerical Identification System (Becton Dickinson). The 
three B. fragilis strains were designated BE1, BE4 and BE12. The two B. vulgatus 
strains were designated BE18 and BE20. The nine B. distasonis strains were 
designated BE2, BE4, BE5, BE14, BE16, BE17, BE50, BE62 and BE66. The four B. 
thetaiotaomicron strains were designated BE22, BE33, BE34 and BE46. The seven 
B. ovatus strains were designated BE10, BE15, BE20, BE35, BE48, BE60 and BE74. 
The B. fragilis strain ATCC23745 was obtained from the American Type Culture 
Collection and has been isolated from a pleural infection. 
The clinical isolate B. fragilis BE1 (Verweij-van Vught et al., 1986) was used 
as a source of chromosomal DNA for cloning, PCR experiments and for functional 
studies on Pbp. The Escherichia coli strain TOP10F’ (Invitrogen) and the plasmid 
pACYC184 (Chang and Cohen, 1978) were used in routine cloning procedures 
(Sambrook et al., 1989). The E. coli strains BL21AI (Invitrogen) and BL21(DE3)omp8 
(Prilipov et al., 1998) and the plasmids pET17b and pET22b (Studier et al., 1990) 
were used for subcloning and controlled expression of the pbp gene.  
The E. coli strains were routinely grown in Luria-Bertani (LB) medium (Miller, 
1992). Appropriate antibiotics were added to the culture medium. All Bacteroides 
strains were maintained on 5% horse blood agar plates (no. 2 agar; Oxoid) and 
cultured anaerobically in BM medium (Verweij-van Vught et al., 1986) in the 
presence of 50 µg/ml kanamycin and 20 µg/ml nalidixic acid (Sigma Chemicals) as 
the standard medium. Anaerobiosis was achieved using the Anaerogen system from 
Oxoid. 
 
General methods  
Recombinant DNA techniques were carried out as described (Sambrook et 
al., 1989). DNA sequencing was carried out using the Big Dye Terminator Cycle 
sequencing kit on an ABI Prism 310 automated sequencer (Perkin Elmer). Bound 
antibodies were visualized on immunoblots by chemiluminescence (Roche Molecular 
Biochemicals). The (relative) intensity of protein bands from both chemoluminescent 
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blots and Coomassie-stained gels were quantified using a FluorS Multi-Imager with 
the Multi-Analyst software package (BioRad).  
 
Polyclonal antibodies and reagents  
Goat anti-human plasminogen antibodies and human plasminogen used in 
plasminogen-binding assays were purchased from Haematologic Technologies. 
Rabbit anti-goat HRP-conjugated antibodies and goat anti-rabbit HRP-conjugated 
antibodies used for immunodetection were obtained from Santa Cruz Biotechnology 
and BioRad, respectively. For Western blotting, anti-Pbp antiserum raised against 
purified histidine-tagged Pbp (His-Pbp) was used. Rabbits were injected with a 
mixture of native and denatured His-Pbp protein (50%/50%; Agrisera, Sweden). 
Antiserum against B. fragilis P46 has been described (Sijbrandi et al., 2005). Antisera 
against E. coli β-lactamase and OmpA were gifts from J.-M. van Dijl and J.-W. de 
Gier, respectively. Restriction enzymes, the Expand long template PCR system, 
Complete EDTA-free protease inhibitors and the Lumi-light western blotting substrate 
were obtained from Roche Molecular Biochemicals. Sigma Chemicals supplied all 
other chemicals. 
 
Cloning of the pbp gene  
The coding sequence of pbp was amplified by PCR using chromosomal 
DNA from B. fragilis BE1 as template. The primers used were the BfFor60 primer 5’-
CGCGCATCGATCTTTGCGTGGCATTTATGGGCAATCC-3’, introducing a ClaI 
restriction site (boldface letters) 85 bp upstream of the putative promoter of pbp and 
the BfRev60 primer 5’-GCGCCGTCGACGTCCGTCATTTGTGTGACGGACAACTC-
3’, introducing a SalI site (boldface letters). The complete gene, including its own 
promoter, was cloned into pACYC184 using the created ClaI and SalI sites. The 
plasmid pACYC-60kDa was introduced into E. coli TOP10F’.  
The T7 expression system was used for IPTG-arabinose inducible 
expression of pbp (Studier et al., 1990). The pbp gene was amplified by PCR using 
the plasmid pACYC-60kDa as template DNA. Primers used were the BfpETFor60 
forward primer 5’-GCGCCCATATGATCAAGAAGTTGTATTTGCCTTTACTTATGG-
3’, introducing a NdeI restriction site (boldface letters) and the BfRev60 primer. The 
pbp gene was cloned into the expression vector pET17b using the NdeI and SalI 
restriction sites of the insert and the compatible NdeI and XhoI restriction sites of the 
vector. 
The pbp gene was also cloned with a histidine tag to facilitate purification of 
the protein. Therefore, the pbp gene was amplified by PCR using the plasmid 
Chapter 6 
 114 
pACYC-60kDa as template DNA. Primers used were the BfpETFor60 forward primer 
and the BfpET22Rev60 reverse primer 5’-TCTCTCGAGTTTTACGATGCTCATGAA-
ATCTGC-3’, introducing a XhoI restriction site (boldface letters). The pbp gene was 
cloned into the expression vector pET22b using the created NdeI and XhoI sites. 
This vector creates a C-terminal fusion to a histidine-tagged sequence. Plasmid 
pET22b-Pbp was introduced into E. coli BL21Omp8 for an IPTG and arabinose 
inducible expression of pbp. The plasmids pACYC-60kD, pET17b-Pbp and pET22b-
Pbp were sequenced to check for second site mutations. 
 
Purification of Pbp  
Strain BL21(DE3)omp8(pET22b-Pbp) over-expressing the C-terminal His-
tagged Pbp, was cultivated in 3 L of LB-medium for the isolation of Pbp. Cells were 
induced with 1 mM IPTG and 0.2% arabinose for 1.5 h at an OD660 of 0.4. The cells 
were harvested, washed with a phosphate buffered saline solution (PBS), 
resuspended in 50 mM Tris-HCl, pH 8.0, containing 1 mM EDTA, protease inhibitors, 
DNase and RNase and lysed using a French pressure cell. After removal of the 
cellular debris, the obtained cell lysate was centrifuged at 270,000 × g for 90 min at 4 
°C. The membrane pellet was resuspended in PBS containing 500 mM NaCl, 5 mM 
Imidazole and 1.0% Triton X-100 and rotated for 16 h. The sample was centrifuged at 
270,000 × g for 90 min at 4 °C. The solubilized proteins were loaded on a Ni2+-
charged HiTrap Chelating column equilibrated in PBS containing 500 mM NaCl, 5 
mM Imidazole and 0.5% Triton X-100, and eluted using a gradient to 250 mM 
imidazole. Peak fractions were pooled, desalted to PBS buffer containing 0.5% Triton 
X-100 using a HiTrap Desalting column and loaded on a HiTrap Heparin column (all 
HiTrap columns from Amersham Biosciences) equilibrated with the same buffer. The 
proteins were eluted from the column using a linear gradient to 2 M NaCl. Peak 
fractions were pooled and purified again on a Ni2+-charged HiTrap Chelating column. 
The purest fractions, as determined by protein staining of an SDS-PAGE gel, were 
pooled and desalted to PBS buffer containing 0.1% Triton X-100. Finally the protein 
sample was concentrated from 4 to 2 ml using a Microsep centrifugal device (Pall 
Life Sciences). The final protein concentration of the purified His-tagged Pbp was 
1.15 mg/ml. 
 
Subcellular localization of Pbp in B. fragilis  
To determine the location of Pbp in B. fragilis BE1, cells were fractionated 
and subcellular fractions (cytoplasm, inner membranes, and outer membranes) were 
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separated by using sucrose density gradient techniques (Kotarski and Salyers, 1984; 
Sijbrandi et al., 2005). Fractions were stored at minus 80 °C. 
 
Detection of plasminogen-binding proteins 
A blot overlay assay (Bergmann et al., 2001; Sijbrandi et al., 2005) was used 
to detect plasminogen-binding proteins. Equal amounts of soluble protein fractions or 
outer membrane preparations of B. fragilis BE1 were separated on an 11% SDS-
polyacrylamide gel and blotted electrophoretically onto PVDF membrane (Immobilon-
P, Millipore). The membranes were then blocked with 4% skimmed milk powder in 
PBS for 30 min. Next, the blots were incubated with human plasminogen (1 µg/ml) in 
PBS for 2 h, washed with PBS and then incubated with anti-human plasminogen in 
Tris-buffered saline (TBS) containing 0.1% Tween 80 for 2 h. After washing, the blots 
were probed with rabbit anti-goat HRP conjugated antibody (Santa Cruz 
Biotechnology) for 1 h. The probed blots were washed four times with TBS containing 
0.3% Tween 80, incubated with Lumilight substrate and exposed to Kodak X-Omat 
AR film. Afterwards, the blot was stained with Coomassie Brilliant Blue to identify the 
bands visualized on film. Where indicated in the text, blots were incubated with 
human plasminogen (1 µg/ml) in the presence of human serum that was diluted 1:5 
in PBS. 
 
Protease accessibility assay 
A protease accessibility assay was used to confirm the cell-surface 
localization of Pbp (Jonsson et al., 2004). Cells of E. coli BL21AI (pET22b-Pbp) 
overexpressing Pbp or of B. fragilis BE1 were washed with PBS and resuspended in 
PBS to an optical density at 660 nm of 20. The cell suspension (250 µl) was 
incubated with Proteinase K to a final concentration of 0.4 mg/ml for 1 h on ice. Other 
samples were incubated with both Proteinase K and 0.5% Triton X-100, 0.5% Triton 
X-100 and proteinase inhibitors, or left untreated. Protease inhibitor cocktail tablets 
were purchased from Roche. Following incubation, the reactions containing Triton X-
100 were immediately boiled in SDS sample buffer. The other reactions were treated 
with PMSF for 45 min on ice and subsequently boiled in SDS sample buffer. Samples 
of 0.1 OD660 unit were taken and resolved by SDS-PAGE. After immunoblotting, the 
levels of Pbp and E. coli OmpA or B. fragilis P46 were analyzed using their 
respective antibodies. 
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Results 
 
The molecular characterization of Pbp 
Previously, the discovery was reported of a 60 kDa protein with 
plasminogen-binding properties in an overlay assay, and present in outer membrane 
protein extracts of B. fragilis BE1 (Sijbrandi et al., 2005). To study this newly found 
protein in more detail, a mass spectrometry analysis of trypsin-digested fragments of 
this protein was carried out. A range of peptide masses were then used to search the 
Swiss-Prot and TrEMBL databases using PeptIdent. This search resulted in a match 
of six fragments with the hypothetical protein BT2844 from B. thetaiotaomicron. The 
complete genome sequence of B. fragilis was not available at the time of this 
analysis, and the search did not match with a protein from B. fragilis. Recently, using 
the predicted amino acid sequence of this protein, a highly homologous protein was 
identified in a protein versus translated DNA BLAST in the genome sequence of B. 
fragilis strain NCTC9343 at http://www.sanger.ac.uk/Projects/B_fragilis/. A virtual 
trypsin digestion was carried out on this protein sequence with the Peptide Mass 
program. Then a comparison was carried out between the predicted peptide masses 
and the masses from the mass spectrometry results on the Pbp protein of B. fragilis 
BE1; 31 of the 45 possible fragments were identical. This suggested that B. fragilis 
NCT9343 contains a gene encoding a protein that is highly comparable to the 
putative plasminogen-binding protein of B. fragilis strain BE1. 
The pbp gene of B. fragilis BE1 was then cloned from the genome of this 
bacterium, using PCR as described in the Materials and Methods section. The entire 
open reading frame (ORF) found after sequencing, encodes a putative protein of 563 
amino acids with a calculated relative molecular mass of 61.5 kDa. This mass is in 
accordance with the relative molecular mass found upon SDS-PAGE of circa 60 kDa 
(Sijbrandi et al., 2005). A protein BLAST with this putative protein sequence in the 
NCBI sequence database (http://www.ncbi.nlm.nih.gov/BLAST/) revealed significant 
homology to proteins with unknown function in other organisms. A hypothetical 
protein designated BF4485 in the recently published genome sequence of B. fragilis 
YCH46 (Kuwahara et al., 2004) is 100% identical to this protein, but the first 10 
amino acids are not present in the ORF. An NCBI Conserved Domain Search 
revealed a 90% alignment of 100 amino acids with a tetratricopeptide repeat (TPR) 
domain. This domain is conserved among proteins from very different species and is 
proposed to be involved in a very broad range of activities including protein-protein 
interactions. Interestingly, the Pbp protein shows a high degree of conservation (55% 
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identity) with the TPR domain of the protein designated PG1028 of Porphyromonas 
gingivalis, an important pathogen of the human oral cavity (Nelson et al., 2003). 
Analysis of the nucleotide sequence upstream of the ORF showed 
sequences that closely resembled the consensus –35 and –10 promoter sequences 
and a Shine-Dalgarno sequence (EMBL Nucleotide Sequence Database accession 
number AJ786264). The ORF is located between two other ORFs in the same 
reading frame probably encoding a 317 amino acid tyrosine type site-specific 
recombinase (upstream) and a 356 amino acid hypothetical protein with homology to 
thiol:disulfide interchange proteins (downstream). 
The recovery of the 60-kDa protein from the outer membrane fraction of B. 
fragilis BE1 makes it likely that newly synthesized Pbp polypeptides contain a signal 
peptide necessary for translocation across the inner membrane. Using the SignalP 
server (Bendtsen et al., 2004), no indications were found for a signal peptidase I 
cleavage site. However, a cysteine residue was present in the N-terminal part of the 
protein sequence that could point to the existence of a lipoprotein signal peptide and 
a signal peptidase II cleavage site. Using the LipoP signal sequence prediction 
algorithm (Juncker et al., 2003), a strong prediction for the presence of a signal 
peptidase II cleavage site between amino acid positions 19 and 20, was obtained. 
This suggests that the 60-kDa protein may be a lipoprotein that will be lipidated at the 
cysteine at position +1 of the mature protein. The amino acid at position +2 is a 
serine, and in accordance with the “+2 rule” the protein would be targeted to the 
outer membrane of gram-negative bacteria (Seydel et al., 1999). When the 
preprotein is cleaved at the expected position, the calculated molecular mass of the 
mature protein (excluding lipids) is 59.4 kDa. 
The pbp gene was then subcloned and expressed in E. coli, and the 
construct was sequenced to check for second site mutations. No base pair 
differences were found between the nucleotide sequence of pbp and ORF BF4485 
from B. fragilis strain YCH46. Five base pair differences were found in comparison to 
the ORF from B. fragilis strain NCTC9343, but these did not result in any differences 
in amino acid sequence. 
 
Purification of His-tagged Pbp 
In order to purify Pbp and to raise specific antibodies for further analyses, 
the pbp gene was cloned in an E. coli expression vector with an inducible promoter.  
The cloned construct encoded Pbp with a C-terminal histidine tag. The His-tagged 
Pbp was then purified (Fig. 1), and specific antibodies were raised in rabbits. 
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Fig. 1. Purification of His-tagged Pbp. E. coli 
BL21(DE3)omp8(pET22b-Pbp) was used to express 
histidine-tagged Pbp. His-Pbp was purified from the 
membranes to near homogeneity using detergent 
extraction of membrane(-associated) proteins 
followed by affinity chromatography using a Ni2+-
charged chelating column and a heparin column. 
Samples from the non-induced (lane 1) and induced 
cells (lane 2) and purified protein (lane 3) were 
subjected to SDS-PAGE and Coomassie staining. 
The arrow indicates the position of His-Pbp in the gel. 
 
 
 
 
 
 
 
Subcellular localization of Pbp and possible cell-surface exposure 
The subcellular distribution of Pbp in B. fragilis cells was analyzed. 
Preparations of soluble proteins, inner membrane proteins, as well as outer 
membrane protein fractions were isolated (Sijbrandi et al., 2005). The presence of 
Pbp in these fractions was then analyzed by SDS-PAGE followed by Coomassie 
staining and/or Western blotting using anti-Pbp antiserum. The Pbp protein was 
mainly found in the outer membrane fraction (Fig. 2, lane 4) and to a lesser extent in 
the inner membrane fraction (lane 3). There was hardly any Pbp detectable in the 
soluble protein fraction that mainly consists of the cytoplasm (lane 2). 
To assess a possible cell-surface localization of Pbp, a protease 
accessibility assay was carried out with cells of B. fragilis BE1. Upon incubation of 
intact cells with Proteinase K (Prot. K), Pbp was completely degraded (Fig. 3, lane 2). 
The α-enolase P46, localized in the cytoplasm and the inner membrane of B. fragilis, 
was used as an intracellular control protein (Sijbrandi et al., 2005). As expected, P46 
was not degraded by Prot. K in intact cells (panel C), but after disruption of the cell 
envelope by the addition of Triton X-100, P46 was also degraded (panel C, lane 4). 
Similar results were obtained using intact cells of E. coli BL21AI (pET22b-Pbp) 
expressing Pbp. Upon incubation with Prot. K, Pbp completely disappeared (panel D 
and E, lane 6). In intact cells, the periplasmic protein β-lactamase (Bla), that is 
inaccessible to externally added proteases, was not cleaved by Prot. K. However, 
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after treatment of the cells with Triton X-100, this “control” protein was completely 
degraded (panel F). Furthermore, the outer membrane protein OmpA was used as a 
control in E. coli. Although part of this protein is surface exposed, it cannot be 
cleaved by the external addition of Prot. K when present in intact membranes (panel 
G), as described before (Morona et al., 1985). OmpA can only be degraded after 
solubilization of the membranes. Also in the presence of protease inhibitors, OmpA 
was degraded after solubilization. A possible explanation could be that only protease 
inhibitors effective against serine and cysteine proteases were used, which do not 
inhibit metallo or aspartic proteases. The proteolysis observed after disruption of cells 
with Triton X-100 and incubation for 45 min on ice in the presence of inhibitors (lane 
3 and 7) could be the result of intracellular proteases not affected by the inhibitors 
added. Together, these results suggest that Pbp is exposed to the surface of B. 
fragilis cells, and that it is also cell-surface exposed when expressed in E. coli. 
 
 
 
 
 
Fig. 2. Subcellular localization of Pbp. SDS-PAGE 
profile (top panel) and Western blot analysis 
(bottom panel) of the different cellular fractions of 
strain B. fragilis BE1. Pure membrane fractions 
were prepared using sucrose density gradients. 
Equal amounts of protein from the different 
subcellular fractions were loaded in each lane. C: 
Cell lysate, Sol: soluble protein, IM: inner 
membrane fraction, OM: outer membrane fraction. 
Anti-Pbp antibodies were used in the 
immunoblotting experiment. The arrow indicates 
the position of Pbp in the Coomassie-stained gel. 
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Fig. 3. Protease accessibility of Pbp in intact cells. A, intact cells of B. fragilis were incubated in 
the absence (lane 1) or presence (lane 2) of Proteinase K (Prot. K). As a control, cells were 
lysed using Triton-X100 in the presence of protease inhibitors (lane 3) or lysed and treated with 
Prot. K (lane 4). Samples were resolved by SDS-PAGE and stained with Coomassie. B, 
immunoblot of the samples from panel A, using anti-Pbp antiserum. C, immunoblot of the 
samples from panel A, using control anti-P46 antiserum. D, whole cells of E. coli BL21AI 
(pET22b-Pbp) overexpressing Pbp were incubated in the absence (lane 5) or presence (lane 6) 
of Proteinase K. As a control, cells were lysed using Triton-X100 in the presence of protease 
inhibitors (lane 7) or lysed and treated with Prot. K (lane 8). Samples were resolved by SDS-
PAGE and stained with Coomassie. E, immunoblot of the samples from panel D, using anti-
Pbp antiserum. F, immunoblot of the samples from panel D, using anti-Bla antiserum. G, 
immunoblot of the samples from panel D, using anti-OmpA antiserum. The arrows indicate the 
position of Prot. K in the stained gels. 
 
 
Pbp binds plasminogen in an overlay assay 
The Pbp protein was originally identified by mass spectrometry analysis of a 
protein band extracted from an SDS-PAGE gel. This band corresponded in apparent 
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molecular mass with the protein band that bound human plasminogen in a blot 
overlay assay (Sijbrandi et al., 2005). To obtain more evidence that Pbp is indeed the 
putative plasminogen-binding protein, Pbp, as well as His-tagged Pbp, was 
expressed in E. coli , with or without induction, and the binding of plasminogen was 
assayed. 
 
 
 
Fig. 4. Plasminogen binding of Pbp with or without a C-terminal histidine tag. Outer membrane 
fractions from B. fragilis BE1 (OM, lanes 1 and 7) and total cell samples from E. coli 
BL21AI(pET17b-Pbp) or BL21AI(pET22b-Pbp) cells expressing Pbp with or without a His-tag, 
respectively, were subjected to SDS-PAGE and stained with Coomassie (left panel) or to 
immunoblotting (right panel). Induction with IPTG and arabinose is indicated above the figure. 
As a control, purified human plasminogen was loaded (Plg, lanes 6 and 12). A blot overlay 
assay was carried out with the blot. The blot was incubated with human plasminogen and 
bound plasminogen was probed with anti-plasminogen antibodies and detected by 
chemiluminescence. The arrow indicates the position of Pbp in de gel and on the blot. 
 
 
A blot overlay assay with human plasminogen was carried out using E. coli 
lysates in which expression of wild type or histidine-tagged Pbp was induced. In this 
assay, plasminogen bound to a 60-kDa protein that was strongly present in the 
induced lysate containing wild type Pbp (Fig. 4, lanes 3 and 9). This protein had the 
same apparent molecular mass as the 60-kDa plasminogen-binding protein in the 
outer membrane fraction of B. fragilis cells (lanes 1 and 7). The protein was less 
pronounced in non-induced samples and clearly less plasminogen bound. The His-
tagged version of Pbp did not bind human plasminogen (lanes 5 and 11). Because 
the His-tag is added to the C terminus of Pbp, it might be that the C-terminal residues 
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of the Pbp protein are involved in the binding of human plasminogen. This is in good 
accordance with observations on other plasminogen-binding proteins (Redlitz et al., 
1995; Pancholi and Fischetti, 1998; Winram and Lottenberg, 1998; Bergmann et al., 
2001; Derbise et al., 2004). The blot overlay experiment has also been carried out 
with human plasminogen in the presence of a complex protein mixture (diluted 
human serum). The results were comparable, indicating that the binding of 
plasminogen to Pbp in the overlay assay was specific (data not shown). 
 
Detection of Pbp like protein in other Bacteropides species 
Based on the high homology between the primary sequence of the Pbp 
protein of B. fragilis and a putative 60-kDa protein of B. thetaiotaomicron, it was 
expected that the anti-Pbp antiserum might cross-react. To investigate the presence 
of a Pbp like protein in B. thetaiotaomicron, as well as in other Bacteroides species 
like B. vulgatus, B. ovatus and B. distasonis, equal amounts of soluble (mainly 
cytoplasmic) protein fractions and outer membrane fractions of representatives of 
these five Bacteroides subspecies were analyzed by SDS-PAGE and 
immunoblotting. As shown in Fig. 5 (top panel), the Pbp protein of B. fragilis BE1 
reacted as expected strongly and specifically with the Pbp antiserum. In the OM 
fractions of B. vulgatus, B. distasonis, B. thetaiotaomicron and B. ovatus a protein 
band of about 60 kDa was recognized by the Pbp antiserum. These results indicated 
that cross-reacting Pbp-like proteins are present in these Bacteroides subspecies. 
Analyses of other clinical isolates of Bacteroides gave comparable results (not 
shown). The binding of plasminogen to Pbp and Pbp-like proteins was also studied 
using an overlay assay (Fig. 5, lower panel). The results indicated that Pbp as well as 
the Pbp-like cross-reacting proteins found in B. thetaiotaomicron and B. ovatus bind 
plasminogen in this assay, albeit to a different extent. The binding of plasminogen to 
the Pbp-like proteins found in B. vulgatus and B. distasonis was less clear, but very 
weak signals were found after long staining and exposure (not shown). 
 
 
Discussion 
 
The pbp gene was cloned from the genome of B. fragilis BE1, and its 
sequence analysis predicted a 60-kDa protein that might be an outer membrane 
located lipoprotein. The experimental results presented in this study show that Pbp is 
indeed an outer membrane protein with plasminogen-binding activity in an overlay 
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assay, and probably exposed at the cell surface. Pbp can also be expressed in E.  
 
 
Fig. 5. Presence of Pbp-like proteins in Bacteroides subspecies. Representatives of each of 
the five available Bacteroides subspecies were used: B. fragilis BE1, B. vulgatus BE18, B. 
distasonis BE5, B. thetaiotaomicron BE33 and B. ovatus BE15. Soluble protein fractions were 
separated from membranes fractions by ultracentrifugation. Crude outer membrane protein 
fractions were prepared by selective extraction of inner membrane proteins from the pelleted 
membranes using sodium sarkosyl. Samples of the soluble protein (lanes 1, 3, 5, 7 and 9) and 
outer membrane protein (lanes 2, 4, 6, 8 and 10) fractions from all subspecies were subjected 
to SDS-PAGE and Western blotting in duplicate. For the top panel, anti-Pbp antibodies were 
used as a probe. The blot in the bottom panel was first incubated with 1 µg/ml human 
plasminogen and then bound plasminogen was detected using anti-plasminogen antibodies. 
The arrow on the left of both panels indicates the position of the B. fragilis Pbp protein.  
 
 
coli and protease experiments also pointed to a cell-surface exposure in this 
bacterium. Because C-terminally His-tagged Pbp did not bind plasminogen anymore, 
the C-terminal lysine residue and probably other C-terminal residues might be crucial 
in plasminogen-binding. 
A homologue of Pbp, BT2844, is present in the genome of B. 
thetaiotaomicron (Xu et al., 2003). Antibody experiments showed cross-reactivity of 
the Pbp of B. fragilis and BT2844 of B. thetaiotaomicron. In a blot overlay assay it 
was shown that this homologue was also capable of binding plasminogen, although 
to a lesser extent than Pbp. Pbp-like proteins were also found in clinical isolates of B. 
vulgatus, B. distasonis and B. ovatus. It is tempting to speculate that the relatively 
high expression of Pbp contributes to the virulence of B. fragilis, the most pathogenic 
strain of the Bacteroides subspecies. 
Cell-surface plasminogen-binding proteins have also been found in other 
bacteria. Especially, α-enolases in Gram-positive bacteria and eukaryotic cells are 
often found to possess plasminogen-binding properties (Redlitz et al., 1995; Pancholi 
and Fischetti, 1998; Bergmann et al., 2001; Jolodar et al., 2003; Jong et al., 2003). A 
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plasminogen-binding lipoprotein has been found in the spirochete Borrelia 
burgdorferi, the causative agent of Lyme disease. This protein is known as BPBP 
(Borrelia Plasminogen Binding Protein), OppA-1 or PlpA (Hu et al., 1997; Kornacki 
and Oliver, 1998). In Helicobacter pylori, which causes gastric ulcers, the two 
proteins PgbA and PgbB were identified as plasminogen-binding proteins (Jonsson 
et al., 2004). Nevertheless, there is no significant homology in the primary sequences 
between Pbp and BPBP, PgbA or PgbB. Pbp might represent a novel class of 
bacterial plasminogen-binding proteins with homologues in other pathogens like B. 
thetaiotaomicron and P. gingivalis. 
The binding of host plasminogen on the bacterial surface might give the 
organism two advantages. First, the bound plasminogen may become more easily 
accessible to either bacterial of host-derived plasminogen activating proteins (Parry 
et al., 2000; Lähteenmäki et al., 2001). These proteins activate plasminogen to 
become plasmin, converting the cell into a proteolytic organism with the capability to 
function in fibrinolysis and to degrade extracellular matrix proteins. This may play a 
role in the spread of the infection as the cell can even penetrate the basal 
membrane. In fact, B. fragilis has been shown to be able to invade HeLa cells 
(Goldner et al., 1991). Cell-surface bound plasmin has been shown to be protected 
against quick inactivation by inhibitors like α-2 antiplasmin (Lottenberg et al., 1992). 
Bound plasminogen may also be protected against activation by plasminogen 
activators. This would in turn prevent dissolution of fibrin clots and shield off the 
organism against the immune system of the host, facilitating the establishment of the 
bacterial infection. Further experiments need to be carried out in order to elucidate 
the precise in vivo role of Pbp as a virulence factor of B. fragilis. 
The computer analyses pointed to a possible lipoprotein nature of Pbp. 
Remarkably, Pbp could be purified using a Heparin Sepharose column (see Materials 
and Methods). Immobilized heparin is often used to purify proteins such as DNA 
binding proteins, coagulation factors and lipoproteins. The affinity of Pbp for Heparin 
is another indication for a possible lipoprotein nature of Pbp. Further experiments 
have to be carried out to show that Pbp is in fact a genuine lipoprotein. In the 
annotated genome of B. fragilis YCH46 six open reading frames are predicted to 
encode (putative) lipoproteins. Pbp is not one of these. On the other hand, one 
predicted lipoprotein is homologous to the lipoprotein ApbE from Salmonella, but is 
most likely not a lipoprotein in B. fragilis because there is no cysteine residue present 
in the N-terminal region of the molecule. Lipoproteins have a so called lipobox 
sequence around the signal sequence cleavage site with an invariant cysteine at 
position +1 from the cleavage site (Sankaran and Wu, 1995). In the genome of B. 
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fragilis, an ORF has been identified that encodes a prelipoprotein diacylglycerol 
transferase enzyme (Lgt) that attaches the lipid molecule to the cysteine at position 
+1, and another ORF has been found to encode a putative lipoprotein signal 
peptidase (LspA or SPaseII). In E. coli, both proteins mentioned above are essential 
for the processing of prelipoproteins at the periplasmic side of the inner membrane 
(Wu, 1996). If the mature lipoprotein does not contain a Lol-avoidance signal (usually 
an aspartate at position +2 (Seydel et al., 1999)), the protein is targeted to the outer 
membrane by the Lol machinery. The Lol system is composed of five proteins 
(LolABCDE) which are all essential for the correct targeting of lipoproteins to the 
outer membrane and even essential for viability of E. coli (Narita et al., 2004). 
However, analysis of the B. fragilis genome only clearly identifies a predicted LolD 
protein. It is not known whether B. fragilis contains proteins that can carry out the 
function of LolA, -B, -C and -E. It has been reported that certain cell-surface localized 
lipoproteins of Gram-negative bacteria are targeted by other mechanisms than the 
Lol system (Pugsley, 1993). In Neisseria meningitidis, LPS is required for the 
biogenesis of cell-surface exposed lipoproteins, but not for outer membrane localized 
lipoproteins facing the periplasm (Steeghs et al., 2001). 
The identification of the putative lipoprotein Pbp as a potentially important 
virulence factor of B. fragilis has interesting clinical implications. Because the 
processing of bacterial lipoproteins absolutely requires a functional Signal Peptidase 
II, inhibition of the SPaseII function by administration of globomycin-type antibiotics in 
patients could interfere with the establishment or further spread of infections (Dev et 
al., 1985). This may be relevant not only to infections where B. fragilis is involved but 
also for other types of infection where lipoproteins play crucial roles in the viability or 
virulence of bacteria. 
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Introduction 
 
Intra-abdominal infections (IAI) caused by secondary peritonitis are a 
common cause of death in humans (Farthmann and Schöffel, 1998; Bosscha et al., 
1999). These infections are usually the result of leakage of the intestinal contents into 
the peritoneal cavity due to surgery or other abdominal traumas. A common 
complication of these infections is the formation of abscesses, making the treatment 
of secondary peritonitis very complicated (Anaya and Nathens, 2003). Often, two 
Gram-negative bacterial species are isolated from the site of infection: the aerobic 
Escherichia coli and the anaerobic Bacteroides fragilis ((Farthmann and Schöffel, 
1998) and references therein). The frequent co-occurrence of these two species has 
led to the concept of microbial synergy between E. coli and B. fragilis. The synergy 
between the two species has been demonstrated experimentally in mouse and rat 
infection models (e.g. Onderdonk et al., 1976; Brook et al., 1984). However, the 
molecular basis of this synergism is only partially understood. The known virulence 
factors of E. coli and B. fragilis that are involved either inhibit phagocytosis by 
polymorphonuclear neutrophyls (PMNs) or aid in the provision of essential growth 
factors to the bacteria. An example of the latter process is the acquisition of iron and 
heme from host proteins, because bacteria need much higher concentrations of iron 
to maintain growth than is freely available in the human body (Weinberg, 1974). A 
hemoglobin protease (Hbp) has been identified that contributes to the synergistic 
abscess formation and heme-dependent growth of B. fragilis in a murine infection 
model (Otto et al., 1998; Otto et al., 2002). It has been proposed that, after 
proteolysis of hemoglobin, heme-bound Hbp provides the heme as an iron or heme 
source to the bacteria at the site of infection. Another mechanism that has been 
implicated in the bacterial synergy between E. coli and B. fragilis is the secretion of 
proteases that cause tissue destruction in the host (Aldridge, 1995). Alternatively, 
bacteria might use host proteins to accomplish this task. Although this has not been 
demonstrated for E. coli or B. fragilis so far, other bacteria have been shown to be 
able to bind host plasminogen at their cell surface and to convert it to plasmin 
(Lähteenmäki et al., 2005). This property gives the bacterium the opportunity to 
interfere in the finely tuned system of coagulation and fibrinolysis of the host (Norris, 
2003). 
 
The experiments presented in this thesis investigate three proteins that are 
or may be involved in the pathogenic synergy between E. coli and B. fragilis in 
human intra-abdominal infections. These three proteins are Hbp of E. coli and P46 
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and Pbp of B. fragilis. Hbp is a hemoglobin protease with heme-binding activity. It is a 
secreted protein belonging to the autotransporter family of proteins. P46 is the α-
enolase of B. fragilis and was shown to reside intracellularly. Finally, Pbp was 
identified as a possible plasminogen-binding factor at the cell surface of B. fragilis. 
 
 
Hemoglobin protease (Hbp) 
 
Hemoglobin protease (Hbp) is a hemoglobin degrading and heme-binding 
protein secreted by human pathogenic E. coli. The protein is a member of the serine 
protease autotransporters of the Enterobacteriaceae (SPATE) group of 
autotransporter proteins. Autotransporters are large proteins carrying three functional 
domains: an N-terminal signal peptide for targeting to and translocation across the 
inner membrane, the passenger domain (the secreted effector molecule), and a C-
terminal translocation unit that is necessary for translocation across the outer 
membrane. In chapter 2, experiments are described that deal with the targeting to 
and translocation across the inner membrane of the Hbp preprotein. In chapter 3, the 
crystal structure of the complete passenger domain of Hbp is described as well as its 
heme binding properties. In chapter 4, the purification, folding properties and 
proposed β-barrel structure of the translocator domain of Hbp are presented. 
 
Inner membrane targeting and translocation 
In chapter 2, the earliest steps in the secretion of Hbp are studied, especially 
the targeting to and translocation across the inner membrane (Fig. 1). Evidence is 
presented showing that Hbp interacts with the signal recognition particle (SRP), that 
Hbp is dependent on SRP for inner membrane targeting and that the Sec-translocon 
is required for its translocation across the inner membrane. SecB is not required for 
targeting of Hbp to the inner membrane, but it can compensate to some extent for the 
lack of a functional SRP pathway. This is the first example of an extracellular 
bacterial protein that follows the co-translational SRP targeting route instead of the 
post-translational SecB pathway that is commonly used by secretory proteins. 
Indications were obtained that pre-pro-Hbp in the cytoplasm is rapidly degraded by 
cytoplasmic proteases. This might be the reason for a faster, co-translational 
targeting pathway, because premature folding and degradation in the cytoplasm can 
be avoided. Following this study two articles from the group of J. Beckwith appeared 
in the literature (Schierle et al., 2003; Huber et al., 2005). These articles describe the 
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Fig. 1. Inner membrane targeting and translocation of autotransporter proteins. Model of the 
SRP and SecB targeting pathways in E. coli, specified for the targeting of the autotransporters 
Hbp (left) and EspP (right). Nascent chains with a particularly hydrophobic signal sequence, 
like Hbp (see text), are recognized by SRP at the ribosome. The ribosome-nascent chain 
complex is bound by FtsY and targeted to the inner membrane, possibly to a proteinaceous 
membrane component (question mark). The nascent polypeptide is then transferred to the Sec-
translocon (SecYEGDF-YidC-YajC) in a GTP-dependent reaction. SecA energizes the 
(cotranslational) translocation of the preprotein through the translocon to the periplasmic space. 
During or after translocation, the signal peptide is cleaved off by Leader peptidase (Lep, not 
shown). Alternatively, less hydrophobic signal sequences, like that of another autotransporter 
EspP, are not bound by SRP. Instead, the cytosolic chaperone/targeting factor SecB binds to 
the mature region of the secretory protein. SecB posttranslationally targets the preprotein to the 
Sec-translocon, where both pathways converge. 
 
 
inner membrane targeting of the E. coli DsbA protein and of other proteins using the 
DsbA signal sequence via the SRP pathway. Their results also suggest that proteins 
found to be targeted by SRP-dependent signal peptides may require this mode of 
export to prevent rapid folding and nonproductive accumulation in the cytoplasm.  
To study the interaction of signal peptides and SRP in more detail, Huber et 
al. (2005) carried out an extensive screen of signal sequences with a range of 
hydrophobicities. From the numerous scales and window lengths tested, the Wertz-
Scheraga scale (Wertz and Scheraga, 1978) and a window length of 12 amino acids 
gave the most optimal performance and a threshold hydrophobicity required for SRP 
recognition was defined. The hydrophobicity of the Hbp signal sequence was 
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calculated using the same optimal scale and window length, and a WS score of 
0.715 was obtained, which was well above the defined threshold of 0.690. This score 
of hydrophobicity was found for the amino acids Cys35 to Phe46, roughly 
corresponding to the hydrophobic H domain of the signal peptides. Recently, 
Szabady et al. (2005) described that the signal peptide of the E. coli EspP 
autotransporter routes the pre-pro-protein into the posttranslational targeting pathway 
(unpublished data in Szabady et al., 2005). FHA, a member of the related two-
partner secretion (or type Vb) family of proteins, was shown to be dependent on 
SecB for its export through the Sec-translocon, but not on SRP (Chevalier et al., 
2004). By calculating the WS scores (also with window length 12) of the signal 
sequences of EspP and FHA, it was found that both signal sequences score below 
the defined 0.690 threshold that was necessary for SRP recognition (0.681 and 
0.659, respectively). 
Although signal sequence hydrophobicity is generally recognized as the 
main determinant for SRP recognition (Peterson et al., 2003; Huber et al., 2005), a 
role for basic residues in the N region of signal peptides has also been described 
(Peterson et al., 2003). It has been suggested that basic residues promote the 
binding of SRP to a subset of signal peptides whose hydrophobicity falls slightly 
below a critical level (Peterson et al., 2003). For the EspP signal peptide, whose 
hydrophobicity (WS score 0.681) falls just below the threshold of 0.690, this actually 
might play a role. Curiously, upon removal of the conserved N-terminal extension that 
is present in the EspP signal peptide, the truncated signal peptide acts as a 
cotranslational targeting signal (Peterson et al., 2003; Szabady et al., 2005). This 
truncated EspP signal peptide has a particularly high number of basic amino acids in 
the N region. It seems that the basic residues somehow have a larger effect when 
they are not preceded by the N-terminal extension. Upon removal of these charges, 
the mutated truncated signal peptide reroutes the protein into the posttranslational 
SecB pathway (Peterson et al., 2003). 
 
The function of the N-terminal extension that is found in a subset of proteins 
belonging to the autotransporter and two-partner secretion pathways is not known. In 
chapter 2, it has been proposed that the N-terminal extension of autotransporter 
signal peptides might actually be the signal for co-translational SRP-dependent 
targeting of these proteins. Based on the recent data described above, this might not 
be the case. Experiments with an N-terminally truncated version of the Hbp signal 
peptide are currently carried out. These experiments will ultimately prove whether or 
not there is rerouting into the SecB pathway upon deletion of the N-terminal 
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extension. However, recent findings of Szabady et al. (2005) indicate a role for the 
extended signal peptides that is completely unrelated to inner membrane targeting. 
The N-terminal extension of EspP was not required for efficient inner membrane 
targeting, but deletion of the extension led to misfolding of EspP in the periplasm and 
impaired later stages of autotransporter biogenesis. These data suggest that the 
translocation unit was not able to adopt its native conformation in the outer 
membrane upon removal of the N-terminal extension. It was suggested that the long 
signal peptide transiently anchors the passenger domain to the periplasmic side of 
the inner membrane and prevents it from folding into a conformation that would block 
translocation across the outer membrane. This tethering to the inner membrane is 
probably accomplished by slowing down the release of the preprotein from the Sec-
translocon. Future research will further elucidate the role of the N-terminal extension 
of the autotransporters and will show whether the results presented for the Hbp 
protein will also be applicable to other autotransporters. 
 
Structure of the passenger domain 
In chapter 3, the three-dimensional structure of the complete passenger 
domain of Hbp is presented. This is the first crystal structure of a full-length 
autotransporter passenger domain, and it is the largest parallel β-helical structure 
solved so far. The protein contains a very long right-handed β-helical structure 
forming three parallel β-sheets. Three distinct domains can be recognized in the 
structure of Hbp (Fig. 2). The N-terminal domain is a large globular domain 
containing the trypsin-like serine protease domain. Folding of this domain and 
functional protease activity can only occur after removal of the signal peptide (i.e. 
after IM translocation). The relatively open active site presumably can attack globular 
proteins (like hemoglobin) and suggests broad substrate specificity. Current research 
on the function of the Hbp protein focusses on the proteolytic properties and 
substrate specificity of the serine protease domain. Besides some decorative loops, 
the β-helical stem contains a small “domain 2” that has homology to a chitin binding 
domain and appears to form a binding pocket of some kind. It was shown that this 
domain is not responsible for the heme binding of Hbp, but it might alternatively be 
involved in the binding to a cell-surface receptor of B. fragilis and/or E. coli. The 
heme-binding site of Hbp has not been identified yet, but studies involving deletion 
mutants are carried out. The third domain, the conserved C-terminal region of the 
protein, may be involved in the translocation of the passenger molecule across the 
outer membrane and in the folding of the mature protein. 
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Fig. 2. A ribbon diagram of the overall structure of the passenger region of Hbp. The C-
terminus of the mature protein contains the autochaperone domain necessary for a proper 
folding of the passenger domain. Halfway the molecule a small side domain is present. 
Possibly its function is docking to extracellular matrix proteins or the bacterial receptor proteins. 
The proteolytic domain of Hbp is N-terminally located in the molecule. This globular domain is 
responsible for the serine protease activity of Hbp. 
 
 
Very little is known about the actual folding of the passenger domain of 
autotransporters. One idea is that autotransporter proteins adopt their final 
conformation during translocation across the outer membrane by virtue of their large 
β-helical content (Klauser et al., 1992). Recently, an autochaperone domain 
important for folding of the passenger was described in the B. pertussis BrkA 
autotransporter (Oliver et al., 2003b). This conserved C-terminal domain is present in 
a subset of autotransporters and was also identified in the C-terminal part of Hbp. 
Interestingly, this domain in Hbp has a remarkably high degree of structural 
homology to the corresponding domain in the crystal structure of P69 pertactin from 
B. pertussis (J. Tame, personal communication). 
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The translocation unit 
The purification and preliminary characterization of the translocation unit of 
Hbp is described in chapter 4. The goal of that study is to resolve the crystal structure 
of the Hbp translocator to obtain more insight in the mechanism of autotransporter 
passenger translocation across the outer membrane. In Hbp, cleavage of the 
passenger domain from the β-barrel structure, takes place between two asparagine 
residues located in the middle of the linker region that is part of the translocation unit. 
Indications were obtained that the predicted α-helical linker region is localized in the 
β-barrel pore. This would imply that, in vivo, the passenger domain can not be 
cleaved off from the translocation unit when the α-helix is formed. In that case, 
cleavage should take place either on the periplasmic side of the outer membrane, 
before translocation is completed, or on the cell surface with an extended linker 
region structure, i.e. before the formation of the linker α-helix. It should be pointed out 
that mature Hbp has always been found in the cell pellets under conditions of 
overexpression (see chapter 2). This observation could mean either of two things: 
processing of pro-Hbp takes place in the periplasm and, as a consequence, mature 
Hbp is present in the periplasm before or during OM translocation, and thus in the 
cell pellet after centrifugation. Alternatively, processing could take place at the cell 
surface and mature Hbp might remain partially attached to the outside of the cell. 
In chapter 4, a model is presented for the three-dimensional structure of the 
Hbp translocation unit. The model was based on the published crystal structure of the 
Neisseria meningitidis NalP translocation unit (Oomen et al., 2004). In this structure, 
the α-helical linker region, which forms part of the translocation unit of NalP, was 
found to reside within the β-barrel pore. The cleavage site between passenger 
domain and translocation unit is located on the cell surface, where autoproteolytic 
cleavage of NalP takes place (Turner et al., 2002). However, the cleavage site 
between passenger domain and translocation unit of Hbp is in the middle of the α-
helical linker region. The consequences for the processing of pro-Hbp when the α-
helix of Hbp is indeed localized in the β-barrel pore are discussed above. 
Currently, several models for autotransporter translocation have been 
proposed, involving either translocation of the passenger through the β-barrel pore, 
translocation through the central channel of a multimeric pore, or translocation 
involving other outer membrane (translocator) proteins (Fig. 3). 
The first and oldest model is the hairpin model, in which the passenger 
domain is pulled through the β-barrel pore structure with the C-terminal end first 
(Pohlner et al., 1987). In this model, the proposed autochaperone domain is  
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Fig. 3. Four models for outer membrane translocation of autotransporter proteins. Only one 
step in the translocation process is depicted for each model. In all models, the insertion of the 
β-barrel domain in the outer membrane occurs either spontaneously or with the help of 
accesory factors. A, hairpin model. The linker region of the translocation unit inserts into the β-
barrel as a transient hairpin structure. The passenger domain is then pulled through the pore 
from the C-terminal to the N-terminal end, probably energized by the folding of the passenger 
domain on the cell surface, which is mediated, by the autochaperone domain. Following the 
translocation of the passenger domain, the linker region adopts an α-helical conformation (not 
shown). B, threading model. Here the passenger domain is also translocated through the β-
barrel pore, but translocation occurs from the N-terminal to the C-terminal end of the molecule. 
The N-terminus of the passenger domain needs to be directed to the entrance of the pore 
(arrow). In A and B, the β-barrel is represented as an incomplete cylinder to visualize the 
targeting to and translocation through the pore. C, multimer model (drawn at smaller scale). 
The translocation of the passenger domain does not occur through the pore formed by the β-
barrel monomer, but through a central channel formed by the multimerization of several 
(probably six) β-barrels into a ring-shaped structure. The endpoint of translocation is 
represented here, with the α-helical linker regions as dark cylinders in the central channel and 
the passenger domain folded at the cell surface (only one passenger domain is shown for 
clarity). D, Omp85 model. An outer membrane protein complex (represented as circles and 
ovals) containing the Omp85/YaeT protein is involved in the translocation of the autotransporter 
passenger domain. The passenger has been proposed to be translocated through the β-barrel 
pore formed by the Omp85/YaeT protein. The passenger domain is shown folded at the cell 
surface, but the linker region has not (yet) adopted an α-helical conformation. 
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translocated first and could facilitate the folding of the rest of the passenger domain 
when it reaches the cell surface (Oliver et al., 2003b). This model dictates that the β-
barrel pore should be able to accommodate two stretches of possibly extended 
polypeptide simultaneously. Based on the size of the β-barrel pore of the NalP 
translocation unit, the two stretches would almost or just fit (Oomen et al., 2004; Otto 
et al., 2005). Alternatively, the N-terminal end of the passenger domain could go first 
through the β-barrel pore. This second model is called the threading model (Oomen 
et al., 2004). In this model, only one stretch of polypeptide has to be transported 
through the pore. The unknown and weak part of this model, is the targeting of the N 
terminus of the passenger domain to the entrance of the channel. A specific N-
terminal signal seems not necessary, because it has been shown that heterologous 
passenger domains could be secreted using the autotransporter system (Jose et al., 
1996; Maurer et al., 1997). Another drawback of this model is that the globular 
catalytic domain instead of the autochaperone domain would be translocated first in 
this model, and that should have implications the folding of the mature protein at the 
cell surface. 
It is obvious from the diameter of the β-barrel pore of NalP that translocation 
of (partially) folded proteins through the pore would be impossible. Nevertheless, 
several authors describe the potential translocation of disulfide bridge-containing 
proteins across the outer membrane using the autotransporter system with 
heterologous proteins (Veiga et al., 1999, 2004) or even natural substrates (Brandon 
and Goldberg, 2001). This, and the observation of ring-like structures of IgA protease 
translocation units under the electron microscope (Veiga et al., 2002), led to the idea 
of the so called multimer model. Veiga et al. (2002) proposed that the translocation of 
autotransporter passengers occurs through the central channel of a multimeric 
assembly of translocation units in the outer membrane. However, because the 
membrane interface of the translocation units is quite hydrophobic, the central cavity 
of a multimer would likely be filled with outer membrane lipids (Oomen et al., 2004). 
A large pore in the outer membrane would also be quite harmful for a bacterial cell. 
An extensive search for oligomeric structures of AIDA translocation units using a 
variety of techniques could not demonstrate higher-order structures other than a 
small percentage of dimers (Müller et al., 2005). The multimeric rings observed by 
Veiga et al. might possibly be formed by alternating upward and downward oriented 
molecules, as was also observed in the crystals of the NalP translocation unit 
(Oomen et al., 2004). Based on these later findings, it seems that oligomeric rings 
are most likely not functional moieties in vivo. Besides, the initial observations of the 
translocation of disulfide-bridge containing proteins across the outer membrane also 
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deserve more attention. For the Shigella flexneri autotransporter IcsA it was found 
that a DsbB-dependent disulfide-bridge could be formed, suggesting this had to take 
place in the periplasm (Brandon and Goldberg, 2001). However, the surface 
localization of IcsA was not dependent on the presence of DsbB. 
Finally, a fourth model for the outer membrane translocation of 
autotransporter proteins was proposed by Oomen et al. (Oomen et al., 2004). This 
model could be referred to as the Omp85 model. This model is based on the 
observation that autotransporter secretion depends on the presence of the conserved 
Omp85 protein in meningococci (Voulhoux et al., 2003). It has been proposed that 
the autotransporter passenger is translocated through the Omp85 outer membrane 
pore instead of through the translocation unit pore. This hypothesis needs further 
investigations. It is likely that the Omp85 protein is involved in the assembly of outer 
membrane proteins in the membrane (Voulhoux et al., 2003). This is supported by 
recent findings of an outer membrane protein complex in E. coli, containing a 
homologue of Omp85, YaeT (Wu et al., 2005). However, not all outer membrane 
proteins are mislocalized after depletion of Omp85 (Genevrois et al., 2003). 
In conclusion, all four models for outer membrane translocation of 
autotransporters have their drawbacks or unresolved questions. Besides, it should be 
taken into consideration that not all autotransporters have to use exactly the same 
translocation mechanism. For instance, the modular organization of the AIDA 
translocation unit is different from that of NalP in having a surface-exposed β1-
domain attached to the transmembrane pore (Konieczny et al., 2001; Mogensen et 
al., 2005). Also, the pore size of the PalA translocation unit appears to be circa 2 nm, 
significantly larger than that of NalP (Lee and Byun, 2003). It is clear that further 
research is necessary to elucidate the mechanism by which autotransporter 
passengers cross the outer membrane. In this respect it is noteworthy to point to the 
dimeric structures of refolded Hbp translocation units, as described in chapter 5. It 
would be highly interesting to know whether these dimers have a physiological 
function, also with respect to the observed dimers of the AIDA translocation units by 
Müller et al. (2005).  
 
 
α-Enolase (P46) 
 
In chapter 5, the identification, cloning and molecular characterization of the 
α-enolase P46 of B. fragilis is described. This 46-kDa protein was shown to be the 
functionalα-enolase of B. fragilis. Surprisingly, the protein was identified as an iron-
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regulated protein, upregulated under conditions of iron- or heme-starvation. This 
property is often observed for bacterial virulence factors, because bacteria have to be 
able to grow under the conditions of low iron concentrations in the human body 
(Finlay and Falkow, 1997; Wandersman and Delepelaire, 2004). The iron-regulation 
of P46 could point to a role for the protein in the virulence of B. fragilis in intra-
abdominal infections. Interestingly, several α-enolases of Gram-positive bacteria and 
eukaryotic cells were shown to function as plasminogen-binding molecules at the cell 
surface (Redlitz et al., 1995; Pancholi and Fischetti, 1998; Bergmann et al., 2001; 
Jolodar et al., 2003; Jong et al., 2003). However, subcellular localization experiments 
showed that P46 was not present at the cell surface, but it is mainly located in the 
cytoplasm and to a lesser extent in the inner membranes. Curiously, under iron-
restricted conditions, moreof P46 is located in or at the inner membranes. The nature 
of the interaction of P46 with the membrane has to be studied in more detail, for 
instance using the blue native-PAGE technique (Stenberg et al., 2005). It is possible 
that this interaction is related to the presence of α-enolase in the RNA degradosome 
complex at the inner membrane (Liou et al., 2001). These multi-enzyme complexes 
are involved in the processing and degradation of mRNAs (Carpousis et al., 1994). It 
is tempting to speculate that the subcellular redistribution of P46 is due to the 
presence of this protein in the degradosomes, especially under iron-limited 
conditions. It has been shown that α-enolase plays a crucial role in the processing of 
mRNA under conditions of cellular stress (Morita et al., 2004), which could very well 
be the case under iron-limited conditions. Alternatively, the upregulation of P46 under 
iron- and heme-limited conditions could have an energetic background. At low 
concentrations of heme, B. fragilis cells depend on glycolysis and on lactate and 
malate as energy sources for ATP generation (Macy et al., 1978; Chen and Wolin, 
1981). In an intra-abdominal abscess, lactate may become the predominant carbon 
source instead of glucose. An increased expression of glycolytic enzymes, like α-
enolase, might be a way to compensate for the lower energy yield from these 
alternative carbon sources. 
The absence of P46 at the cell surface of B. fragilis makes it unlikely that 
P46 functions as a plasminogen-binding protein. Plasminogen-binding activity could 
not be detected for P46. This is consistent with the lack of known plasminogen-
binding motifs in P46. This protein contains neither a C-terminal lysine, nor the 
consensus FYDKERKVY motif. These motifs were shown to be necessary for 
plasminogen-binding by Gram-positive α-enolases (Pancholi and Fischetti, 1998; 
Bergmann et al., 2001; Bergmann et al., 2003). However, the role for the C-terminal 
lysine in plasminogen-binding has become questionable by the recent publication of 
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the crystal structure of S. pneumoniae α-enolase (Ehinger et al., 2004). In this 
structure, the α-enolase is present as an octamer in which the C-terminal lysines are 
shielded from the environment. In contrast, the internal motif FYDKERKVY is 
exposed to the surface of the octamer. It should be noted that the role for the C-
terminal lysine in plasminogen-binding is commonly assayed by solid phase assays: 
the so called blot overlay assay (Miles et al., 1991; Pancholi and Fischetti, 1998; 
Bergmann et al., 2001). In this assay, the α-enolase is subjected to SDS-PAGE and 
Western blotting in the denatured form. Then, the blot is incubated with native 
plasminogen, and subsequently probed for bound plasminogen. One could envision 
binding of a freely available C-terminal lysine residue to the plasminogen Kringle 
domains, while this would not be possible with the α-enolase in its native 
conformation (Bergmann et al., 2003). Therefore, results from these solid phase 
assays should always be supported by (in vivo) experiments using properly folded 
protein. The C-terminal lysine residues of S. pyogenes surface enolase (SEN) were 
shown to contribute significantly to the plasminogen-binding activity and penetration 
of the extracellular matrix (ECM) of intact Group A streptococci (Derbise et al., 2004). 
However, recently, the internal plasminogen-binding motif in S. pneumoniae α-
enolase (Eno) was shown to be the key cofactor for plasmin-mediated degradation of 
extracellular matrix proteins and transmigration through ECM by pneumococci 
(Bergmann et al., 2005).  
 
 
Plasminogen-binding protein (Pbp) 
 
Instead of the α-enolase P46, another protein in B. fragilis was identified as 
a possible plasminogen-binding protein (Sijbrandi et al., 2005). This 60-kDa protein is 
referred to as Pbp for Plasminogen-binding protein (chapter 5, chapter 6). It was 
found that Pbp-like proteins are present in other Bacteroides subspecies. Subcellular 
localization experiments showed that Pbp and Pbp-like proteins are located in or at 
the outer membrane. B. fragilis Pbp was found to be accessible to extracellular 
protease, suggesting a cell-surface localization for this protein. The plasminogen-
binding properties of Pbp were studied in a solid phase assay. The lack of 
plasminogen-binding of a C-terminally His-tagged version of the protein in E. coli 
suggests that the C-terminal lysine residue is important for the plasminogen-binding 
activity. The blot overlay assay also demonstrated plasminogen-binding properties 
for Pbp-like proteins of other Bacteriodes subspecies. As discussed above, the 
results of these solid phase assays should be supported by experiments using 
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correctly folded protein. Additionally, the in vivo relevance of the plasminogen-binding 
activity of Pbp should be investigated. 
Finally, analysis of the primary structure of Pbp showed that the protein is 
probably a lipoprotein. Although this prediction still has to be confirmed 
experimentally, the possibility of a surface localized lipoprotein in B. fragilis raises an 
interesting question regarding the targeting of B. fragilis lipoproteins. In silico analysis 
of the B. fragilis genome showed that the organism probably possesses genes 
encoding a specific lipoprotein signal peptidase and a diacylglycerol transferase. 
Both proteins are essential for the processing of prelipoproteins at the inner 
membrane, at least in E. coli (Wu, 1996). However, no homologs of lolA, -B, -C and  
-E were found in the B. fragilis genome, while these genes and their products are 
essential for the targeting of lipoproteins to the outer membrane in E. coli (Narita et 
al., 2002; Narita et al., 2004). It would be very interesting to identify the targeting 
factors that direct Pbp to the outer membrane, when Pbp is indeed a genuine 
lipoprotein. 
 
 
Concluding remarks 
 
In this thesis, three proteins were analyzed that could play a role as 
virulence factors in the bacterial synergy between E. coli and B. fragilis in human 
intra-abdominal infections: Hbp, P46 and Pbp (Fig. 4).  
For Hbp, a role in the synergistic abscess formation in these infections has 
already been demonstrated using a murine infection model (Otto et al., 2002). Hbp 
has shown to contribute to the heme-dependent growth of B. fragilis. It is very likely 
that E. coli itself can also benefit directly from the secretion of this hemoglobin 
protease in a similar fashion. 
Based on the finding that Pbp might be a plasminogen-binding factor on the 
surface of B. fragilis cells, a role for this protein as a virulence factor can be 
envisioned. Binding of plasminogen and conversion to plasmin increases the 
proteolytic potential of the cell and creates to possibility to degrade the fibrin network 
that the host uses to trap the microorganisms, thereby preventing that bacteria 
emerge into the circulation. The contribution of both Hbp and Pbp to abscess 
formation in bacterial peritonitis will be further tested in a rat infection model 
(Bosscha et al., 2000).  
A potential role for P46 in the virulence of B. fragilis and in intra-abdominal 
infections is more difficult to envision. 
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Fig. 4. Model for the synergy of E. coli and B. fragilis in intra-abdominal infections, including the 
proteins described in this thesis. In E. coli, the Hbp protein is synthesized and secreted through 
the Sec-translocon (Sec) and the Hbp translocation unit (TU). After folding and secretion, Hbp 
degrades hemoglobin (Hb) and binds the released heme moiety. The hemoglobin may have 
been released from circulating red blood cells by the action of hemolysins secreted by B. 
fragilis (not shown). The holo-Hbp molecule is probably recognized and bound by a 
proteinaceous outer membrane (OM) component of B. fragilis and very likely also E. coli, after 
which heme uptake takes place (not shown). The α-enolase P46 is localized intracellularly in B. 
fragilis where it functions in glycolysis. Under iron (Fe)-limited conditions, P46 is upregulated 
and redistributed to the inner membrane (IM) where it may form part of the RNA degradosome 
complex. B. fragilis also produces the plasminogen binding protein Pbp. Pbp is probably 
translocated across the IM through the Sec-translocon, after which cleavage of the signal 
peptide of this putative lipoprotein takes place by Signal peptidase II (SPaseII, not shown). 
After lipidation, the molecule is transferred to the OM, where translocation takes place through 
an unknown mechanism. Once localized at the cell surface, Pbp is able to bind circulating host 
plasminogen (Plg). By the action of plasminogen activators (PA), Plg is converted to the 
protease plasmin (Pl). This gives the bacterium the ability to degrade fibrin and extracellular 
matrix proteins at the site of infection. 
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The three-dimensional structures of the Hbp translocation unit, P46 and Pbp 
would be a very useful tool in the study of these proteins. Currently, attempts are 
being made to elucidate the crystal structures of all these proteins. It is expected that 
the research described in this thesis, upcoming results and suggested future studies 
on Hbp, P46 and Pbp will help in the understanding of the molecular mechanism of 
the bacterial synergy between E. coli and B. fragilis in human intra-abdominal 
infections. This knowledge in turn may help in the prevention and/or treatment of 
these life-threatening infections in the future. 
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Moleculair inzicht in de pathogene synergie tussen E. coli en 
B. fragilis in secundaire peritonitis 
 
Intra-abdominale infecties (IAI) die door secundaire peritonitis worden 
veroorzaakt zijn een veel voorkomende doodsoorzaak in mensen. Deze infecties zijn 
gewoonlijk het resultaat van lekkage van de darminhoud in de buikholte, veroorzaakt 
door chirurgie of andere buiktrauma's. Een veel voorkomende complicatie van deze 
infecties is de vorming van abcessen, die de behandeling van secundaire peritonitis 
zeer ingewikkeld maken. Vaak worden twee Gram-negatieve bacteriesoorten 
geïsoleerd van de plaats van infectie: de aërobe Escherichia coli en anaërobe 
Bacteroides fragilis. Het frequente samen-voorkomen van deze twee soorten heeft 
geleid tot het concept van microbieel synergisme tussen E. coli en B. fragilis. Het 
synergisme tussen de twee soorten is experimenteel aangetoond in muis- en 
ratteninfectiemodellen. Op dit moment wordt de moleculaire basis van dit synergisme 
slechts gedeeltelijk begrepen. Bekende virulentiefactoren van E. coli en B. fragilis die 
hierbij betrokken zijn, remmen fagocytose door polymorfonucleaire neutrofielen 
(PMNs) of helpen in de levering van essentiële groeifactoren aan de bacteriën. Een 
voorbeeld van het laatstgenoemde proces is de voorziening van ijzer en heem 
afkomstig van gastheereiwitten, omdat de bacteriën veel hogere concentraties ijzer 
nodig hebben om de groei te handhaven dan vrij beschikbaar is in het menselijk 
lichaam. Een hemoglobine protease (Hbp) is geïdentificeerd dat bijdraagt tot de 
synergistische abcesvorming en de heem-afhankelijke groei van B. fragilis in een 
ratteninfectiemodel. Het wordt gedacht dat, na afbraak van hemoglobine, Hbp het 
gebonden heem als ijzer- of heembron aan de bacteriën op de plaats van infectie 
verstrekt. Een ander mechanisme dat betrokken is bij het bacteriële synergisme 
tussen E. coli en B. fragilis is de uitscheiding van proteasen die weefselafbraak in de 
gastheer veroorzaken. Ook zouden de bacteriën gastheereiwitten kunnen gebruiken 
om deze taak uit te voeren. Hoewel dit tot dusver niet voor E. coli of B. fragilis is 
aangetoond, is bij andere bacteriën gevonden dat ze plasminogeen van de gastheer 
op hun celoppervlak kunnen binden, waarna het wordt omgezet in plasmine. Deze 
eigenschap biedt de bacterie de mogelijkheid om zich te mengen in het fijn 
afgestemde systeem van coagulatie en fibrinolyse van de gastheer. 
 
De experimenten die in dit proefschrift worden beschreven behandelen drie 
eiwitten die (mogelijk) betrokken zijn bij het pathogene synergisme tussen E. coli en 
B. fragilis bij menselijke intra-abdominale infecties. Deze drie eiwitten zijn Hbp van E. 
coli en P46 en Pbp van B. fragilis. Hbp is een hemoglobine protease met heem-
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bindende activiteit. Het is een uitgescheiden (gesecreteerd) eiwit dat tot de 
autotransporter familie van eiwitten behoort. P46 is het α-enolase van B. fragilis en 
dit eiwit bevindt zich intracellulair. Tot slot werd Pbp geïdentificeerd als mogelijk 
plasminogeen-bindend eitwit aan het celoppervlak van B. fragilis. 
 
Hemoglobine protease (Hbp) 
Het hemoglobine protease (Hbp) is een hemoglobine afbrekend en heem-
bindend eiwit dat door ziekteverwekkende E. coli bacteriën wordt gesecreteerd. Het 
eiwit maakt deel uit van de groep van serine protease autotransporters van de 
Enterobacteriaceae (SPATE). Autotransporters zijn grote eiwitten die drie functionele 
domeinen bevatten: een N-terminaal signaalpeptide voor het sturen (targeting) naar 
en de translocatie over het binnenmembraan, het passagiersdomein (het 
uitgescheiden effector-molecuul), en een C-terminaal translocatiedomein dat voor 
translocatie over het buitenmembraan noodzakelijk is. 
In hoofdstuk 2 worden de vroegste stappen in de secretie van Hbp 
bestudeerd, met name het sturen naar en de translocatie over het binnenmembraan. 
Het wordt aangetoond dat Hbp interactie heeft met het Signal Recognition Particle 
(SRP, vertaald: Signaal Herkennings Deeltje), dat Hbp om naar het binnenmembraan 
gestuurd te worden afhankelijk is van SRP en dat het Sec-translocon nodig is voor 
de translocatie over het binnenmembraan. SecB is niet noodzakelijk om Hbp naar 
het binnenmembraan te sturen, maar het kan tot op zekere hoogte het gebrek aan 
een functionele SRP-route compenseren. Dit is het eerste voorbeeld van een 
extracellulair bacterieel eiwit dat de zogenaamde co-translationele SRP-route in 
plaats van de post-translationele SecB-route volgt, die normaalgesproken door 
gesecreteerde eiwitten wordt gebruikt. Aanwijzingen werden verkregen dat pre-pro-
Hbp in het cytoplasma snel door cytoplasmatische proteasen wordt afgebroken. Dit 
zou de reden kunnen zijn voor het gebruik van de snellere, co-translationele SRP-
route, aangezien hierdoor voortijdige vouwing en afbraak in het cytoplasma kunnen 
worden vermeden. 
In hoofdstuk 3 wordt de driedimensionale structuur van het volledige 
passagiersdomein van Hbp gepresenteerd. Dit is de eerste volledige kristalstructuur 
van een passagiersdomein van een autotransporter eiwit en het toont de grootste 
parallelle β-spiraalvorm (β-helix) tot dusver opgelost. Het eiwit bevat een zeer lange 
rechtshandige β-helix structuur die drie parallelle β-bladen (β-sheets) vormt. Drie 
verschillende domeinen kunnen in de structuur van Hbp worden herkend. Het N-
terminale domein is een groot bolvormig domein dat het trypsine-achtige serine 
proteasedomein bevat. Vouwing van dit domein en proteaseactiviteit kan slechts 
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optreden na verwijdering van het signaalpeptide (d.w.z. na binnenmembraan-
translocatie). De vrij open actieve plaats (active site) kan vermoedelijk bolvormige 
eiwitten (zoals hemoglobine) aanvallen en suggereert brede substraatspecificiteit. 
Naast sommige “decoratieve” uitstekende delen, bevat de β-helix stam een klein 
"domein 2" dat homologie met een chitine-bindend domein heeft en een soort 
bindingsplaats lijkt te vormen. Het werd aangetoond dat dit domein niet voor de 
heem-binding van Hbp verantwoordelijk is, maar het zou betrokken kunnen zijn bij 
het binden aan een receptor op het celoppervlak van B. fragilis en/of E. coli. Het 
derde domein, het geconserveerde C-terminale domein van het eiwit, is vermoedelijk 
betrokken bij de translocatie van het passagiersdomein over het buitenmembraan en 
het vouwen van het volwassen eiwit. 
De zuivering en de voorlopige karakterisering van het translocatiedomein 
van Hbp worden beschreven in hoofdstuk 4. Het doel van die studie is de 
kristalstructuur van het translocatiedomein van Hbp op te lossen om meer inzicht te 
verkrijgen in het mechanisme van de translocatie van het passagiersdomein van 
autotransporters over het buitenmembraan. Bij Hbp vindt de splitsing tussen het 
passagiersdomein en het translocatiedomein plaats tussen twee asparagineresiduen 
die zich bevinden in het midden van het linkerdomein dat deel uitmaakt van de 
translocatie-eenheid. Aanwijzingen werden verkregen dat het voorspelde 
spiraalvormige (α-helix vormige) linkergebied in de porie van het translocatiedomein 
gelokaliseerd is. Dit impliceert dat in de bacterie het passagiersdomein niet van de 
translocatie-eenheid kan worden afgesplitst wanneer de α-helix reeds is gevormd. In 
dat geval zou het splitsen of aan de periplasmatische kant van het buitenmembraan 
moeten plaatsvinden, dus vóór de translocatie, of op het celoppervlak met een 
uitgestrekt linkerdomein, d.w.z. voordat de vorming van de α-helix van het 
linkerdomein wordt voltooid. In hoofdstuk 4 wordt een model voorgesteld voor de 
driedimensionale structuur van het Hbp translocatiedomein. 
 
α-Enolase (P46) 
In hoofdstuk 5 worden de identificatie, het kloneren en de moleculaire 
karakterisering van het α-enolase P46 van B. fragilis beschreven. Van dit eiwit werd 
aangetoond dat het het functionele enolase van B. fragilis is. Verrassend genoeg 
werd gevonden dat het eiwit een ijzer-gereguleerd eiwit is dat onder ijzer- of heem-
beperkte omstandigheden wordt opgereguleerd. Deze eigenschap wordt vaak 
waargenomen bij bacteriële virulentiefactoren, omdat de bacteriën onder de 
omstandigheden van lage ijzerconcentraties in het menselijk lichaam moeten kunnen 
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groeien. De ijzer-reguleerbaarheid van P46 kan een rol spelen in de virulentie van B. 
fragilis in intra-abdominale infecties. 
De afwezigheid van P46 aan het celoppervlak van B. fragilis maakt het 
onwaarschijnlijk dat P46 als plasminogeen-bindend eiwit functioneert. Een 
plasminogeen-bindende activiteit kon niet voor P46 worden ontdekt. 
 
Plasminogeen bindend eiwit (Pbp) 
In plaats van het P46 eiwit werd een ander eiwit in B. fragilis geïdentificeerd 
als mogelijk plasminogeen bindend eiwit. Dit eiwit wordt Pbp genoemd, voor 
Plasminogeen bindend proteïne (hoofdstuk 6). Het werd aangetoond dat eiwitten die 
sterk lijken op Pbp in andere Bacteroides ondersoorten aanwezig zijn. Subcellulaire 
localisatie-experimenten toonden aan dat Pbp zich in of aan het buitenmembraan 
bevindt. B. fragilis Pbp bleek toegankelijk voor extracellulair protease te zijn, wat een 
localisatie aan het celoppervlak voor dit eiwit suggereert. De plasminogeen-bindende 
eigenschappen van Pbp werden bestudeerd en het eindstandige aminozuur lysine 
lijkt bij de plasminogeen-binding betrokken te zijn. Tot slot toonde de analyse van de 
primaire structuur van Pbp aan dat het eiwit waarschijnlijk een lipoproteïne is, hoewel 
deze voorspelling nog experimenteel moet worden bevestigd. Wanneer Pbp 
inderdaad een echt lipoproteïne is, zou het zeer interessant zijn om de factoren te 
identificeren die Pbp naar het buitenmembraan sturen. 
 
In dit proefschrift werden drie eiwitten geanalyseerd die een rol als 
virulentiefactoren in het bacteriële synergisme tussen E. coli en B. fragilis kunnen 
spelen in menselijke intra-abdominale infecties: Hbp, P46 en Pbp. Voor Hbp is een 
rol in de synergistische abcesvorming in deze infecties reeds aangetoond met behulp 
van een ratteninfectiemodel. Van Hbp is reeds aangetoond dat het tot de heem-
afhankelijke  groei van B. fragilis bijdraagt. Het is zeer waarschijnlijk dat E. coli zelf 
ook direct van de uitscheiding van dit eiwit kan profiteren op een soortgelijke manier. 
Omdat Pbp een plasminogeen-bindend eiwit op het oppervlak van B. fragilis cellen 
zou kunnen zijn, is een rol voor dit eiwit als virulentiefactor zeer wel denkbaar. De 
mogelijkheid om plasminogeen te binden en om te zetten in plasmine verhoogt het 
proteolytische potentieel van de cel en geeft de mogelijkheid om het fibrine netwerk 
te degraderen dat de gastheer gebruikt om de micro-organismen in te sluiten, 
daardoor verhinderend dat de bacteriën in de circulatie terechtkomen. De bijdrage 
van zowel Hbp als Pbp tot abcesvorming in bacteriële peritonitis zal verder getest 
worden in een ratteninfectiemodel. Een potentiële rol voor P46 in de virulentie van B. 
fragilis en in intra-abdominale infecties is moeilijker voor te stellen.  
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De driedimensionale structuren van het Hbp translocatiedomein, P46 en 
Pbp zouden een zeer nuttig hulpmiddel in de studie van deze eiwitten zijn. 
Momenteel worden pogingen gedaan om de kristalstructuren van al deze eiwitten op 
te lossen. Het valt te verwachten dat het onderzoek dat in dit proefschrift wordt 
beschreven, nog te verwachten resultaten en voorgestelde toekomstige studies naar 
Hbp, P46 en Pbp zullen bijdragen aan het begrip van het moleculaire mechanisme 
van het bacteriële synergisme tussen E. coli en B. fragilis in menselijke intra-
abdominale infecties. Deze kennis kan op haar beurt helpen bij de preventie en/of de 
behandeling van deze levensgevaarlijke infecties in de toekomst.  
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Tenslotte wil ik graag een aantal mensen bedanken die zo belangrijk zijn 
geweest voor de totstandkoming van dit proefschrift. 
 
Ben (Mac-Ben), als primaire begeleider en copromotor kom jij voor mij 
bovenaan in dit lijstje. Ik heb in de afgelopen jaren veel aan je ideeën, kennis en hulp 
gehad. Met ons wat meer medisch gerichte onderzoek voelden we ons binnen 
MolMic misschien wel eens wat minder begrepen, maar dit proefschrift toont volgens 
mij aan dat het allemaal wel ergens toe geleid heeft. Veel succes met de grote 
hoeveelheid plannen die je nog hebt met Hbp en al die nog te karakteriseren fragilis 
eiwitten. En blijf tegenstand bieden aan Bill Gates! 
 
Bauke (voor mij blijft het Bob), bedankt voor je inzet als promotor, niet in de 
laatste plaats de aandacht voor de voortgang in het afgelopen jaar toen ik al niet 
meer op de VU rondliep. Ondanks alle bestuurlijke bezigheden kwam je altijd weer 
met enthousiaste en goede input tijdens de werkbesprekingen op maandagmorgen 
en had je goed in de gaten hoe de proeven vorderden. 
 
Joen (waar staat die S. toch voor?), met jou als tweede copromotor had ik 
iets minder direct te maken, zeker nadat het SRP-verhaal af was. Maar je positief-
kritische blik op mijn resultaten gaven altijd weer stof tot nadenken en verder 
onderzoek, en hebben daarmee een belangrijke bijdrage geleverd aan het 
uiteindelijke resultaat. 
 
Nellie (soms ook Snellie genoemd), jij maakt de staf letterlijk en figuurlijk 
compleet. Bedankt voor je interesse in mijn onderzoek. Je had vaak net een andere 
invalshoek om naar de data te kijken, waardoor er regelmatig weer nieuwe ideeën 
ontstonden om mee verder te gaan. 
 
Ronald (Roon), nooit meer zal ik jarig zijn en nooit meer kan ik Herman van 
Veen horen zonder aan jou te moeten denken. Het op en neer reizen tussen Utrecht 
en Amsterdam was met jou altijd weer een goed begin of einde van de dag, vooral 
als er weer iets raars werd omgeroepen (Heren, …). Maak er wat moois van in 
Genève en natuurlijk ook daarna. 
 
Wouter (Wout), jij bent de volgende! Succes met de laatste loodjes en 
bedankt voor alle goede gesprekken over autotransporters en aanverwante zaken. 
Jouw parate kennis van de literatuur is me regelmatig goed van pas gekomen. En ik 
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wens je toe dat je nooit van je leven meer een PowerPoint hoeft te maken voor een 
promotiestukje, want dat heeft je inmiddels al genoeg jaren van je leven gekost. 
 
Edwin (de hooligan), je was een fijne kamer- en labgenoot. Al ben ik geloof 
ik wel blij dat je je favoriete muziek alleen luisterde met oordopjes in. Ach, smaken 
verschillen. Maar dat zei ze vast gisteravond ook… Als je nou niet te vaak en te lang 
werkt, zien we elkaar vast nog wel eens in Utrecht. 
 
Edith (de kleine), ik vraag me af hoe vaak MolMic na jouw vertrek nog in de 
Stelling is geweest. Met jou was het in elk geval altijd lachen op het lab, en vooral in 
de legendarische combinatie met Ronald in het RNC. Veel succes nog in Basel en 
natuurlijk bedankt dat je in de leescommissie wilde zitten. 
 
Malene (de rooie), al wat langer weg bij MolMic, maar in dit lijstje mag je 
zeker niet ontbreken. Ook jij bedankt voor je bijdrage aan de goede tijd die ik als AIO 
heb gehad. Het beste met je werk en je gezin. 
 
Erica, we hebben elkaar helaas niet lang genoeg meegemaakt voor een 
bijnaam. Toch ben je wel degelijk belangrijk geweest voor dit proefschrift en ik wil je 
dan ook bedanken voor wat je allemaal na mijn vertrek nog hebt gedaan aan het Pbp 
eiwit. 
 
Gregory en Corinne (Greg en Co), eens te meer mag weer gezegd worden 
hoe onmisbaar jullie zijn voor het lab. Ik geloof echt dat zonder jullie het lab allang 
eens ontruimd had moeten worden van de inspectie. Als ik nog eens een 
restaurantje in Amsterdam zoek, weet ik jullie te vinden voor advies. Maar graag iets 
minder pittig dan jullie het zelf graag hebben. 
 
Gert Jan en Dirk-Jan (GJ en DJ), fijn om jullie als postdocs op het lab gehad 
te hebben. En leuk dat we elkaar bij sociale gebeurtenissen nog altijd tegenkomen. 
Ook de collega’s van al wat langer geleden: Rob, Maho en Aafke, bedankt voor jullie 
aanwezigheid en gezelligheid. 
 
Inge en Jessica, “mijn” studenten, bedankt voor jullie goede en enthousiaste 
bijdrage aan mijn project. Zoals jullie aan dit proefschrift al kunnen zien, moet die 
receptor voor Hbp nog altijd gevonden worden. Maar nu mag iemand anders dat 
doen. Ook de andere studenten “van Ben” bedankt voor jullie inzet in ons clubje. 
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Papa en mama, heel erg bedankt voor alle mogelijkheden die ik heb 
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